[go: up one dir, main page]

AU781939B2 - 6-position substituted indoline, production and use thereof as a medicament - Google Patents

6-position substituted indoline, production and use thereof as a medicament Download PDF

Info

Publication number
AU781939B2
AU781939B2 AU10233/01A AU1023301A AU781939B2 AU 781939 B2 AU781939 B2 AU 781939B2 AU 10233/01 A AU10233/01 A AU 10233/01A AU 1023301 A AU1023301 A AU 1023301A AU 781939 B2 AU781939 B2 AU 781939B2
Authority
AU
Australia
Prior art keywords
group
alkyl
amino
phenyl
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
AU10233/01A
Other versions
AU1023301A (en
Inventor
Armin Heckel
Frank Hilberg
Norbert Redemann
Gerald Jurgen Roth
Walter Spevak
Ulrike Tontsch-Grunt
Jacobus Van Meel
Rainer Walter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26006858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU781939(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19949208A external-priority patent/DE19949208A1/en
Priority claimed from DE2000142696 external-priority patent/DE10042696A1/en
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Publication of AU1023301A publication Critical patent/AU1023301A/en
Assigned to BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG reassignment BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Amend patent request/document other than specification (104) Assignors: BOEHRINGER INGELHEIM PHARMA KG
Application granted granted Critical
Publication of AU781939B2 publication Critical patent/AU781939B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

71488pct.203 Boehringer Ingelheim Pharma KG Case 5/1275-Ro D-55216 INGELHEIM Foreign filing text Indolinones substituted in the 6-position, the preparation thereof and their use as pharmaceutical compositions The present invention relates to new indolinones of general formula
R
3 R 4
-N
N N R
R
2 i
R
substituted in the 6 position, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof which have valuable properties.
The above compounds of general formula I wherein R 1 denotes a hydrogen atom or a prodrug group have valuable pharmacological properties, in particular an inhibiting effect on various kinases, especially receptor tyrosine kinases such as VEGFR2, PDGFRc, PDGFRP, FGFR1, FGFR3, EGFR, HER2, IGF1R and HGFR, as well as complexes of CDK's (Cyclin Dependent Kinases) such as CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9 with their specific cyclins Bl, B2, C, D1, D2, D3, E, F, Gl, G2, H, I and K) and to viral cyclin (cf. L. Mengtao in J.
Virology 71(3), 1984-1991 (1997)), and on the proliferation of cultivated human cells, in particular endothelial cells, e.g.
in angiogenesis, but also on the proliferation of other cells, in particular tumour cells.
2 The other compounds of the above general formula I wherein R, does not denote a hydrogen atom or a prodrug group are valuable intermediate products for preparing the abovementioned compounds.
The present invention thus relates to the above compounds of general formula I, whereby those compounds wherein R 1 denotes a hydrogen atom or a prodrug group have valuable pharmacological properties, pharmaceutical compositions containing the pharmacologically active compounds, the use thereof and processes for preparing them.
In the above general formula I X denotes an oxygen or sulphur atom,
R
I denotes a hydrogen atom or a prodrug group such as a
C.
4 -alkoxycarbonyl or C, 4 -alkanoyl group,
R
2 denotes a carboxy group, a straight-chain or branched
C
1 6 -alkoxy-carbonyl group, a C 4 ,_-cycloalkoxy-carbonyl or an aryloxycarbonyl group, a straight-chain or branched C 1 6 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C,~-alkoxy-carbonyl, aminocarbonyl,
C
1 3 -alkylamino-carbonyl or di-(C,- 3 -alkyl)-aminocarbonyl group, a straight-chain or branched C2-6-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, CI.3-alkoxy, amino, C1-3-alkylamino or di-(CI.3-alkyl)-amino group, -3an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C,-3-alkoxy group or; if does not denoto an aminosulphony 1-phenyl or N- (Cl- 5 -alkyl) -C,,-alkylaminocarbonyl-phenyl group, it may also denote a di-(Cl- 2 -alkyl) -aminocarbonyl group,
R
3 denotes a hydrogen atom, a C 16 -alkyl, C 3 cycloalkyl, trifluoromethyl or heteroaryl group, a phenyl or naphthyl group, a phenyl or naphthyl group monoor disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, Cl-,-alkyl or C 1 3 -alkoxy group, whilst in the event of disubstitution the substituents may be identical or different and wherein the abovementioned unsubstituted as well as the mono- and disubstituted phenyl and naphthyl groups may additionally be substituted by a hydroxy, hydroxy-C 1 3 -alkyl or C,--alkoxy-Cl 1 3 -alkyl group, by a cyano, carboxy, carboxy-C 1 3 -alkyl,
C,-
3 -alkoxycarbonyl, aminocarbonyl, C 1 alkylamino-carbonyl or di- (Cl- 3 -alkyl) -aminocarbonyl group, by a nitro group, by an amino, CI- 3 -alkylamino, di-(C 1 3 ,-alkyl) -amino or amino-C- 3 -alkyl group, by a C.
3 -alkylcarbonylamino, N-(C 1 3 -alkyl) -Cl- 3 -alkylcarbonylamino, Cl 1 3 -alkylcarbonylamino-C alkyl, N- (C, 3 -alkyl) -C 1 3 -alkylcarbonylamino-Cl 1 3 -alkyl, Cl- 3 -alkylsuiphonylamino, Cl 1 3 -alkylsulphonylamino-Cl.
3 -alkyl, N- (Cl 3 -alkyl) -Cl- 3 -alkylsulphonylamino-Cl, -alkyl or aryl-C- 3 -alkylsulphonylamino group, 4 by a cycloalkylamino, cycloalkyleneimino, cycloalkyleneiminocarbonyl, cycloalkyleneimino-C, 3 -alkyl, cycloalkyleneiminocarbonyl-C, 3 -aky or cycloalkyleneiminosulphonyl-C 3 -alkyl group having 4 to 7 ring members in each case, whilst in each case the methylene group in position 4 of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, b' a sulphinyl, sulphonyl, -NH or -N(Cl- 3 -alkyl) group, or by a heteroaryl or heteroaryl-C,3-alkyl group,
R
4 denotes a C 3 ,-cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7membered cycloalkyl group may be substituted by an amino, Cl- 3 -alkylamino or di-(C, 3 -alkyl)-amino group or replaced by an -NH or -N(C 1 3 -alkyl) group, or a phenyl group substituted by the group which may additionally be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C 1 5 -alkyl, trifluoromethyl, hydroxy, CI-3-alkoxy, carboxy, C 1 -3-alkoxycarbonyl, amino, acetylamino, C, 3 -alkyl-sulphonylamino, aminocarbonyl, Cl_ 3 -alkyl-aminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, aminosulphonyl, C,- 3 -alkyl-aminosulphonyl, di-(C 1 3 -alkyl)-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein R, denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, Cl_ 5 -alkyl, C 3 _,-cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, the group of formula 0
XNH
H 0 wherein the hydrogen atoms bound to a nitrogen atom may in each case be replaced independently of one another by a Cl- 3 -al kyl group,, a C- 3 -alkoxy group, a C,-,-alkoxy-C 1 3 -alkoxy, phenyl-C 1 3 -alkoxy, amino -C 2 3 -alkoxy, CI-3-a lkylamino-C 2 3 -alkoxy, di- (Cl- 3 -alkyl) -amino -C 2 -1-alkoxy, phenyl-Cl- 3 -alkylamino-
C
2 3 -alkoxy, N- (CI- 3 -alkyl) -phenyl-C,-,-alkylamino-C 2 3 -alkoxy, C,-,-cycloalkyleneimino-C 2 3 -alkoxy or kylmercapto group, a carboxy, C, 4 -alkoxycarbonyl, aminocarbonyl, Cl 1 3 -alkylamino-carbonyl, N- (C 1 5 -alkyl) -C- 3 -alkylaminocarbonyl, phenyl-Cl- 3 -alkylamino-carbonyl, N- (Cl 3 -alkyl) -phenyl-CI- 3 -alkylamino-carbonyl, piperazinocarbonyl or N- (Cl 1 3 -alkyl) -pipe ra zinocarbonyl group, a C- 3 -alkylaminocarbonyl or N- (C 1 5 ,-alkyl) Cl- 3 -alkylaminocarbonyl group wherein an alkyl moiety is substituted by a carboxy or cl-,-alkoxycarbonyl group or in the 2 or 3 position by a di- (C 1 3 -alkyl) -amino, piperazino, N-(Cl- 3 -alkyl)-piperazino or a 4- to 7-membered cycloalkyleneimino group, a C 3 7 -cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be substituted by an amino, Cl- 3 -alkylamino or di- (Cl 1 3 -alkyl) -amino group or replaced by an -NH or -N(C 1 3 -alkyl) group, 6 a 4- to 7-membered cycloalkyleneimino group wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or the cycloalkylene moiety may be fused to a phenyl ring or one or two hydrogen atoms may each be replaced by a alkyl group and/or in each case the methylene group in the 4 position of a 6or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C 1 l 3 -alkoxycarbonyl, aminocarbonyl,
C
1 _3-alkylaminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, phenyl-C 1 3 -alkylamino or N-(C 1 _3-alkyl)phenyl-C_ 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl), -N(phenyl), -N(C_.3-alkyl-carbonyl) or -N(benzoyl) group, a C 1 .4-alkyl group substituted by the group wherein
R
7 denotes a C 3 _,-cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be substituted by an amino, C 1 3 -alkylamino or di- (C_3-alkyl)-amino group or replaced by an -NH or -N(C.3-alkyl) group or in a 5- to 7-membered cycloalkyl group a -(CH 2 group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by a -NH-CO-NH or -CO-NH-CO group or a
-(CH
2 4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl group, -7 an aryl or heteroaryl group, 11 IhYd'roxy or C, -aikuxy group, an amino, C 1 7 -alkylamino, di- (C 17 -alkyl) -amino, phenylamino, N-phenyl -C,-,-alkyl -amino, phenyl-C,-,-alkylamino, N- (C 13 -alkyl) -phenyl-C 1 3 -alkylamino or di- (phenyl-C,- 3 -alky1) -amino group, an co-hydroxy-C,-,-alkyl -amino, N- (C,-,-alkyl) -co-hydroxy-
C
2 3 -alkyl-amino, di- (o-hydroxy-C 23 alkyl) -amino, di- (co- (Cl- 3 -alkoxy) -C 2 3 -alkyl) -amino or N-(dioxolan- 2-yl)-CI- -alkyl-amino group, a C 1-3 -alkylcarbonylamino-C,-,-alkyl -amino or
C-
3 -alkylcarbonylamino-C 2 3 -alkyl-N- (Cl 13 -alkyl) -amino group, a Cl- 3 -alkylsulphonylamino, N- (Cl 13 -alkyl) -C 1 3 -alkylsuiphonylamino, Cl- 3 -akylsulphonylamino-C 2 3 -alky1-amino or
C-
3 -alkylsulphonylamino-C 2 3 -alky1-N- (C 13 -alkyl) -amino group, a hydroxycarbonyl-Cl- 3 -alkylamino or N- (C 13 -alkyl) hydroxycarbonyl-C 1 3 -alkyl -amino group, a guanidino group wherein one or two hydrogen atoms may each be replaced by a C 1 3 -alkyl group, a group of formula
N(R
8
)VCO-(CH
2 )n-R 9
(II),
wherein 8 R, denotes a hydrogen atom or a C, 1 3-alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and
R
9 denotes an amino, C 1 4 -alkylamino, di-(C 1 4 -alkyl)-amino, phenylamino,
N-(C
1 _4-alkyl)-phenylamino, benzylamino,
N-(C
1 4 -alkyl)-benzylamino or C 1 4 -alkoxy group, a 4- to 7-membered cycloalkyleneimino group, whilst in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 3 -alkyl), -N(phenyl), -N(C 1 3-alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula
-N(R
1 0 )-(CH2)m-(CO)o-R 1
(III),
wherein Ri 0 denotes a hydrogen atom, a C 1--alkyl group, a
C_
3 -alkylcarbonyl, arylcarbonyl, phenyl-C 1 3 -alkylcarbonyl, C 1 3 -alkylsulphonyl, arylsulphonyl or phenyl-C. 3-alkylsulphonyl group, m denotes one of the numbers 1, 2, 3 or 4, o denotes the number 1 or, if m denotes one of the numbers 2, 3 or 4, o may also denote the number 0 and
R
11 denotes an amino, C 1 4 -alkylamino, di-(Cl_ 4 -alkyl)-amino, phenylamino, 4 -alkyl)-phenylamino, benzylamino, N- (C,_-alkyl) -benzylamino, C 1 _4-alkoxy or 9
C
1 3 -alkoxy-C, 3 -alkoxy group, a di-(C 1 _-alkyl)-amino-Ci_3alkylamino group optionally substituted in the 1 position by a C 1 _-alkyl group or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH,
-N(C
1 3 -alkyl)', -N(phenyl), -N(C 1 3 -alkyl-carbonyl) or -N(benzoyl) group, a C4_,-cycloalkylamino, C4_,-cycloalkyl-C_-3-alkylamino or
C
4 7 ,-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a Cs.,-cycloalkyl,
C
2 -4-alkenyl or C 1 4 -alkyl group, a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C 1 3 -alkyl, CI- 3 -alkoxy or amino group, and/or one or two hydrogen atoms may each be replaced by a
C
1 3 -alkyl, Cs,.-cycloalkyl or phenyl group and/or the methylene group in the 3 position of a cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-Ci_ 3 -alkyl, C,_3-alkoxy or
C,_
3 -alkoxy-C, 1 3 -alkyl group, the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may in each case be 0 -10 substituted by a hydroxy, hydroxy-C,-,-alkyl, C1- 3 -alkoxy, Cl-,-alkoxy- C 1 3 -alkyl, carboxy, Cl- 4 -alkoxycarbonyl, aminocarbonyl, cl'3-a1lkmlai..ca--ny, di- tC 1-aikyi) -aminocarbonvi, phenyl-Cl- 3 -alkylamino or N- (C 13 -alkyl) -phenyl-C 1 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, siilphonyl, -NH, 3 -alkyl-), -N(phenyl), -N(phenyl-C- 3 -alkyl-), -N(C 13 -alkyl-carbonyl-), -N(Cl- 4 -hydroxy-carbonyl-), -N(Cl 14 -alkoxy-carbonyl-), -N(benzoyl-) or -N(phenyl-C 1 3 -alkyl-carbonyl-) group, wherein a methylene group linked to an iminonitrogen atom of the cycloalkylendimino group may be replaced by a carbonyl or sulphonyl group or in a to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the iminonitrogen atom may each be replaced by a carbonyl group, or R 6 denotes a C 14 -alkyl group which is substituted by a carboxy, C 13 -alkoxycarbonyl, aminocarbonyl,
C
1 3 -alkylaminocarbonyl or di- (Cl 13 -alkyl) -aminocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, an N-(C 1 3 -alkyl) -C 2 4 -al kanoylamino group which is additionally substituted in the alkyl moiety by a carboxy or 1,3-akxcroy group, a group of formula -N(Rl 2 -Go-(CH 2 R1 3 (IV) 11 wherein
R
12 denotes a hydrogen atom, a C 16 -alkyl or C 3 7 -cycloalkyl group or a C 3 aky group t inally susituted by a phenyl, heteroaryl, trifluoromethyl, hydroxy, C_.3-alkoxy, aminocarbonyl, C-_4-alkylamino-carbonyl, di-(C-_4-alkyl)amino-carbonyl, C 1 -3-alkyl-carbonyl, C_ 3 -alkyl-sulphonylamino, N-(C 13 -alkyl)-C 1 3 -alkyl-sulphonylamino,
C,_
3 -alkyl-aminodulphonyl or di- (C 1 .3-alkyl)-aminosulphonyl group and p denotes one of the numbers 0, 1, 2 or 3 and assumes the meanings of the abovementioned group R,, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula
-N(R
1 4 )-(CH2)q-(CO)-R5 wherein
R
14 denotes a hydrogen atom, a C-_4-alkyl group, a C .3-alkylcarbonyl, arylcarbonyl, phenyl-Cl3-alkylcarbonyl, heteroarylcarbonyl, heteroaryl-C 1 3 -alkylcarbonyl,
C
1 4 -alkylsulphonyl, arylsulphonyl, phenyl-C 1 3 -alkylsulphonyl, heteroarylsulphonyl or heteroaryl-Cl_ 3 -alkyl-sulphonyl group, q denotes one of the numbers 1, 2, 3 or 4, r denotes the number 1 or, if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and R1s assumes the meanings of the abovementioned group R,, 12 a group of formula
-N(R
16 )-S0 2
-R
17
(VI),
wherein R,6 denotes a hydrogen atom or a C, 1 -alkyl group optionally terminally substituted by a cyano, trifluoromethyl-carbonylamino or
N-(C
13 -alkyl)-trifluoromethyl-carbonyl-amino group and
R
17 denotes a C,-3-alkyl group, an amino group substituted by a di-(Ci.
3 -alkyl)amino-C 3 -alkyl-carbonyl or di-(C 1 3 -alkyl)amino-C 1 3 -alkyl-sulphonyl group and a di-(C 13 -alkyl)aminocarbonyl-C_ 3 -alkyl group, or an N-(C_.3-alkyl)-C-_s-alkylsulphonylamino or
N-(C
1 3 -alkyl)-phenylsulphonylamino group wherein the alkyl moiety is additionally substituted by a cyano or carboxy group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R, may be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C 1 _-alkyl, trifluoromethyl, hydroxy, C_ 3 -alkoxy, carboxy, C_- 3 -alkoxycarbonyl, aminocarbonyl,
C
1 -4-alkylamino-carbonyl, di- (C, 4 -alkyl) -amino carbonyl, aminosulphonyl, C 1 .3-alkyl-aminosulphonyl, di-(Cl- 3 -alkyl) -aminosulphonyl, C 1 3 -alkyl-sulphonylamino, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, 13 and R, denotes a hydrogen atom or a C -alkyl group, wherein by an aryl group is meant a phenyl or naphthyl group optionally mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a cyano, trifluoromethyl, nitro, carboxy, aminocarbohyl, C 1 3 -alkyl or C 1 3 -alkoxy group and by a heteroaryl group is meant .a monocyclic 5- or 6-membered heteroaryl group optionally substituted by a C 1 _3-alkyl group in the carbon skeleton, wherein the 6-membered heteroaryl group contains one, two or three nitrogen atoms and the 5-membered heteroaryl group contains an imino group optionally substituted by a C 1 _3-alkyl or phenyl-C 1 3 -alkyl group, an oxygen or sulphur atom or an imino group optionally substituted by a C_ 3 -alkyl or phenyl-C_ 3 -alkyl group or an oxygen or sulphur atom and additionally a nitrogen atom or an imino group optionally substituted by a Ci 3 -alkyl or phenyl-C, 3 -alkyl group and two nitrogen atoms, and moreover a phenyl ring may be fused to the abovementioned monocyclic heterocyclic groups via two adjacent carbon atoms and the bonding takes place via a nitrogen atom or via a carbon atom of the heterocyclic moiety or a fused phenyl ring, some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the 14 above-defined groups of formula I optionally being replaced by fluorine atoms, the saturated alkyl and alkoxy moieties with more Lhan 2 carbon atoms which are present in the groups defined hereinbefore also include the branched isomers thereof, such as for example the isopropyl, tert.butyl, isobutyl group, unless otherwise stated, and additionally the hydrogen atom of any carboxy group present or a hydrogen atom bound to a nitrogen atom, e.g. a hydrogen atom of an amino, alkylamino or imino group or a saturated Nheterocycle such as the piperidinyl group, may each be replaced by a group which can be cleaved in vivo.
By a group which can be cleaved in vivo from an imino or amino group is meant, for example, a hydroxy group, an acyl group such as the benzoyl or pyridinoyl group or a C,, 6 -alkanoyl group such as the formyl, acetyl, propionyl, butanoyl, pentanoyl or hexanoyl group, an allyloxycarbonyl group, a C,_,,-alkoxycarbonyl group such as the methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, tert.butoxycarbonyl, pentoxycarbonyl, hexyloxycarbonyl, octyloxycarbonyl, nonyloxycarbonyl, decyloxycarbonyl, undecyloxycarbonyl, dodecyloxycarbonyl or hexadecyloxycarbonyl group, a phenyl-C,- -alkoxycarbonyl group such as the benzyloxycarbonyl, phenylethoxycarbonyl or phenylpropoxycarbonyl group, a C 1 3-alkylsulphonyl-
C
2 4 -alkoxycarbonyl, C, 1 3 -alkoxy-C 2 4 -alkoxy-C 2 4 -alkoxycarbonyl or ReCO-O-(RfCR,)-O-CO group wherein Re denotes a C, -alkyl, C,_-cycloalkyl, phenyl or phenyl- C_ 3-alkyl group, 15 R, denotes a hydrogen atom, a C 1 3 -alkyl, C.,-cycloalkyl or phenyl group and R, denotes a hydrogen atom, a C 1 -alkyl or ReCO-O- (RCRg)group wherein Re to R, are as hereinbefore defined, wherein additionally the amino group may be a phthalimido group, whilst the abovementioned ester groups may also be used as a group which cap be converted in vivo into a carboxy group.
One sub-group of compounds of general formula I which deserves special mention comprises those wherein X, Ri and R 3 to R 5 are as hereinbefore defined and
R
2 denotes a straight-chain or branched C 6 -alkoxy-carbonyl group, a C4_,-cycloalkoxycarbonyl or a aryloxycarbonyl group, a straight-chain or branched Cl._-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl, C,.3-alkylaminocarbonyl or di-(C.
3 -alkyl)-aminocarbonyl group, a straight-chain or branched C2-6-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C 1 3 -alkoxy, amino, Ci.
3 -alkylamino or di-(C,_ 3 -alkyl)-amino group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A second sub-group of compounds of general formula I which deserves special mention comprises those wherein 16 X, R i and R 3 to R 5 are as hereinbefore defined and
R
2 denotes an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or N-(C,.s-alkyl)-C 1 .3-alkylaminocarbonyl-phenyl group, R, may also denote a di-(C 1 -2-alkyl)-aminocarbonyl group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A third sub-group of compounds of general formula I which deserves special mention comprises those wherein X, Ri to R 3 and R. are as hereinbefore defined and
R
4 denotes an R,-(C 1 ,_-alkyl)-phenyl group, wherein R, denotes an amino, C- 7 _-alkylamino, di-(C 1 _,-alkyl) -amino, phenylamino, N-phenyl-C 1 3 -alkyl-amino, phenyl-C 1 3 -alkylamino, N-(Cl_ 3 -alkyl)-phenyl-C 1 3 -alkylamino or di-(phenyl-C_3-alkyl)-amino group, or a phenyl group substituted by the group of formula
-N(R
1 2
)-CO-(CH
2 )p-R13 (IV), wherein R 12 p and R 13 are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
Preferred compounds of general formula I are those wherein 17 R, and R 3 are as hereinbefore defined and X denotes an oxygen atom,
R
2 denotes a carboxy group, a straight-chain or branched C,1_-alkoxy-carbonyl group, a Cs,_-cycloalkoxycarbonyl or a phenoxycarbonyl group, a straight-chain or branched C 1 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl, C,.3-alkylaminocarbonyl or di- (C 13 -alkyl) -aminocarbonyl group, a straight-chain or branched C 2 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom, by a hydroxy, C 1 -_-alkoxy, amino, C, 3 -alkylamino or di- (C_.3-alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C -3-alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or
N-(C
1 is-alkyl)-C, 3 -alkylaminocarbonyl-phenyl group, it may also denote a di-(C_ 2 -alkyl)-aminocarbonyl group,
R
4 denotes a C 3 ,--cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7membered cycloalkyl group may be substituted by an amino,
C
1 3 -alkylamino or di-(Cl_ 3 -alkyl)-amino group or replaced by an -NH or -N(C 1 -3-alkyl) group, or a phenyl group substituted by the group which may additionally be mono- or disubstituted by fluorine, chlorine or bromine atoms, by CI.3-alkyl, trifluoromethyl, hydroxy, 18
C
13 -alkoxy, carboxy, Cl- 3 -alkoxycarbonyl, amino, acetylamino, aminocarboiyl, C- 3 -alkyl-aminocarbonyl, di- (C, 13 -alkyl) -aminocarbonyl, nitro or cyano groups, wherein the substitiuents may be identical dr iffeen and wherein R. denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, C,-,-alkyl, C 3 7 -cycloalkyl, trifluoromethyl, phenyl, tetrazolyl'or heteroaryl group, the group of formula 0
NH
wherein a hydrogen atom bound to the nitrogen atom may be replaced by a C--a lkyl group, a C 1 3 -alkoxy group, an amino- C- 3 alkoxy, Cl-,-alkylamino-
C
2 3 -alkoxy, di (C 1 3 alkyl) amino-C 2 3 alkoxy, phenyl- Cl- 3 -alkylamino-C 2 -alkoxy, N- (Cl 1 3 -alkyl) -phenyl-
C,-
3 -alkylamino-C 2 -alkoxy, pyrrolidino-C 2 3 alkoxy, piperidino-C 2 3 -alkoxy or C 1 3 -alkylmercapto group, a carboxy, C,- 4 -alkoxycarbonyl, aminocarbonyl, C,- 3 -alkylamino-carbonyl, phenyl-C- 3 -alkylamino-carbonyl or N- (Cl- 3 -alkyl) -phenyl-C 1 3 -alkylamino-carbonyl group, a C 3 7 -cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be replaced by an -NH or
-N(C
1 3 -alkyl) group, 19 a 4- to 7-membered cycloalkyleneimino group, wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or one or two hydrogen atoms may each be replaced by a C1_3-alkyl group and/or in each case thO methylene group in the 4 position of a 6or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C _3-alkoxycarbonyl, aminocarbonyl, C, 3-alkylaminocarbonyl, di- (C, 3 -alkyl) -aminocarbonyl, phenyl-Ci_ 3 -alkylamino or N-(C,_-alkyl)phenyl-C,.3-alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or -N(C, 1 ,-alkyl) group, a C,_4-alkyl group terminally substituted by the group R,, wherein
R
7 denotes a C 5 .,-cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be replaced by an -NH or -N(C 3 -alkyl) group or in a 5- to 7-membered cycloalkyl group a -(CH 2 2 group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by a -NH-CO-NH- or a -(CH 2 4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 alkyl group, a phenyl or heteroaryl group, 20 a hydroxy or C 13 -al koxy group, an amino, C, 1 6 -alkylamino, di- (Cl- 6 -alkyl) -amino, phenylaimino, N-pfheriyi-C, -a-Lkyi aio pheny1-C,-,-alkylamino, N- (C,-,-alkyl) -pheny1-C,-,-alkylamino or di- (phenyl-C 1 3 ,-alkyl) -amino group, a o-hydroxy-C 2 -alkyl -amino, N- (C,-,-alkyl) -zo-hydroxyikyl -amino, di- (ao-hydroxy-C 2 3 -alkyl) -amino, di- (co- (Cl- 3 -alkoxy) -C 2 -alkyl) -amino or N- (dioxolan-2-yl) -Cl- -alkyl-amino group, a CI- 3 -alkylcarbonylamino-C 2 3 -alkyl -amino or
C-
3 -alkylcarbonylamino-C 2 3 -alkyl-N- (C 1 3 -alkyl) -amino group, a CI al kyl suiphonyl amino, N- (C 1 3 -alkyl)
C-
3 -al kylsuiphonylamino, C- 3 -alkylsuiphonylamino-
-C
2 3 -a ikyl -amino or C,-,-alkylsulphonylamino-C 2 3 -alkyl- (Cl- 3 -alkyl) -amino group, a hydroxycarbonyl-C 1 3 -alkylamino or N- (CI- 3 -alkyl) -hydroxycarbonyl -C 1 3 -alkyl -amino group a guanidino group wherein a hydrogen atom may be replaced by a C 1 3 -alkyl group, a group of formula
N(R
8 )-C0(CH 2 )n-R 9 wherein R. denotes a hydrogen atom or a C 1 3 alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and 21
R
9 denotes an amino, C 1 _-alkylamino, di-(C 1 3 -alkyl)amino, phenylamino, benzylamino or C.-,-alkoxy group, a to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH, -N(C 1 .3-alkyl), -N(phenyl), -N(C 1 3 -alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2'or 3, it may also denote a hydrogen atom, a group of formula -N(Rio)-(CH 2 )m-(CO)o-R 11
(III),
wherein Rio denotes a hydrogen atom, a C 13 -alkyl group, a
C
1 3 -alkylcarbonyl or Ci.3-alkylsulphonyl group, m denotes one of the numbers 1, 2 or 3, o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and
R
11 denotes an amino, C 1 3 -alkylamino, di-(C_3-alkyl)-amino, C-.
4 -alkoxy or
C,.
3 -alkoxy-C..
3 -alkoxy group or a 5- to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH, -N(Ci.
3 -alkyl), -N(phenyl), -N(C 1 alkyl-carbonyl) or -N(benzoyl) group, a C, 4 7 -cycloalkylamino or C 4 ,-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond, 22 a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or one or two hydrogen atoms may each be replaced by a
C
1 3 -alkyl group and/or the methylene group in position 3 of the pyrrolidino group may be substituted by a hydroxy or C 1 3 -alkoxy group, in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl,
C
1 3-alkoxy, carboxy, Ci.
3 -alkoxycarbonyl, aminocarbonyl, C_-3-alkylaminocarbonyl, di-(C,~ 3 -alkyl) -aminocarbonyl, phenyl-C_3-alkylamino or N- 3 -alkyl) -phenyl-C, 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 -3-alkyl) -N(phenyl), -N(phenyl-C_3-alkyl) -N(C, 3 -alkyl-carbonyl), -N(C_.4-alkoxy-carbonyl), -N(benzoyl) or -N(phenyl-Cl_ 3 -alkyl-carbonyl) group, wherein a methylene group linked to an iminonitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 6-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the iminonitrogen atom may each be replaced by a carbonyl group, 23 or R 6 denotes a C 1 4 ,-alkyl group which is terminally substituted by a carboxy, Cl_3-alkoxycarbonyl, aminocarbonyl, -alkylaminocarbonyl or di-(C -alky)-a inocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, a group of formula -N(R~2)-CO-(CH2)p-RI3 (IV), wherein
R
12 denotes a hydrogen atom, a C 1 alkyl, Cs 7 ,-cycloalkyl, phenyl-C_3-alkyl or heteroaryl-C 1 3 -alkyl group and p denotes one of the numbers 0, 1, 2 or 3 and
R,
3 assumes the meanings of the abovementioned group R,, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula -N(Rl 4 )-(CH2)q-(CO)r-R5 wherein
R,
4 denotes a hydrogen atom, a C 1 4 -alkyl group, a C_3-alkylcarbonyl, phenylcarbonyl, phenyl-C 3 -alkylcarbonyl, heteroarylcarbonyl, heteroaryl-C 3 -alkylcarbonyl, C,_ 4 -alkylsulphonyl, phenylsulphonyl, phenyl-C 1 3 -alkylsulphonylheteroarylsulphonyl or heteroaryl-C 1 3 -alkyl-sulphonyl group, q denotes one of the numbers 1, 2, 3 or 4, 24 r denotes the number 1 or, if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and
R
1 assumes the meanings of the abovementioned group R,, a group of formula -7 (R 1 6 )-S0 2
-R
1 7
(VI),
wherein
R
16 denotes a hydrogen atom or a C_-4-alkyl group optionally terminally substituted by a cyano, trifluoromethylcarbonylamino or N- 3 -alkyl) -trifluoromethyl- -carbonyl-amino group and
R
17 denotes a Cl_ 3 -alkyl group, an amino group substituted by a di- (C 1 3 -alkyl)amino-C 3 -alkyl-carbonyl or di- (Ci_3-alkyl)amino-C 1 3 -alkyl-sulphonyl group and a di-(C 1 3 -alkyl)aminocarbonyl-C,~ 3 -alkyl group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R, may be monoor disubstituted by fluorine, chlorine or bromine atoms, by C 1 3 -alkyl, trifluoromethyl, hydroxy,
C_.
3 -alkoxy, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl,
C
1 3 -alkyl-aminocarbonyl, aminosulphonyl,
C.
3 -alkyl-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, and R, denotes a hydrogen atom or a C,3-alkyl group, 25 whilst by a heteroaryl group as mentioned above is meant a pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, pyrrolyl, furyl, thienyl, oxazolyl, thiazolyl, pyrazolyl, imidazolyl or triazoly; group optionally substituted in Lhe carbon skeleton by a C,.3-alkyl group wherein a hydrogen atom bound to a nitrogen atom may be replaced by a C.3-alkyl or phenyl-C 1 .,-alkyl group and wherein the 5-membered heteroaryl groups containing at least one imino group are bound via a carbon or nitrogen atom, a hydrogen atom bound to a nitrogen atom in the abovementioned groups may be replaced by a group which can be cleaved in vivo, particularly by an acetyl or tert.butoxycarbonyl group, the carboxy groups contained in the abovementioned groups may each be substituted by a group which can be cleaved in vivo and may occur, for example, in the form of the tert.butoxycarbonyl group, some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the above-defined groups of formula I optionally being replaced by fluorine atoms and the saturated alkyl and alkoxy moieties contained in the abovementioned groups, which contain more than 2 carbon atoms, may be straight-chain or branched, unless otherwise stated, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
One subgroup of preferred compounds of general formula I deserving special mention comprises those wherein X, R, and R 3 to R s are as hereinbefore defined and 26
R
2 denotes a straight-chain or branched C 1 6 -alkoxy-carbonyl group, a C_,--cycloalkoxycarbonyl or a phenoxycarbonyl group, a straight-chain or branched C, 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenylcarboxy, C -3-alkoxycarbonyl, aminocarbonyl,
C,
3 -alkylaminocarbonyl or di-(C.3-alkyl)-aminocarbonyl group, a straight-chain or branched C 2 _,-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a hydroxy,
C,_
3 -alkoxy, amino, Cl.
3 -alkylamino or di-(C 1 3 -alkyl)-amino group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A second sub-group of preferred compounds of general formula I deserving special mention comprises those wherein X, Ri and R 3 to R 5 are as hereinbefore defined and
R
2 denotes an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C., 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or
N-(C
1 _.-alkyl)-C_.
3 -alkylaminocarbonyl-phenyl group, R 2 may also denote a di-(C 1 -2-alkyl)-aminocarbonyl group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A third sub-group of preferred compounds of general formula I deserving special mention comprises those wherein X, RI to R 3 and R 5 are as hereinbefore defined and 27
R
4 denotes an R,-(n-CI, 4 -alkyl)-phenyl group, wherein R, denotes an amino, C, -alkylamino, di-(C -aiky)-amino, phenylamino, N-phenyl-C,_3-alkyl-amino, phenyl-Ci 3-alkylamino, 3 -alkyl) -phenyl-CI_3-alkylamino or di-(phenyl- C,_3-alkyl)-amino group, or a phenyl group substituted by the group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein R1 2 p and are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
Particularly preferred compounds of general formula I are those wherein X denotes an oxygen atom, R, denotes a hydrogen atom,
R
2 denotes a carboxy group, a straight-chain or branched C _4-alkoxycarbonyl group or a phenoxycarbonyl group, a straight-chain or branched Cl 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, carboxy, C,.
3 -alkoxycarbonyl, aminocarbonyl, Ci,3-alkylaminocarbonyl or di-(CI_3-alkyl)-aminocarbonyl group, a straight-chain or branched C2-,-alkoxy-carbonyl group which is terminally substituted in the alkyl moiety by a hydroxy, 28 C,.3-alkoxy, amino, C 1 3 -alkylamino or di-(C 1 3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C -3-alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or
N-(C_
5 -alkyl)-Cl.
3 -alkylaminocarbonyl-phenyl group, it may also denote a di-(C- 2 -alkyl)-aminocarbonyl group,
R
3 denotes a C 1 4 -alkyl group or a phenyl group which may be substituted by a fluorine, chlorine or bromine atom, by a trifluoromethyl, C 1 3 -alkyl, hydroxy or C 1 .3-alkoxy group,
R
4 denotes a C 5 6 -cycloalkyl group, wherein the methylene group in position 4 of the cyclohexyl group may be substituted by an amino,
C
1 3 -alkylamino or di-(C 1 -3-alkyl)-amino group or replaced by an -NH or -N(C_ 3 -alkyl) group, a phenyl group, a phenyl group disubstituted by C 1 3 -alkyl,
C
1 3 -alkoxy or nitro groups, wherein the substituents may be identical or different, or a phenyl group substituted by the group which may additionally be substituted by a fluorine, chlorine or bromine atom or by an amino or nitro group, wherein
R
6 denotes a fluorine, chlorine or bromine atom, a C 1 3 -alkyl, C 1 3 -alkoxy, nitro, amino or Cs_ 6 -cycloalkyl group, a pyrrolyl, pyrazolyl, imidazolyl, triazolyl or tetrazolyl group bound via a carbon atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be 29 substituted by a C 3-alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 -alkyl or phenyl-C 1 3 -alkyl group, the group of formula 0
CNH
CH
N
H
a carboxy, C,.4-alkoxycarbonyl, phenyl-C-_ -alkylamino-carbonyl or C 5 7 -cycloalkyl-carbonyl group, a 5 or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH or
-N(C
1 .3-alkyl) group, an unbranched C 1 .3-alkyl group terminally substituted by the group wherein
R
7 denotes a C 5 _-cycloalkyl group, wherein in a 5 or 6-membered cycloalkyl group a group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by an -NH-CO-NH- or a -(CH 2 4 group may be replaced by an -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl group, a phenyl or pyridinyl group or a pyrrolyl, pyrazolyl, imidazolyl or triazolyl group bound via a carbon or nitrogen atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be substituted by a 30
C
1 3 -alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a -al kyl group, a hydroxy or C, ,-alkoxy group, an amino, Cl- 6 -alkylamino, di- (C 1 6 -alkyl) -amino, phenylamino, N-phenyl-C,- 3 -alkylamino, phenyl-C,-,-alkylamino or N- (C 1 3 -alkyl) -phenyl- Cl- 3 ikylamino group, a o-hydroxy-C 2 3 -alkyl -amino, N- (CI- 3 -alkyl) -w-hydroxy-C,,-alkylamino, di- (wo-hydroxy-C 2 3 -alkyl) -amino or di- (Cl- 3 -alkoxy) -C 2 3 -alkyl) -amino group, a Cl- 3 -alkylcarbonylamino-C- 3 -alkyl-amino or Cl- 3 -alkylcarbonylamino-C 2 3 -alkyl-N- (C 1 3 -alkyl) -amino group, a Cl- 3 -alkylsulphonylamino, N- (C 1 3 -alkyl)
C-
3 -alkylsuiphonylamino, Cl-3-alkylsuiphonylamino-
-C
2 3 -alkylamino or C- 3 -alkylsuiphonylamino-
-C
2 3 -alkyi-N- (C 1 3 -aikyi) -amino group, a hydroxycarbonyl-CI-3-alkylamino or N- (Cl 3 -alkyl) -hydroxycarbonyl-Cl- 3 -alkyl-amino group, a guanidino group wherein a hydrogen atom may be replaced by a C 1 3 -alkyl group, a group of formula
N(R
8
)VCOI(CH
2 )n-R 9
(II),
wherein 31 R, denotes a hydrogen atom or a CI_3-alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and
R
9 denotes an amino, C 1 3 -alkylamino, di-(C 1 .3-alkyl)-amino or C 4-alkoxy group, a 5- or 6membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH, -N(C _--alkyl) or
-N(C
1 3 -alkyl-carbonyl) group, or, if n denotes one of the numbers 1, 2 or 3, R 9 may also denote a hydrogen atom, a group of formula -N(Rio)-(CH 2 )m-(CO)o-R11 (III), wherein
R
10 denotes a hydrogen atom or a C -3-alkyl group, m denotes one of the numbers 1, 2 or 3, o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and
R
1 denotes an amino, C 1 .3-alkylamino, di-(C 1 .3-alkyl)-amino, C-,4-alkoxy or methoxy-C 1 ~,-alkoxy group or a 5- or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH,
-N(C
1 3 -alkyl) or -N(Cl--alkyl-carbonyl) group, an azetidino, pyrrolidino, piperidino, 2,6-dimethyl-piperidino, 3,5-dimethyl-piperidino or azepino group, wherein 32 the methylene group in position 3 of the pyrrolidino group may be substituted by a hydroxy group, the methylene group in position 4 of the piperidino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl or C, 3 -alkoxy group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl) -N(C- 3 -alkylcarbonyl), -N(benzoyl) or -N(phenyl-C 1 3 -alkyl-carbonyl) group, wherein a methylene group linked to an iminonitrogen atom of the pyrrolidino, piperidino or piperazino group may be replaced by a carbonyl group, or R 6 denotes a straight-chain C 1 _3-alkyl group which is terminally substituted by a carboxy or C,.3-alkoxy-carbonyl group, a group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein
R
12 denotes a hydrogen atom, a C, 3 -alkyl or phenyl-C 1 3 alkyl group, p denotes one of the numbers 0, 1 or 2 and
R
13 denotes an amino, C 1 _4-alkylamino, di-(C 1 _4-alkyl)-amino, benzylamino, N-(C_ 3 -alkyl)-benzylamino,
CI.
3 -alkoxy-Cl_ 3 -alkylamino, N- (C, 3 -alkyl)- 33 Cl 3 -alkoxy-C 1 3 -alkylamino, di- (2-methoxy-ethyl) -amino, di- (-hydroxy-C 2 3 -alkyl) -amino or aminocarbonyl-methyl-N- (methyl)-amino group, a pyrrolyl, pyrazolyl or imidazolyl group bound via a nitrogen atom and optionally substituted by a C- 3 -alkyl group, a pyrrolidino, iperidino, morpholino, thiomorpholino or a piperazino group optionally substituted in the 4 position by a C- 3 -alkyl, phenyl-Cl- 3 -alkyl, C 1 3 -alkylcarbonyl or
C,-
4 -alkoxycarbonyl group or, if n denotes the number 1 or 2, it may also denote a hydrogen atom, a group of formula
-N(R
1 4 (CH2)q(CO)r-Rl5 (V) wherein
R
14 denotes a hydrogen atom, a C,-,-alkyl, C,-,-alkylcarbonyl, phenylcarbonyl, phenyl-C 13 -alkylcarbonyl, furylcarbonyl, pyridinyl-carbonyl, furyl-CI- 3 -alkylcarbonyl, pyridinyl-C 1 3 -alkylcarbonyl, C 1 4 -alkylsulphonyl, phenylsuiphonyl or phenyl-C 1 3 -alkylsulphonyl group, q denotes one of the numbers 1, 2 or 3, r denotes the number 1 or, if q is one of the numbers 2 or 3, it may also denote the number 0 and R. denotes an amino, C 1 4 -alkylamino, di-(C 1 4 ,-alkyl) -amino, phenylamino, N-(C 1 4 ,-alkyl) -phenylamino, benzylamino or N- (C 14 -alkyl) -benzylamino group, 34 or a group of formula
-N(R
1 6 )-S0 2
-R
17
(VI),
wherein
R
16 denotes a hydrogen atom or a C 3-alkyl group optionally terminally substituted by a cyano, trifluoromethyl-carbonylamino or
N-(C
1 3 -alkyl)-trifluoromethyl-carbonyl-amino group and
R,
7 denotes a CI3-alkyl group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R 6 may be substituted by a fluorine, chlorine or bromine atom, by a methyl, trifluoromethyl, methoxy, nitro or cyano group and Rs denotes a hydrogen atom, wherein a hydrogen atom bound to a nitrogen atom in the abovementioned groups may be replaced by an acetyl or tert.butoxycarbonyl group, the carboxy groups contained in the abovementioned groups may also be present in the form of the tert.butoxycarbonyl precursor group and the saturated alkyl and alkoxy moieties contained in the abovementioned groups, which contain more than 2 carbon atoms, may be straight-chain or branched, unless otherwise stated, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
35 One subgroup of particularly preferred compounds of general formula I deserving special mention comprises those wherein X, R, and R, are as hereinbefore defined,
R
2 denotes a straight-chain or branched C.4,-alkoxycarbonyl group or a phenoxycarbonyl group, a straight-chain orbranched C 1 3 -alkoxycarbonyl group, which is terminally substituted in the alkyl moiety by a phenylcarboxy, C -3-alkoxycarbonyl, aminocarbonyl,
C
1 3 -alkylaminocarbonyl or di-(C 1 3 -alkyl)-aminocarbonyl group, or a straight-chain or branched C 2 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a hydroxy,
C
1 .3-alkoxy, amino, C 3 3-alkylamino or di-(C 1 3 -alkyl)-amino group, and
R
4 denotes an R,-(n-C_3-alkyl)-phenyl group, wherein R, denotes an amino, C,_--alkylamino, di-(C-_ 4 -alkyl) -amino, o-hydroxy-C 2 -3-alkyl-amino, N- (C_ 3 -alkyl) -o-hydroxy-C 2 -3-alkyl-amino, di- (o-hydroxy-C 2 3 -alkyl)-amino or di- (C,_--alkoxy)-C2-3-alkyl)-amino group, or a phenyl group substituted by the group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein R 12 p and R 13 are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
36 A second subgroup of particularly preferred compounds of general formula I deserving special mention comprises those wherein X, R 3 and R. are as hereinbefore defined,
R
2 denotes an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 1 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or N-(Cis-alkyl)-C 1 3 -alkylaminocarbonyl-phenyl group, R 2 may also denote a di-(C 1 -2-alkyl)-aminocarbonyl group and
R
4 denotes a R,-(n-C 1 3 -alkyl)-phenyl group, wherein
R
7 denotes an amino, C 1 6 -alkylamino, di-(C 1 4 -alkyl)-amino, )-hydroxy-C2- 3 -alkyl-amino, N- (C 1 3 -alkyl) -o-hydroxy- -C2-3-alkyl-amino, di-((o-hydroxy-C2-3-alkyl)-amino or di- (CI_ 3 -alkoxy)-C2- 3 -alkyl)-amino group, or a phenyl group substituted by the group of formula -N(RI2)-CO-(CH2)p-RI3 (IV), wherein R 12 p and R 13 are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
Most particularly preferred compounds of general formula I are those wherein X denotes an oxygen atom, 37 R and R, each denote a hydrogen atom,
R
2 denotes a methoxycarbonyl, ethoxycarbonyl or aminocarbonyl group,
R
3 denotes a phenyl group and
R
4 denotes a phenyl group monosubstituted by the group R 6 wherein
R
6 denotes an N-methyl-imidazol-2-yl group, an unbranched C 1 .3-alkyl group which is terminally substituted by a C,4-alkylamino, di-(C-_4-alkyl) -amino, piperidino or 2,6-dimethyl-piperidino group, a group of formula
-N(R
1 2
)-CO-(CH
2 )p-R1 3
(IV),
wherein
R
12 denotes a Cl -alkyl group, p denotes one of the numbers 1 or 2 and
R
13 denotes a di-(C- 3 _-alkyl)-amino group, or a group of formula -N(R14)-(CH2)q-(CO)r-R1 5 wherein R,4 denotes a C-_ 3 -alkyl-carbonyl or C,_-alkylsulphonyl group, 38 q denotes one of the numbers 1, 2 or 3, r denotes the number 1 or, if q is one of the numbers 2 or 3, r may also denote the number 0 and
R
15 denotes a di-(C, 3 -alkyl)-amino group, wherein the saturated alkyl moieties contained in the abovementioned groups which contain more than 2 carbon atoms may be straight-chain or branched, unless otherwise stated, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
A subgroup of most particularly preferred compounds of general formula I deserving special mention comprises those wherein X, R, and R s are as hereinbefore defined,
R
2 denotes a methoxycarbonyl or ethoxycarbonyl group and
R
4 denotes a di-(C.3-alkyl)-amino-C 1 3 -alkylphenyl group or a phenyl group substituted by the group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein R 12 p and R 13 are as hereinbefore defined, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof.
The following are mentioned as examples of particularly preferred compounds: 39 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylenel -6-ethoxycarbonyl-2-indolinone, -I PL e e-ii A- '34 -Y 'I ni±'-1Ij -i-p -leilylmethylene] -6-carbamoyl-2-indolinone, 3-Z-[1-C4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6 -methoxycarbonyl indolinone, 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] ethoxycarbonyl indolinone, 3-Z-[l-(4-((2,6-dimethyl-piperidin-1-yl)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- CN-(2-dimethylamino-ethyl)-N-acetyl-amino)-ani- 1mo) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- (3-dimethylamino-propyl) -N-acetyl-amino)-ani- 1mo) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, Ch) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone, Wi 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, 3-Z- (N-acetyl-N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, Ck) 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl -2-indol inone, 3-Z-[1-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, 0 -40 (in) 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone, 3-Z- (3dimethylamino-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinoie, 3-Z- (N-dimethylaminocarbonylmethyl-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6met hoxycarbonyl indol inane, 3-Z- ((2-dimethylamino-ethyl) -carbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane, 3-Z- (2-dimethylamino-ethyl)-N-acetyl-amino)-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone and 3-Z- (1-(4-methylaminomethyl-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone the tautomers, the mixtures and the salts thereof.
Another subgroup of compounds of general formula I comprises those wherein X denotes an oxygen or sulphur atom, R. denotes a hydrogen atom or a prodrug group such as a c 4 -alkoxycarbonyl or C 24 -alkanoyl group, 41 R2 denotes a carboxy group, a straight-chain or branched -alkoxycarbonyl group, a C,-,-cycloalkoxycarbonyl or phenyl- C,-3-alkoxycarbonyl group, an aminocarbonyl or C,-7-alkylaminocarbonyl grouip or, if R 4 does not denct- an aminosuiphonyl-phenyl or N- (C 1 5 ,-alkyl)-C-,-alkylaminocarbonylphenyl group, a di-(Cl 1 2 -alkyl)-aminocarbonyl group,
R
3 denotes a hydrogen atom, a C-6-alkyl, C,-,-cycloalkyl, trifluoromethyl or heteroaryl group, a phenyl or naphthyl group, a phenyl or naphthyl group monoor disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, C,-,-alkyl or C- 3 -alkoxy group, whilst in the event of disubstitution the substituents may be identical or different and wherein the abovementioned unsubstituted as well as the mono- and disubstituted phenyl and naphthyl groups may additionally be substituted by a hydroxy, hydroxy-C 1 3 ,-alkyl or C 1 alkoxy-C 1 alkyl group, by a cyano, carboxy, carboxy-Cl 1 3 -alkyl, C-3-alkoxycarbonyl, aminocarbonyl, C 1 alkylamino-carbonyl or di-(Cl- 3 -alkyl) -aminocarbonyl group, by a nitro group, by an amino, C-3-alkylamino, di-(Cl 1 3 -alkyl) -amino or amino-C 1 3 -alkyl group, by a C 1 3 -alkylcarbonylamino, N-(C 1 3 -alkyl) -C 1 3 -alkylcarbonylamino, C- 3 alkylcarbonylamino-C alkyl, N- (Cl- 3 -alkyl) -Cl- 3 -alkylcarbonylamino-C- 3 -alkyl, Cl- 3 -alkylsulphonylamino, Cl 1 3 -alkylsulphonylamino-C al kyl, N- (CI- 3 -alkyl) -Cl- 3 -alkylsulphonylamino-C 1 3 -alkyl or aryl-Cl- -alkylsulphonylamino group, 42 by a cycloalkylamino, cycloalkyleneimino, cycloalkyleneiminocarbonyl, cycloalkyleneimino-C, 3 -alkyl, cycloalkyleneiminocarbonyl-C-_3-alkyl or cycloalkyleneiminosulphonyl-C 1 3 -alkyl group having 4 to 7 ring members in each case, whilst in each case the methylene group in position 4 of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or
-N(CI_
3 -alkyl) group, or by a heteroaryl or heteroaryl-C_3-alkyl group,
R
4 denotes a C3.
7 -cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7membered cycloalkyl group may be substituted by an amino, C1 3-alkylamino or di-(C_ 3 -alkyl)-amino group or replaced by an -NH or -N(C_ 3 -alkyl) group, or a phenyl group substituted by the group which may additionally be substituted by a fluorine, chlorine, bromine or iodine atom, by a Cl_-alkyl, trifluoromethyl, C_ 3 -alkoxy, carboxy, C_.
3 -alkoxycarbonyl, aminosulphonyl, nitro or cyano group, wherein R, denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, C,_s-alkyl, C 3 _7-cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, a C-.3-alkoxy group optionally sunstituted by 1 to 3 fluorine atoms, a C-.3-alkoxy-Ci_ 3 -alkoxy, phenyl-Cl.
3 -alkoxy, amino-C2- -alkoxy, C_- 3 -alkylamino-C_ 3 -alkoxy, di-(C 3 -alkyl) -amino-C_ 3 -alkoxy, phenyl-C.
3 -alkylamino- 43
C
2 3 -alkoxy, N- (C,-,-alkvl) -phenyl-CI--alkvlamino-C2- alkoxy, cycloalkyleneimino-C 2 3 -alkoxy or C,-,-alkylmercapto group, -a ca-rboxy, C r inc c b -onyl amino-carbonyl, N- (C,-,-alkyl) -C alkylaminocarbonyl, phenyl-C 1 3 -alkylamino-carbonyl, N- (Cl 3 -alkyl) -phenyl-C 1 3 -alkylamino-carbonyl, piperazinocarbonyl or N- (Cl 1 3 -alkyl) -piperazinocarbonyl group, a C 1 3 -alkylaminocarbonyl or N-(C 1 5 ,-alkyl)- Cl- 3 -alkylaminocarbonyl group wherein an alkyl moiety is substituted by a carboxy or C 1 3 -alkoxycarbonyl group or is substituted in the 2 or 3 position by a di-(C 1 3 -alkyl)-amino, piperazino, N-(C 1 3 -alkyl) -piperazino or a 4- to 7-membered cycloalkyleneimino group, a 4- to 7-membered cycloalkyleneimino group, wherein a methylene group linked to the imino group may be replaced by a carbonyl or suiphonyl group or the cycloalkylene moiety may be fused to a phenyl ring or one or two hydrogen atoms may each be replaced by a CI-3-aikyl group and/or in each case the methylene group in the 4 position of a 6or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C- 3 -alkoxycarbonyl, aminocarbonyl,
C-
3 -alkylaminocarbonyl, di-(C 13 ,-alkyl)-aminocarbonyl, phenyl-C.
3 -aikylamino or N- (Cl 1 3 -alkyl)phenyl-C 1 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl) -N(phenyl),
-N(C
1 3 ,-alkyl-carbonyl) or -N(benzoyl) group, 44 a C 1 _4-alkyl group which may be substituted _y a ydroxy or C, -al'Aoxy group, by an amino, Cl_,-alkylamino, di-(C 1 7 -alkyl)-amino, di-N-(C,~ 3 -alkyl) -amino-C 2 3 -alkylamino, tri-N,N,N' (C- 3 -alkyl) -amino-C 2 3 -alkylamino, phenylamino, N-phenyl-C_ 3 -alkyl-amino, phenyl-C 3-alkylamino, N-(C_.3-alkyl)-phenyl-C, 3 alkylamino or di- (phenyl-C_3-alkyl)-amino group, by a Ci_ 3 -alkylcarbonylamino, N-(Ci.
3 -alkyl)-
C
1 3-alkylcarbonylamino, C, 3 alkoxycarbonyl-C, 3 -alkylamino or N-(C_3-alkyl)-C-.
3 -alkoxycarbonyl-C_ 3 -alkylamino group, by a C_,-cycloalkylamino, C 4 7 -cycloalkyl-CI _-alkylamino or
C
4 ,_-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a C 1 3 -alkyl group wherein some or all of the hydrogen atoms are replaced by fluorine atoms, by a CI-cycloalkyl, C 2 _4-alkenyl or C 1 _4-alkyl group, by a 4- to 7-membered cycloalkyleneimino group, wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C,_ 3 -alkyl, C, 3 alkoxy or amino group or 45 one or two hydrogen atoms may each be replaced by a
C,
1 -alkyl, Cs,-cycloalkyl or phenyl group and/or in each case the methylenc group in the 4 posiLion of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, carboxy, C, 4 -alkoxycarbonyl, aminocarbonyl, C.
3 ,-alkylaminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, phenyl-C 1 3 -alkylamino or
N-(C
1 3 -alkyl)'-phenyl-Ci- 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl), -N(phenyl), -N(C_.3-alkyl-carbonyl) or -N(benzoyl) group, by a carboxy, C,_--alkoxycarbonyl, aminocarbonyl,
C,.
3 -alkylaminocarbonyl or di-(C 1 .3-alkyl)-aminocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, an amino, pyrrolidino, piperidino, morpholino, benzoylamino or
N-(C_
3 -alkyl)-benzoylamino group, an N-(C_.3-alkyl)-C, 4 alkanoylamino group which is additionally substituted in the alkyl moiety by a carboxy or C,_3-alkoxycarbonyl group, a group of formula
-N(R
8
)-CO-(CH
2 )n-R 9
(II),
wherein R, denotes a hydrogen atom or a Ci.3-alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and 46-
R
9 denotes an amino, C 1 -4-alkylamino, phenylamino, N-(Cl.
4 -alkyl)-phenylamino, benzylamino, N-(Ci- 4 -alky])-benzylamino or di-(Ci.,-alkyl)-amino group, a 4- to 7-membered cycloalkyleneimino group, whilst in each case the methylene group in the 4 position of a 6- or 7membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH,
-N(C
1 _3-alkyl), -N(phenyl), -N(CI_ 3 -alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula
-N(R
10
)-(CH
2 )m-(CO)o-R 1
(III),
wherein Rio denotes a hydrogen atom, a C 1 3 -alkyl group, a
C
1 3 -alkylcarbonyl, arylcarbonyl, phenyl-C 1 3 -alkylcarbonyl,
C
1 3 -alkylsulphonyl, arylsulphonyl or phenyl-C~.3-alkylsulphonyl group, m denotes one of the numbers 1, 2, 3 or 4, o denotes one of the numbers 0 or 1 and
R
1 denotes an amino, Cl,4-alkylamino, phenylamino,
N-(C
1 4 -alkyl)-phenylamino, benzylamino,
N-(C-
4 -alkyl)-benzylamino or di-(Ci.
4 -alkyl)-amino group, a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, 3 -alkyl), -N(phenyl), -N(C,.3-alkyl-carbonyl) or 47 -N(benzoyl) group, a C 1 _3-alkoxy group or a di- (C, 4 -alkyl) -amino-C 1 3 -alkylamino group optionally substituted in the 1 position by a C~ 3-alkyl group, or an N-(C _3-alkyl) 5 -alkylsulphonylamino or
N-(C
1 3 -alkyl)-phenylsulphonylamino group wherein the alkyl moiety is additionally substituted by a cyano or carboxy group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R 6 may be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C.,-alkyl, trifluoromethyl, C_ 3 -alkoxy, carboxy, Cl_ 3 -alkoxycarbonyl, aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, and Rs denotes a hydrogen atom or a C 1 3 -alkyl group, wherein by an aryl group is meant a phenyl or naphthyl group optionally mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, C 1 .3-alkyl or Cl_--alkoxy group and by a heteroaryl group is meant a monocyclic 5- or 6-membered heteroaryl group optionally substituted by a C 1 3 -alkyl group, wherein the 6-membered heteroaryl group contains one, two or three nitrogen atoms and the 5-membered heteroaryl group contains an imino group optionally substituted by a C_13-alkyl group, an oxygen or sulphur atom or an imino group optionally substituted by a C 1 3 -alkyl group and an oxygen or sulphur atom or one or two nitrogen atoms, and moreover a phenyl ring may 48be fused to the abovementioned monocyclic heterocyclic groups via two adjacent carbon atoms, the saturated alkyl and alkoxy moieties present in the groups defined above which contain more than 2 carbon atoms also include the branched isomers thereof such as, for example, the isopropyl, tert.butyl or isobutyl group, unless otherwise stated, and additionally any carboxy, amino or imino group present may be substituted by a group which can be cleaved in vivo, the isomers and the salts thereof.
According to the invention the new compounds are obtained, for example, by the following methods known in principle from the literature: a. reacting a compound of general formula R3 X
(VII),
N
R
2
I
R18 wherein X and R 3 are as hereinbefore defined,
R
2 has the meanings given for R 2 hereinbefore,
R,
1 denotes a hydrogen atom or a protecting group for the nitrogen atom of the lactam group, wherein one of the groups
R
2 and Ri, may also denote a bond to a solid phase optionally formed via a spacer and the other one of the groups and R,, 49 has the abovementioned meanings, and Z, denotes a halogen atom, a hydroxy, alkoxy or aryl-alkoxy group, e.g. a chlorine or bromine atom, a methoxy, ethoxy or benzyloxy group, with an amine of general formula /Rs H N (VIII), R4 wherein
R
4 and R s are as hereinbefore defined, and if necessary subsequently cleaving any protecting group used for the nitrogen atom of the lactam group or cleaving from a solid phase.
The protecting group for the nitrogen atom of the lactam group may be, for example, an acetyl, benzoyl, ethoxycarbonyl, tert.butyloxycarbonyl or benzyloxycarbonyl group and the solid phase may be a resin such as a 4-(2',4'-dimethoxyphenylaminomethyl)-phenoxy resin, the bond preferably being formed via the amino group, or a pbenzyloxybenzyl alcohol resin, wherein the bond is conveniently formed via an intermediate member such as a dimethoxy-4-hydroxy-benzyl derivative.
The reaction is conveniently carried out in a solvent such as dimethylformamide, toluene, acetonitrile, tetrahydrofuran, dimethylsulphoxide, methylene chloride or mixtures thereof, optionally in the presence of an inert base such as triethylamine, N-ethyl-diisopropylamine or sodium hydrogen carbonate at temperatures between 20 and 175 0 C, whilst any protecting group used can be cleaved at the same time by transamidation.
50 If Z in a compound of general formula VII denotes a halogen atom, the reaction is preferably carried out in the presence of an inert base at temperatures of between 20 and 1200C.
If Z 1 in a compound of general formula VII denotes a hydroxy, alkoxy or arylalkoxy group, the reaction is preferably carried out at temperatures between 20 and 200 0
C.
If a protecting group used subsequently has to be cleaved, this is conveniently done either hydrolytically in an aqueous or alcoholic solvent, e.g. in methanol/water, ethanol/water, isopropanol/water, tetrahydrofuran/water, dioxan/water, dimethylformamide/water, methanol or ethanol in the presence of an alkali metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures between 0 and 100 0 C, preferably at temperatures between 10 and 50 0
C,
or advantageously by transamidation with an organic base such as ammonia, butylamine, dimethylamine or piperidine in a solvent such as methanol, ethanol, dimethylformamide and the mixtures thereof or in an excess of the amine used, at temperatures between 0 and 100 0 C, preferably at temperatures between 10 and 50 0
C.
Cleaving from any solid phase used is preferably carried out using trifluoroacetic acid and water at temperatures between 0 and 35 0 C, preferably at ambient temperature.
b. In order to prepare a compound of general formula I wherein
R
2 has the meanings given hereinbefore, with the exception of the carboxy group: reacting a compound of general formula 51 R3 R1 0
(IX),
HOOC
I
RI
Ri wherein Ri and R 3 to R s are as hereinbefore defined, or the reactive derivatives thereof, with a compound of general formula H R 19 wherein
R
19 denotes a C 1 6 -alkanol, a C 4 7 -cycloalkanol or an aromatic alcohol, a C 1 .6-alkanol which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C_ 3 -alkoxy-carbonyl, aminocarbonyl, C 3-alkylamino-carbonyl or di-(C 1 .3-alkyl)-aminocarbonyl group, a C 2 6 -alkanol which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C_.3-alkoxy, amino,
C,.
3 -alkylamino or di-(CI_3-alkyl)-amino group, an amino or methylamino group, an ethylamino group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 1 -3-alkoxy group or a di-(C 1 -2-alkyl)-amino group.
The esterification or amidation is preferably carried out in a solvent such as methylene chloride, diethylether, tetrahydrofuran, toluene, dioxan, acetonitrile, dimethylsulphoxide or dimethylformamide, optionally in the presence of an inorganic or a tertiary organic base, 52 preferably at temperatures between 20 0 C and the boiling temperature of the solvent used. The reaction with a corresponding acid is preferably carried out in the presence of a dehydrating agent, e.g. in the presence of isobutyl chloroformate, tetraethyl orthocarbonate, trimethyl orthoacetate, 2,2-dimethoxypropane, tetramethoxysilane, thionylchloride, trimethylchlorosilane, phosphorus trichloride, phosphorus pentoxide, N,N'-dicyclohexylcarbodiimide, N,N'-dicyclohexylcarbodiimide/N-hydroxysuccinimide, N,N'-dicyclohexylcarbodiimide/1-hydroxy-benzotriazole, 2-(1H-benzotriazol-lyl)-1,1,3,3-tetramethyluronium-tetrafluoroborate, 2-(1Hbenzotriazol-l-yl)-1,1,3,3-tetramethyluroniumtetrafluoroborate/l-hydroxy-benzotriazole, N,N'-carbonyldiimidazole or triphenylphosphine/carbon tetrachloride, and optionally with the addition of a base such as pyridine, 4-dimethylaminopyridine, N-methyl-morpholine or triethylamine, conveniently at temperatures between 0 and 150 0 C, preferably at temperatures between 0 and 100 0 C, and the acylation with a corresponding reactive compound such as an anhydride, ester, imidazolide or halide thereof, is optionally carried out in the presence of a tertiary organic base such as triethylamine, N-ethyl-diisopropylamine or N-methyl-morpholine at temperatures between 0 and 150 0 C, preferably at temperatures between 50 and 100 0
C.
c. In order to prepare a compound of general formula I, wherein R 4 denotes a C 1 4 -alkyl group substituted by the group
R
7 wherein R, denotes an amino, C 1 _,-alkylamino, di-(C 1 ,-alkyl)-amino, phenylamino, N-phenyl-C_ 3 -alkyl-amino, phenyl-C 1 3 -alkylamino, N-(C_ 3 -alkyl)-phenyl-C_ 3 -alkylamino or di-(phenyl-C,_ 3 -alkyl)-amino group, 53 a ow-hydroxy-C,-,-alkyl -amino, N- (C 1 3 -alkyl) -w-hydroxy-C,_,-alkyl -amino, di- (wo-hydroxy-C,_,-alkyl) -amino, di- (Cl- 3 -alkoxy) -C,-,-alkyl) -amino or N- (dioxolan-2-yl) -C- 3 -alkyl-amino group, a C 1 3 -alkylcarbonylamino-C 2 -alkyl -amino or
C
3 -alkylcarbonylamirio-C 2 3 -alkyl-N- (C,-,-alkyl) -amino group, a C 1 3 -alkylsulphonylamino, N- (C,-,-alkyl)
C-
3 -a lkylsulphonylamino,
C-
3 -alkylsulphonylamino-C 2 3 -alky1 -amino or Cl- 3 -alkylsulphonylamino-C 2 3 -alky1-N- (C,-,-alkyl) -amino group, a group of formula N(RjO)-(CH 2 )m-4CO)o-Rjj (III), wherein Rio denotes a hydrogen atom, a C 1 3 -alkyl group, a
C
1 3 -alkylcarbonyl, arylcarbonyl, phenyl-Cl- 3 -alkylcarbonyl, Cl-3-al kylsuiphonyl, arylsuiphonyl or phenyl- C- alkylsuiphonyl group, m denotes one of the numbers 1, 2, 3 or 4, o denotes the number 1 and
R
11 denotes an amino, C,-,-alkylamino, di- (Cl- 4 -alkyl) -amino, phenylamino, N- (Cl 4 -alkyl) -phenylamino, benzylamino, N- (C 1 4 -alkyl) -benzylamino, C 1 4 -alkoxy or
C-
3 -alkoxy-C 1 3 -alkoxy group, a di- (C,-,-alkyl) -amino-C- 3 54 alkylamino group optionally substituted in the 1 position by a C 1 3 alkyl group, or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiet may b fused to a phenyl ring or in ach case the methylene group in the 4 position of a 6- or 7membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH,
-N(C
1 3 -alkyl), -N(phenyl), -N(C_ 3 -alkyl-carbonyl) or -N(benzoyl) group, a C 4 7 -cycloalkylamino, C 4 ,_-cycloalkyl-C-,-alkylamino or C4-7-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a Cs.,-cycloalkyl,
C
2 -4-alkenyl or C_ -alkyl group, or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C_3-alkyl, C1_3-alkoxy or amino group, and/or one or two hydrogen atoms may each be replaced by a C,.3-alkyl, Cs,_-cycloalkyl or phenyl group and/or the methylene group in the 3 position of a cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl, C_ 3 -alkoxy or C,.3-alkoxy-Ci_ 3 -alkyl group, in each case the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C,_ 3 -alkyl, 55 Ci.3-alkoxy, C 1 _3-alkoxy-C 1 .3-alkyl, C-_4-alkoxycarbonyl, aminocarbonyl, CI_--alkylaminocarbonyl, di-(C 3 -alkyl)aminocarbonyl, phenyl-C- 3 -alkylamino or N-(C 3 -alkyl)phienyl -a-i-y-Llamjino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl-), -N(phenyl), -N(phenyl-C,_ 3 -alkyl-) -N(C- 3 -alkyl-carbonyl-), -N(Cl_ 4 -alkoxy-carbonyl-), -N(benzoyl-) or -N(phenyl-C. 3-alkyl-carbonyl-) group, wherein a methylene group linked to an iminonitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the iminonitrogen atom may each be replaced by a carbonyl group: reacting a compound of general formula
R
3 Rs I A- Z2
N
x
(XI),
N
R2'
RI
wherein
R
3
R
5 and X are as hereinbefore defined,
R
2 has the meanings given for R 2 hereinbefore, Ri 8 denotes a hydrogen atom or a protecting group for the nitrogen atom of the lactam group, wherein one of the groups
R
2 and R 8 may also denote a bond to a solid phase optionally 56 formed via a spacer and the other one of the groups R 2 and R,, has the abovementioned meanings, A denotes a C,-4-alkyl group and Z 2 denotes a leaving group, for example an alkyl or arysulphonyloxy group such as the methysulphonyloxy, ethylsulphonyloxy, p-toluenesulphonyloxy or trifluoromethanesulphonyloxy group, with an amine of general formula
(XII),
wherein R has the meanings given for R, hereinbefore, and subsequently, if necessary, cleaving any protecting group used for the nitrogen atom of the lactam group, or cleaving from a solid phase.
The reaction is conveniently carried out in a solvent such as methylene chloride, tetrahydrofuran, 1,4-dioxan, toluene, acetonitrile, dimethylsulphoxide, dimethylformamide, dimethylacetamide, N-methylpyrrolidone or the mixtures thereof, optionally with the addition of water as a co-solvent and/or with the addition of an inert auxiliary base, e.g. sodium hydrogen carbonate, pyridine, 2,4,6-trimethylpyridine, quinoline, triethylamine, N-ethyldiisopropylamine, N-ethyldicyclohexylamine, 1,4-diazabicyclo[2,2,2]octane or 1,8diazabicyclo[5,4,0]undec-7-ene, at temperatures between -50 0
C
and +100 0 C, preferably between -10 0 C and +50 0 C, while any protecting group used may be cleaved at the same time by transamidation.
If any protecting group used for the nitrogen atom of the lactam group has to be removed or if the compound has to be cleaved from a solid phase this is carried out as described under method above.
57 If according to the invention a compound of general formula I is obtained which contains an alkoxycarbonyl group, this may be converted by hydrolysi into a corresponding carboxy compound, or if a compound of general formula I is obtained which contains an amino or alkylamino group, this may be converted by reductive alkylation into a corresponding alkylamino or dialkylamino compound, or if a compound of general formula I is obtained which contains an amino or alkylamino group, this may be converted by acylation or sulphonation into a corresponding acyl or sulphonyl compound, or if a compound of general formula I is obtained which contains a carboxy group, this may be converted by esterification or amidation into a corresponding ester or aminocarbonyl compound, or if a compound of general formula I is obtained which contains a cycloalkyleneimino group wherein a methylene group is replaced by a sulphur atom, this may be converted by oxidation into a corresponding sulphinyl or sulphonyl compound, or if a compound of general formula I is obtained which contains a nitro group, this may be converted by reduction into a corresponding amino compound, or if a compound of general formula I is obtained wherein R 4 denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group, this may subsequently be converted, by reaction with a corresponding cyanate, isocyanate or carbamoyl halide, into a corresponding urea compound of general formula I, or 58 if a compound of general formula I is obtained wherein R 4 denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group, this may subsequently be converted, by reaction with a corresponding compound which transfers the amidino group or by reaction with a corresponding nitrile, into a corresponding guanidino compound of general formula I.
The subsequent hydrolysis is preferably carried out in an aqueous solvent, e.g. in water, methanol/water, ethanol/water, isopropanol/water, tetrahydrofuran/water or dioxan/water, in the presence of an acid such as trifluoroacetic acid, hydrochloric acid or sulphuric acid or in the presence of an alkali metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures between 0 and 100 0
C,
preferably at temperatures between 10 and 50 0
C.
The subsequent reductive alkylation is preferably carried out in a suitable solvent such as methanol, methanol/water, methanol/water/ammonia, ethanol, ether, tetrahydrofuran, dioxan or dimethylformamide, optionally with the addition of an acid such as hydrochloric acid in the presence of catalytically activated hydrogen, e.g. hydrogen in the presence of Raney nickel, platinum or palladium/charcoal, or in the presence of a metal hydride such as sodium borohydride, lithium borohydride, sodium cyanoborohydride or lithium aluminium hydride at temperatures between 0 and 100 0
C,
preferably at temperatures between 20 and 80 0
C.
The subsequent acylation or sulphonylation is preferably carried out with the corresponding free acid or a corresponding reactive compound such as the anhydride, ester, imidazolide or halide thereof, preferably in a solvent such as methylene chloride, diethylether, tetrahydrofuran, toluene, dioxan, acetonitrile, dimethylsulphoxide or dimethylformamide, 59 optionally in the presence of an inorganic or tertiary organic base at temperatures between -20 and 200°C, preferably at temperatures between 200C and boiling temperature of the solvent used. The reaction with the free acid may optionally be carried out in the presence of an acid-activating agent or a dehydrating agent, e.g. in the presence of isobutyl chloroformate, tetraethyl orthocarbonate, trimethyl orthoacetate, 2,2-dimethoxypropane, tetramethoxysilane, thionyl chloride, trimethylchlorosilane, phosphorus trichloride, phosphorus pentoxide, N,N'-dicyclohexylcarbodiimide, N,N'-dicyclohexylcarbodiimide/N-hydroxysuccinimide, N,N'-dicyclohexylcarbodiimide/l-hydroxy-benzotriazole, 2-(1H-benzotriazol-l-yl)-1,1,3,3-tetramethyluroniumtetrafluoroborate, 2-(1H-benzotriazol-l-yl)-1,1,3,3tetramethyluronium-tetrafluoroborate/1-hydroxy-benzotriazole, N,N'-carbonyldiimidazole or triphenylphosphine/carbon tetrachloride, and optionally with the addition of a base such as pyridine, 4-dimethylamino-pyridine, N-methyl-morpholine or triethylamine, conveniently at temperatures between 0 and 1500C, preferably at temperatures between 0 and 100 0 C. The reaction with a corresponding reactive compound may optionally be carried out in the presence of a tertiary organic base such as triethylamine, N-ethyl-diisopropylamine, N-methylmorpholine or pyridine or by using an anhydride in the presence of the corresponding acid at temperatures between 0 and 1500C, preferably at temperatures between 50 and 100 0
C.
The subsequent esterification or amidation is conveniently carried out by reacting a corresponding reactive carboxylic acid derivative with a corresponding alcohol or amine as described hereinbefore.
The subsequent oxidation of the sulphur atom is preferably carried out in a solvent or mixture of solvents, e.g. in water, water/pyridine, acetone, methylene chloride, acetic 60 acid, acetic acid/acetic anhydride, dilute sulphuric acid or trifluoroacetic acid, usefully at temperatures of between and 100 0 C depending on the oxidising agent used.
In order to prepare a corresponding sulphinyl compound of general formula I the oxidation is expediently carried out with one equivalent of the oxidising agent used, e.g. with hydrogen peroxide in glacial acetic acid, trifluoroacetic acid or formic acid at 0 to 20 0 C or in acetone at 0 to 60 0 C, with a peracid such as performic acid in glacial acetic acid or trifluoroacetic acid at 0 to 50 0 C or with m-chloroperbenzoic acid in methylene chloride, chloroform or dioxan at -20 to 0 C, with sodium metaperiodate in aqueous methanol or ethanol at -15 to 25 0 C, with bromine in glacial acetic acid or aqueous acetic acid optionally in the presence of a weak base such as sodium acetate, with N-bromosuccinimide in ethanol, with tert.butyl hypochlorite in methanol at -80 to -30 0 C, with iodobenzodichloride in aqueous pyridine at 0 to 50 0 C, with nitric acid in glacial acetic acid at 0 to 20 0 C, with chromic acid in glacial acetic acid or in acetone at 0 to 20 0 C and with sulphuryl chloride in methylene chloride at -70 0 C, the resulting thioether-chlorine complex is expediently hydrolysed with aqueous ethanol.
In order to prepare a sulphonyl compound of general formula I the oxidation is expediently carried out starting from a corresponding sulphinyl compound with one or more equivalents of the oxidising agent used or starting from a corresponding mercapto compound, expediently with two or more equivalents of the oxidising agent used, e.g. with hydrogen peroxide in glacial acetic acid/acetic anhydride, trifluoroacetic acid or in formic acid at 20 to 100 0 C or in acetone at 0 to 60 0 C, with a peracid such as performic acid or m-chloroperbenzoic acid in glacial acetic acid, trifluoroacetic acid, methylene chloride or chloroform at temperatures between 0 and 60 0 C, with nitric acid in glacial acetic acid at 0 to 20 0 C, with chromic acid, 61 sodium periodate or potassium permanganate in acetic acid, water/sulphuric acid or in acetone at 0 to 20 0
C.
The subsequent reduction of a nitro group is preferably carried out by hydrogenolysis, e.g. with hydrogen in the presence of a catalyst such as palladium/charcoal or Raney nickel in a solvent such as methanol, ethanol, ethyl acetate, dimethylformamide, dimethylformamide/acetone or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid or glacial acetic acid at temperatures of between 0 and 50 0 C, but preferably at ambient temperature, and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to bar.
The subsequent preparation of a corresponding urea compound of general formula I is conveniently carried out with an inorganic cyanate or a corresponding isocyanate or carbamoylchloride, preferably in a solvent such as dimethylformamide and optionally in the presence of a tertiary organic base such as triethylamine at temperatures between 0 and 50 0 C, preferably at ambient.
The subsequent preparation of a corresponding guanidino compound of general formula I is conveniently carried out by reacting with a compound which transfers the amidino group such as 3,5-dimethylpyrazole-l-carboxylic acid amidine, preferably in a solvent such as dimethylformamide and optionally in the presence of a tertiary organic base such as triethylamine at temperatures of between 0 and 50 0
C,
preferably at ambient temperature.
In the reactions described hereinbefore, any reactive groups present such as carboxy, hydroxy, amino, alkylamino or imino groups may be protected during the reaction by conventional protecting groups which are cleaved again after the reaction.
62 For example, a protecting group for a carboxyl group may be a trimethylsilyl, methyl, ethyl, tert.butyl, benzyl or tetrahydropyranyl group and protecting groups for a hydroxy, amino, alkylamino or imino group may be an acetyl, trifluoroacetyl, benzoyl, ethoxycarbonyl, tert.butoxycarbonyl, benzyloxycarbonyl, benzyl, methoxybenzyl or 2,4-dimethoxybenzyl group and additionally, for the amino group, a phthalyl group.
Any protecting group used is optionally subsequently cleaved for example by hydrolysis in an aqueous solvent, e.g. in water, isopropanol/water, tetrahydrofuran/water or dioxan/water, in the presence of a acid such as trifluoroacetic acid, hydrochloric acid or sulphuric acid or in the presence of an alkali metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide, at temperatures between 0 and 100 0 C, preferably at temperatures between 10 and 50 0
C.
However, a benzyl, methoxybenzyl or benzyloxycarbonyl group is cleaved, for example, hydrogenolytically, e.g. with hydrogen in the presence of a catalyst such as palladium/charcoal in a solvent such as methanol, ethanol, ethyl acetate, dimethylformamide, dimethylformamide/acetone or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid or glacial acetic acid at temperatures between 0 and 500C, but preferably at ambient temperature, and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to bar.
A methoxybenzyl group may also be cleaved in the presence of an oxidising agent such as cerium(IV)ammonium nitrate in a solvent such as methylene chloride, acetonitrile or 63 acetonitrile/water at temperatures of between 0 and 50 0 C, but preferably at ambient temperature.
A 2,4-dimethoxybenzyl group, however, is preferably cleaved in trifluoroacetic acid in the presence of anisole.
A tert.butyl or tert.butyloxycarbonyl group is preferably cleaved by treating with an acid such as trifluoroacetic acid or hydrochloric acid, optionally using a solvent such as methylene chloride, dioxan, ethyl acetate or ether.
A phthalyl group is preferably cleaved in the presence of hydrazine or a primary amine such as methylamine, ethylamine or n-butylamine in a solvent such as methanol, ethanol, isopropanol, toluene/water or dioxan at temperatures between and 50 0
C.
Moreover, chiral compounds of general formula I obtained may be resolved into their enantiomers and/or diastereomers.
Thus, for example, the compounds of general formula I obtained which occur as racemates may be separated by methods known per se (cf. Allinger N. L. and Eliel E. L. in "Topics in Stereochemistry", Vol. 6, Wiley Interscience, 1971) into their optical antipodes and compounds of general formula I with at least 2 asymmetric carbon atoms may be resolved into their diastereomers on the basis of their physical-chemical differences using methods known per se, e.g. by chromatography and/or fractional crystallisation, and, if these compounds are obtained in racemic form, they may subsequently be resolved into the enantiomers as mentioned above.
The enantiomers are preferably separated by column separation on chiral phases or by recrystallisation from an optically active solvent or by reacting with an optically active 64 substance which forms salts or derivatives such as e.g. esters or amides with the racemic compound, particularly acids and the activated derivatives or alcohols thereof, and separating the mixture of diasLereomeric salts or derivatives thus obtained, e.g. on the basis of their differences in solubility, whilst the free antipodes may be released from the pure diastereomeric salts or derivatives by the action of suitable agents. Optically active acids in common use are e.g.
the D- and L-forms of tartaric acid or dibenzoyltartaric acid, di-o-tolyltartaric acid, malic acid, mandelic acid, camphorsulphonic acid, glutamic acid, N-acetylglutamic acid, aspartic acid, N-acetylaspartic acid or quinic acid. An optically active alcohol may be for example or (-)-menthol and an optically active acyl group in amides, for example, may be a or (-)-menthyloxycarbonyl group.
Furthermore, the compounds of formula I obtained may be converted into the salts thereof, particularly for pharmaceutical use into the physiologically acceptable salts with inorganic or organic acids. Acids which may be used for this purpose include for example hydrochloric acid, hydrobromic acid, sulphuric acid, phosphoric acid, fumaric acid, succinic acid, lactic acid, citric acid, tartaric acid, maleic acid or methanesulphonic acid.
Moreover, if the new compounds of formula I thus obtained contain a carboxy group, they may subsequently, if desired, be converted into the salts thereof with inorganic or organic bases, particularly for pharmaceutical use into the physiologically acceptable salts thereof. Suitable bases for this purpose include for example sodium hydroxide, potassium hydroxide, cyclohexylamine, ethanolamine, diethanolamine and triethanolamine.
The compounds of general formulae VII to XII used as starting materials are known from the literature in some cases or may 65 be obtained by methods known from the literature or may be obtained by the methods described hereinbefore and in the Examples. For example, the compounds of general formula VI are described in German Patent Application 198 24 922.5.
Moreover, the compounds of general formula XI may be obtained from the compounds of general formula I wherein R 4 denotes a
C
1 4 -alkyl-phenyl group substituted in the alkyl moiety by a hydroxy group, for example, by reacting with alkyl- or arylsulphonyl chlorides.
As already mentioned, the new compounds of general formula I wherein R 1 denotes a hydrogen atom or a prodrug group have valuable pharmacological properties, particularly inhibitory effects on various kinases, especially on receptor-tyrosine kinases such as VEGFR2, PDGFRa, PDGFRP, FGFR1, FGFR3, EGFR, HER2, IGF1R and HGFR, as well as on complexes of CDK's (Cyclin Dependent Kinases) such as CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9 with their specific cyclins Bl, B2, C, D1, D2, D3, E, F, Gl, G2, H, I and K) and on viral cyclin, on the proliferation of cultivated human cells, particularly endothelial cells, e.g. in angiogenesis, but also on the proliferation of other cells, particularly tumour cells.
The biological properties of the new compounds were tested by the following standard procedure, as follows: Human umbilical endothelial cells (HUVEC) were cultivated in IMDM (Gibco BRL), supplemented with 10 foetal calf serum (FBS) (Sigma), 50 AM of I-mercaptoethanol (Fluka), standard antibiotics, 15 Ag/ml of endothelial cell growth factor (ECGS, Collaborative Biomedical Products) and 100 Ag/ml of heparin (Sigma) on gelatine-coated culture dishes (0.2 gelatine, Sigma) at 37 0 C, under 5 CO 2 in a water-saturated atmosphere.
66 In order to investigate the inhibitory activity of the compounds according to the invention the cells were starved for 16 hours, i.e. kept in culture medium without growth factors (ECGS heparin). The cells were detached from the culture dishes using trypsin/EDTA and washed once in serumcontaining medium. Then they were seeded out in amounts of x 10 3 cells per well.
The proliferation of the cells was stimulated with 5 ng/ml of
VEGF
16 5 (vascular endothelial growth factor; H. Weich, GBF Braunschweig) and 10 gg/ml of heparin. As a control, 6 wells in each dish were not stimulated.
The compounds according to the invention were dissolved in 100% dimethylsulphoxide and added to the cultures in various dilutions in triplicate, the maximum dimethyl sulphoxide concentration being 0.3 The cells were incubated for 76 hours at 37 0 C, then for a further 16 hours 3 H-thymidine (0.1 A Ci/well, Amersham) was added in order to determine the DNA synthesis. Then the radioactively labelled cells were immobilised on filter mats and the radioactivity incorporated was measured in a 6counter. In order to determine the inhibitory activity of the compounds according to the invention the mean value of the non-stimulated cells was subtracted from the mean value of the factor-stimulated cells (in the presence or absence of the compounds according to the invention).
The relative cell proliferation was calculated as a percentage of the control (HUVEC without inhibitor) and the concentration of active substance which inhibits the proliferation of the cells by 50 (IC 5 0 was determined.
S -67 The test results of the following compounds to of general formula I are given by way of example: methy-7ene] -6-etAoyIarbonyl-2-indolinone, Ib Z-[(L-(4Itpiperidi -1-yl-methyl) -ai Lio-penl methylene] -6-carbxayl-2-indolinone, 3-Z- [1-(4-(piperidin-1-yl-methyl)-anilino)--phenylmethylene] -6 -methaoyaboy-indolinone, 3-Z- (1-(4-(dimethylinoymethyl)-anilino) phenylmethylene] -6-methoxycarbonyl-2-indolinone, 3-Z-[l-(4-((2,6-dilmty-ppri-1y)methyl)-anilino)-i-hnl 1-hlmethylene -6-ethoxycarbonyl-2-indolinone, 3-Z- [1-(4-(N(2-dimethylaminoethinyl)-aetyl-ai) alo-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- [l-(4-(N-(3-dimethylamino-proyl)-N-acetyl-amino)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone, 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] -6 -methoxycarbonyl -2-indolinone, 3-Z- (N-acetyl-N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone, 68 3-Z-[1-(4-C1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, Cm) 3-Z-[li- CN-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2ndol inone, 3-Z- (3-dimethylamina-prapyl) -N-methylsulphanylamino) -anilina) -1-phenyl-methylene] -6-methoxycarbanyl-2indalinane, 3-Z- Ii- (N-dimethylaminocarbonylmethyl-Nmethylsuiphanyl-amino) -anilina) -1-phenyl-methylene] -6methaxycarbanyl-2 -indal inane, 3-Z- ((2-dimethylamina-ethyl) -carbanyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indalinone, 3-Z- (N-(2-dimethylamino-ethyl)-N-acetyl-amina)anilina) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone and 3-Z- [1-C4-methylaminomethyl-anilina) -l-phenyl-methylene] 6-methoxycarbonyl-2-indolinone.
69 The following Table contains the results found: Compound IC50 [im] 0.04 0.35 0.01 0.02 0.05 0.01 0.003 0.01 0.03 0.02 0.03 0.1 0.02 0.02 0.01 0.02 0.02 0.01 0.04 In view of their inhibitory effect on the proliferation of cells, particularly endothelial cells and tumour cells, the compounds of general formula I are suitable for treating diseases in which the proliferation of cells, particularly endothelial cells, plays a part.
Thus, for example, the proliferation of endothelial cells and the concomitant neovascularisation constitute a crucial stage in tumour progression (Folkman J. et al., Nature 339, 58-61, (1989); Hanahan D. and Folkman Cell 86, 353-365, (1996)).
Furthermore, the proliferation of endothelial cells is also 70 important in haemangiomas, in metastasisation, rheumatoid arthritis, psoriasis and ocular neovascularisation (Folkman Nature Med. 1, 27-31, (1995)). The therapeutic usefulness of inhibitors of endothelial cell proliferation was demonstrated in the animal model for example by O'Reilly et al. and Parangi et al. (O'Reilly M.S. et al., Cell 88, 277- 285, (1997); Parangi S. et al., Proc Natl Acad Sci USA 93, 2002-2007, (1996)).
The compounds of general formula I, their tautomers, their stereoisomers or the physiologically acceptable salts thereof are thus suitable, for example, for treating tumours (e.g.
plate epithelial carcinoma, astrocytoma, Kaposi's sarcoma, glioblastoma, lung cancer, bladder cancer, carcinoma of the neck, melanoma, ovarian cancer, prostate cancer, breast cancer, small-cell lung cancer, glioma, colorectal carcinoma, urogenital cancer and gastrointestinal carcinoma as well as haematological cancers, such as multiple myeloma), psoriasis, arthritis rheumatoid arthritis), haemangioma, angiofibroma, eye diseases diabetic retinopathy), neovascular glaucoma, kidney diseases (e.g.
glomerulonephritis), diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy, fibrotic diseases cirrhosis of the liver), mesangial cell proliferative diseases, arteriosclerosis and damage to the nerve tissue and also for inhibiting the reocclusion of blood vessels after treatment with a balloon catheter, in vascular prosthetics or after the insertion of mechanical devices for keeping blood vessels open stents), or other diseases in which cell proliferation or angiogenesis are involved.
By reason of their biological properties the compounds according to the invention may be used on their own or in conjunction with other pharmacologically active compounds, for example in tumour therapy, in monotherapy or in conjunction 71 with other anti-tumour therapeutic agents, for example in combination with topoisomerase inhibitors etoposide), mitosis inhibitors vinblastin, taxol), compounds which interact with nucleic acids cis-platin, cyclophosphamide, adriamycin), hormone antagonists (e.g.
tamoxifen), inhibitors of metabolic processes etc.), cytokines interferons), kinase inhibitors, antibodies, or in conjunction with radiotherapy, etc. These combinations may be'administered either simultaneously or sequentially.
For pharmaceutical use the compounds according to the invention are generally used for warm-blooded vertebrates, particularly humans, in doses of 0.01-100 mg/kg of body weight, preferably 0.1-20 mg/kg. For administration they are formulated with one or more conventional inert carriers and/or diluents, e.g. with corn starch, lactose, glucose, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, tartaric acid, water, water/ethanol, water/glycerol, water/sorbitol, water/polyethylene glycol, propylene glycol, stearyl alcohol, carboxymethylcellulose or fatty substances such as hard fat or suitable mixtures thereof in conventional galenic preparations such as plain or coated tablets, capsules, powders, injectable solutions, ampoules, suspensions, solutions, sprays or suppositories.
72 The Examples which follow are intended to illustrate the invention: Abbreviations used: FMOC 9-fluorenylmethoxycarbonyl HOBt l-hydroxy'lH-benzotriazole TBTU O-benzotriazol-l-yl-N,N,N',N'-tetramethyluroniumtetrafluoroborate DBU 1,8-diazabicyclo[5.4.0]undec-7-ene Preparation of the starting compounds: Solid phase Example I g of Rink resin (MBHA resin, made by Messrs Novabiochem) are left to swell in 30 ml of dimethylformamide. Then 40 ml of piperidine in dimethylformamide are added and the mixture is shaken for 7 minutes to cleave the FMOC protecting group.
The resin is then washed repeatedly with dimethylformamide.
Then 0.4 g of 2-indolinone-6-carboxylic acid (prepared analogously to Langenbeck et al., Justus Liebigs Ann. Chem.
499, 201-208 (1932)), 297 mg HOBt, 706 mg TBTU and 0.9 ml of N-ethyl-diisopropylamine in 30 ml of dimethylformamide are added and the mixture is shaken for 1 hour. Then the solution is suction filtered and the resin is washed five times with ml of dimethylformamide and three times with 30 ml of methylene chloride. To dry it, nitrogen is blown through the resin.
Yield: 1.9 g of charged resin 73 Solid phase example II 1.9 g of the resin obtained in Example I are stirred with 6 ml of acetic anhydride and 6 mi of triethyl orthobenzoate for 3 hours at 110 0 C. Then the mixture is left to cool and the resin is washed with dimethylformamide and subsequently with methylene chloride.
Yield: 1.9 g of moist resin The following charged resins are prepared analogously to Example II: resin charged with 3-Z-(1-ethoxy-methylene)-6-carbamoyl-2indolinone Prepared by reacting the resin obtained according to Example I with triethyl orthoformate resin charged with 3-Z-(1-methoxy-l-methyl-methylene)-6carbamoyl-2-indolinone Prepared by reacting the resin obtained according to Example I with trimethyl orthoacetate resin charged with 3-Z-(l-methoxy-l-ethyl-methylene)-6carbamoyl-2-indolinone Prepared by reacting the resin obtained according to Example I with trimethyl orthopropionate resin charged with 3-Z-(l-methoxy-l-propyl-methylene)-6carbamoyl-2-indolinone Prepared by reacting the product of Example I and trimethyl orthobutyrate 74 Example III N-(4-nitrophenyl)-N-methyl-methanesulphonamide g of N-methyl-4-nitroaniline are dissolved in 20 mi ot pyridine and 2.4 g of methanesulphonic acid chloride added dropwise at room temperature. The mixture is stirred for 12 hours at room temperature. After this time the mixture is poured onto water, the precipitate formed is filtered off and dried at 50°C in vabuo.
Yield: 4.0 g (87 of theory), Rf value: 0.5 (silica gel, ethyl acetate/toluene 7:3) Melting point: 107-108 °C Example IV N-(2-dimethylamino-ethyl)-N-methylsulphonyl-4-nitroaniline 38.9 g of N-methylsulphonyl-4-nitroaniline are dissolved in 1 of acetone, 51.9 g of l-chloro-2-dimethylamino-ethane, 77.4 g of potassium carbonate and 5.0 g of sodium iodide are added and the mixture is stirred for a total of 4 days at 500C, while after 12 hours a further 25.9 g of l-chloro-2dimethylamino-ethane, 49.8 g of potassium carbonate and 5.0 g of sodium iodide in 500 ml of acetone are added and after 36 hours another 26.0 g of l-chloro-2-dimethylamino-ethane, 50.0 g of potassium carbonate and 5.0 g of sodium iodide in 100 ml of acetone are added. After this time the mixture is filtered and the filtrate evaporated down. The residue is stirred with ether, suction filtered and dried at 400C.
Yield: 25.3 g (49 of theory), Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia 9:1:0.1) CI HN4S ESI mass spectrum: m/z 288 75 The following compounds are prepared analogously to Example
IV:
4-LN-(3-dimethylamino-propyl)-N-methylsulphonyl-amino]nitrobenzene N-carboxymethyl-N-methylsulphonyl-4-nitroaniline N-cyanomethyl-N.methylsulphonyl-p-phenylenediamine 4-[N-(2-(N-benzyl-N-methyl-amino)-ethyl)-Nmethylsulphonyl-amino]-nitrobenzene 4-[N-(3-phthalimido-2-yl-propyl)-N-methylsulphonyl-amino]nitrobenzene 4-[N-(3-(N-benzyl-N-methyl-amino)-propyl)-Nmethylsulphonyl-amino]-nitrobenzene Example V N-(dimethylaminocarbonyl-methyl)-N-methylsulphonyl-4nitroaniline g of N-carboxymethyl-N-methylsulphonyl-4-nitroaniline, g of dimethylamine hydrochloride, 8.1 g of TBTU and 3.9 g of HOBT are dissolved in 125 ml of dimethylformamide and at 0 C 17.6 ml of N-ethyl-diisopropylamine are added. The mixture is stirred for 4 hours at room temperature, diluted with 1 1 of water and the precipitate formed is suction filtered. After washing with water, ethanol and ether the residue is dried at 0 C in vacuo.
Yield: 5.3 g (69 of theory), Rf value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
1
H
15 N0OsS ESI mass spectrum: m/z 300 76 The following compounds are prepared analogously to Example V: 4-[(N-dimethylaminocarbonylmethyl)-amino]-nitrobenzene prepared from 4-(N-carboxymethyl-amino)-nitrobenzene and dimethylamine hydrochloride 4-(N-methylaminocarbonylmethyl-N-methylsulphonyl-amino)nitrobenzene Prepared from N-carboxymethyl-N-methylsulphonyl-4-nitroaniline and methylamine hydrochloride 4-[(N-(methylcarbamoyl-methyl)-N-methyl-amino)-methyl]nitrobenzene Prepared from 4-[(N-carboxymethyl-N-methyl-amino)-methyl]nitrobenzene and methylamine hydrochloride 4-[(N-(dimethylcarbamoyl-methyl)-N-methyl-amino)-methyl]nitrobenzene Prepared from 4-[(N-carboxymethyl-N-methyl-amino)-methyl]nitrobenzene and dimethylamine hydrochloride Example VI 4-[N-(2-dimethylamino-ethyl)-N-acetyl-amino]-nitrobenzene 3.6 g of 4-(2-dimethylamino-ethylamino)-nitrobenzene (according to Gabbay et al., J. Am. Chem. Soc. 91, 5136 (1969)) are dissolved in 50 ml of methylene chloride and ml of triethylamine are added. 1.3 ml of acetyl chloride are slowly added dropwise to this mixture at room temperature and the mixture is stirred for 2 hours at room temperature. After this time another 5.0 ml of triethylamine and 1.3 ml of acetylchloride are added and the mixture is refluxed for another 2 hours. The solvent is removed, the residue is taken up in ethyl acetate and the organic phase is extracted twice 77 with water. After drying over MgSO, the solvent is removed and the residue dried in vacuo.
Yield: 2.0 g (45 of theory), R, value: 0.55 (silica gel, methylene chloride/methanol/ammonia 9:1:0.1)
C
12 HIN303 ESI mass spectrum: m/z 252 The following compounds are prepared analogously to Example
VI:
4-[N-(3-dimethylamino-propyl)-N-acetyl-amino]-nitrobenzene Prepared from 4-(3-dimethylamino-propylamino)-nitrobenzene (according to Gabbay et al., J. Am. Chem. Soc. 91, 5136 (1969) and acetyl chloride 4-[N-(2-dimethylamino-ethyl)-N-propionyl-amino]nitrobenzene Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and propionyl chloride 4- [N-acetyl-N-(dimethylaminocarbonylmethyl)-amino]nitrobenzene Prepared from 4-[N-(dimethylaminocarbonylmethyl)-amino]nitrobenzene and acetyl chloride 4-[N-(2-dimethylamino-ethyl)-N-butyryl-amino]-nitrobenzene Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and butyryl chloride 4-[N-(2-dimethylamino-ethyl)-N-isobutyryl-amino]nitrobenzene Prepared from 4-(2-dimethylamino-ethylamino)-nitrobenzene and isobutyryl chloride 78 4-E[N- (2 -dimethylamino- ethyl) -N-benzoyl -amino] nitrobenzene Prepared from 4- (2-dimethylamino-ethylamino) -nitrobenzene and benzoyl chloride 4- [N-(2-dimethylamino-ethyl)-N-acetyl-amino] -1,3dinitrobenzene Prepared from 4- (2-dimethylamino-ethyl-amino) -1,3dinitrobenzene and acetyl chloride 4- (2-dimethylamino-ethyl) (furan-2-carbonyl) -amino] nitrobenzene Prepared from 4- (2-dimethylamino-ethylamino) -nitrobenzene and furan-2-carbonyl chloride 4 IN- (2 -dimethylamino- ethyl) (2 -methoxy-benzoyl) amino]nitrobenzene Prepared from 4- (2-dimethylamino-ethylamino) -nitrobenzene and 2-methoxy-benzoyl chloride 4-IN- (2-dimethylamino-ethyl) (pyridine-3-carbonyl) amino] -nitrobenzene Prepared from 4- (2 -dimethylamino -ethyl amino) -nitrobenzene and nicotinic acid chloride (11) 4 -IN- (2 -dimethylamino -ethyl) (phenyl -acetyl) amino] nitrobenzene Prepared from 4- (2-dimethylamino-ethylamino) -nitrobenzene and phenylacetyl -chloride (12) 4-I[N- (2 -dimethylamino-ethyl) -N-acetyl -amino] 3-bromonitrobenzene Prepared from 4-E(N- (2 -dimethylamino- ethyl) -amino] -3-bromonitrobenzene and acetyl chloride (13) N-acryloyl-N-methyl-4-nitro-aniline 79 Prepared from 4-methylamino-nitrobenzene and acrylic acid chloride (14) N-acroyoyl-N-isopropyl-4-nitro-aniline Prepared from 4-isopropylamino-nitrobenzene and acrylic acid chloride N-acryloyl-N-benzyl-4-nitro-aniline Prepared from 4-bentylamino-nitrobenzene and acrylic acid chloride (16) N-bromoacetyl-N-methyl-4-nitro-aniline Prepared from 4-methylamino-nitrobenzene and bromoacetyl chloride (17) N-bromoacetyl-N-isopropyl-4-nitro-aniline Prepared from 4-isopropylamino-nitrobenzene and bromoacetyl chloride (18) N-bromoacetyl-N-benzyl-4-nitro-aniline Prepared from 4-benzylamino-nitrobenzene and bromoacetyl chloride Example VII N-(dimethylaminomethylcarbonyl)-N-methyl-4-nitro-aniline 1.8 g of dimethylamine hydrochloride and 5.5 g of potassium carbonate are placed in 80 ml of acetone and 4.2 g of Nbromoacetyl-N-methyl-4-nitroaniline are added in three batches at room temperature. The mixture is stirred for 12 hours at room temperature. After this time the mixture is filtered and the filtrate is evaporated down. The residue is dissolved in ethyl acetate, washed twice with water, dried over sodium sulphate and finally concentrated by rotary evaporation.
Yield: 2.8 g (79 of theory), R, value: 0.5 (silica gel, ethyl acetate/methanol 7:3) 80 Melting point: 121-122 0
C
The following compounds are prepared analogously to Example
VII:
N- (piperidin-l-yl-methylcarbonyl) -N-methyl-4-nitroaniline N- (morpholin-4-yl-methylcarbonyl) -N-methyl-4-nitroaniline N- [(4-benzyl-piperazin-l-yl) -methylcarbonyl] -N-methyl-4nitroaniline N- (pyrrolidin-l-yl-methylcarbonyl) -N-methyl-4-nitroaniline N-tI(N-aminocarbonylmethyl-N-methyl-amino) -methylcarbonyl] N-methyl -4 -nitroaniline N- [(N-benzyl-N-methyl-amino) -methylcarbonyl] -N-methyl-4nitroaniline N- [di- (2-methoxyethyl) -amiino-methylcarbonyl] -N-methyl-4nitroaniline N- (dimethylaminomethylcarbonyl) -N-isopropyl-4-nitroaniline N- (piperidin-l-yl-methylcarbonyl) -N-isopropyl-4-nitroaniline N- [(4-tert.butoxycarbonyl-piperazin-l-yl) methylcarbonyl] -N-isopropyl-4-nitro-aniline (11) N- [(N-benzyl-N-methyl-amino) -methylcarbonyl] -N-benzyl-4nitro-aniline (12) N- (dimethylaminomethylcarbonyl) -N-benzyl-4-nitro-aniline 81 (13) N-(piperidin-1-yl-methylcarbonyl)-N-benzyl-4-nitroaniline (14) N-[di-(2-hydroxyethyl)-amino-methylcarbonyl]-N-methyl-4nitroaniline N-[(N-(2-methoxyethyl)-N-methyl-amino)-methylcarbonyl]-Nmethyl-4-nitroanilife (16) N-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)methylcarbonyl]-N-methyl-4-nitroaniline (17) N-[(4-methyl-piperazin-l-yl)-methylcarbonyl]-N-methyl-4nitroaniline (18) N-((imidazol-1-yl)-methylcarbonyll-N-methyl-4nitroaniline (19) N-[(phthalimido-2-yl)-methylcarbonyl]-N-methyl-4nitroaniline Example VIII N-[(2-dimethylamino-ethyl)-carbonyl]-N-benzvl-4-nitro-aniline g of dimethylamine hydrochloride, 1.1 ml of triethylamine and 1.2 g of N-acryloyl-N-benzyl-4-nitro-aniline are dissolved in 50 ml of methanol and stirred for 24 hours at room temperature. After this time the mixture is evaporated down.
The residue is purified over an aluminium oxide column (activity 2-3) with methylene chloride/ethanol 50:1 as eluant.
Yield: 1.4 g (98 of theory), Rf value: 0.8 (aluminium oxide, methylene chloride/ethanol 20:1) Melting point: 73 0
C
82 The following compounds are prepared analogously to Example
VIII:
N- (2-dinethylamin ethyl) 4-carbony -N-isopropyl -4 -nitroaniline Prepared from N-acryloyl-N-isopropyl-4-nitro-aniline and dimethylamine hydrochloride N-[(2-dimethylartino-ethyl)-carbonyl]-N-methyl-4-nitroaniline Prepared from N-acryloyl-N-methyl-4-nitro-aniline and dimethylamine hydrochloride N-[(2-(4-tert.butoxycarbonyl-piperazin-1-yl)-ethyl)carbonyl]-N-methyl-4-nitro-aniline Prepared from N-acryloyl-N-methyl-4-nitro-aniline and N-tert.butoxycarbonyl-piperazine N-[(2-(piperidin-1-yl)-ethyl)-carbonyl] -N-methyl-4-nitroaniline Prepared from N-acryloyl-N-methyl-4-nitro-aniline and piperidine N-[(2-(N-benzyl-N-methyl-amino)-ethyl)-carbonyl]-N-methyl- 4-nitro-aniline Prepared from N-acryloyl-N-methyl-4-nitro-aniline and N-benzyl-N-methyl-amine Example IX 4-(4-methyl-piperazine-l-yl)-nitrobenzene 31.5 g of 4-chloro-l-nitrobenzene and 44.4 ml of 1methylpiperazine are combined and stirred for 18 hours at 0 C. Then the solution is poured onto ice water and the precipitate formed is suction filtered, washed with water and -83 recrystallised from ethanol/water 1:1. The residue is dried in vacuo at 75 0
C.
Yield: 44.0 g (99 of theory), Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1) Melting point: 108-112 0
C
The following compounds are prepared analogously to Example
IX:
N- (2-dimethylaminoethyl) -N-methyl-4-nitroaniline Prepared from 1-fluoro-4-nitrobenzene and 1-dimethylamino-2methylamino-ethane N- (3-dimethylaminopropyl) -N-methyl-4-nitroaniline Prepared from 1-fluoro-4-nitrobenzene and 1-dimethylamino-3methylamino-propane 4- (N-carboxymethyl-amino) -nitrobenzene Prepared from 1-f luoro-4-nitrobenzene and glycine N-cyclohexyl -p-phenylenediamine Prepared from IL-fluoro-4*-nitrobenzene and cyclohexylamine 6- (2-dimethylamino-ethyl) -N-methylsulphonyl-amino] -3phthalimido-2 -yl-nitrobenzene Prepared from 2-nitro-4-phthalimido-2-yl-fluorobenzene, N- (2-dimethylamino-ethyl) -methanesulphonamide and sodium hydride as base 6- (2-dimethylamino-ethyl) -N-methylsulphonyl-amino] -1,3dinitrobenzene Prepared from 2,4-dinitro-chlorobenzene, N- (2-dimethylaminoethyl) -methanesulphonamide and sodium hydride as base 84 4-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3chloro-nitrobenzene Prepared from 2-fluoro-5-nitro-chlorobenzene, N-(2-dimethylamino-ethyl)-methanesuiphonamide and sodium hydride as base 4-(2-dimethylamino-ethyl-amino)-1,3-dinitrobenzene Prepared from l-chloro-2,4-dinitro-benzene and N,N-dimethylethylenediamine 4-[N-(2-dimethylamino-ethyl)-N-(ethylsuiphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-ethanesuiphonamide and sodium hydride as base 4-[N-(2-dimethylamino-ethyl)-N-(propylsulphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-propanesulphonamide and sodium hydride as base (11) 4-[N-(2-dimethylamino-ethyl)-N-(butylsulphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-butanesulphonamide and sodium hydride as base (12) 4-EN-(2-dimethylamino-ethyl)-N-(benzylsulphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-C-phenylmethanesulphonamide and sodium hydride as base (13) 4-EN-(2-dimethylamino-ethyl)-N-(phenylsulphonyl)-amino]nitrobenzene Prepared from 1-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-benzenesulphonamide and sodium hydride as base (14) 4-EN-(2-dimethylamino-ethyl)-N-(isopropylsulphonyl)amino]-nitrobenzene 85 Prepared from l-fluoro-4-nitro-benzene, N-(2-dimethylaminoethyl)-isopropylsulphonamide and sodium hydride as base 4- (2--dimeLhylaiiiino-eLhyl) -aminoj -3-bromo-nitrobenzene Prepared from 2-bromo-l-fluoro-4-nitro-benzene and N,Ndimethyl-ethylenediamine (16) 4-isopropylamino-nitrobenzene Prepared from l-flu6ro-4-nitrobenzene and isopropylamine (17) 4-benzylamino-nitrobenzene Prepared from l-fluoro-4-nitrobenzene and benzylamine Example X 4-(imidazol-4-vl)-nitrobenzene g of 2-phenylimidazole are carefully dissolved in 50 ml of concentrated sulphuric acid and 5.8 g of ammonium nitrate are added to this solution at 0°C. After a further 60 minutes stirring at 0°C the mixture is poured onto ice water, made basic with ammonia water and the precipitate formed is suction filtered and recrystallised from ethanol.
Yield: 8.0 g (64 of theory), R, value: 0.6 (silica gel, ethyl acetate/ethanol 10:1)
C
9
HN
3 0 2 Mass spectrum: m/z 189 The following compounds are prepared analogously to Example X: 4-(imidazol-2-yl)-nitrobenzene Prepared from 4-(imidazol-2-yl)-benzene 4-(5-methyl-imidazol-4-yl)-nitrobenzene Prepared from 4-methyl-5-phenyl-imidazole Heterocycl.
Chem. 1983, 20, 1277-1281) 86 Example XI 4-(2-(imidazol-4-yl)-ethylene)-nitrobenzene g of 4-nitrobenzaldehyde and 7.45 g of (N-trityl-imidazol- 4-yl-methyl)-triphenylphosphonium chloride are dissolved in ml of tetrahydrofuran and to this solution 3.0 ml of DBU are added dropwise at room temperature. After a further 120 minutes stirring at room temperature the mixture is poured onto water and the precipitate formed is suction filtered. The product is taken up in 25 ml of 1N hydrochloric acid and refluxed for 4 hours. After this time it is neutralised with ammoniacal water, extracted with ethyl acetate and the organic phase is washed with water, dried over sodium sulphate and evaporated down. The residue is purified over a silica gel column with methylene chloride/methanol 10:1 as eluant.
Yield: 1.0 g of (47 of theory), Rf value: 0.6 (silica gel, ethyl acetate/ethanol 10:1) Melting point: 185-188 0
C
Example XII 4-(Diperidin-l-vl-methyl)-nitrobenzene 40.0 g of 4-nitrobenzyl bromide are dissolved in 500 ml of methylene chloride, 51.5 ml of triethylamine are added and 18.3 ml of piperidine are carefully added dropwise. After the end of the exothermic reaction the mixture is refluxed for another 30 minutes. After cooling it is washed with water and the organic phase is dried over sodium sulphate. Finally, the organic phase is evaporated down.
Yield: 36.3 g of (89 of theory), R, value: 0.6 (silica gel, methylene chloride/methanol 9:1)
C
12 Hi 6 N202 Mass spectrum: m/z 221 [M
S
87 The following compounds are prepared analogously to Example
XII:
4- [(2,6-dimethyl-piperidin-l-yl) -methyl] -nitrobenzene 3- (N,N-dimethyl-aminomethyl) -nitrobenzene 4- (N,N-dimethyl-aminomethyl) -nitrobenzene 4- (2-dimethylamino-ethyl) -nitrobenzene 4- (2-diethylamino-ethyl) -nitrobenzene 4- (diethylamino-methyl) -nitrobenzene 4- (N-benzyl-N-methyl-aminomethyl) -nitrobenzene 4- (N-ethyl-N-methyl-aminomethyl) -nitrobenzene 4- (n-hexyl) -N-methyl-aminomethyl] -nitrobenzene 4- (thiomorpholii-4--rl -rrethyl) -nitrcbenzene (11) 4- [(4-methyl-piperazine-l-yl) -methyl] -nitrobenzene (12) 4- (imidazol-l-yl-methyl) -nitrobenzene (13) 4- (4-hydroxy-piperidin-1-yl) -ethyl-amino] -nitrobenzene (14) 4- [(3-hydroxy-pyrrolidin-l-yl) -methyl] -nitrobenzene 4- (l,2,4-triazol-l-yl-methyl) -nitrobenzene (16) 4- (1,2,3-triazol-2-yl-methyl) -nitrobenzene (17) 4-(l,2,3-triazol-l-yl-methyl)-nitrobenzene 88 (18) 4- [(N-ethoxycarbonylmethyl-N-methyl-amino) -methyl] nitrobenzene (19) 4-[I(N-aminocarbonylmethyl-N-methyl-amino) -methyl] nitrobenzene 4- (azetidin-l-yl-methyl) -nitrobenzene (21) 4- (2-methoxy-ethyl) -amino) -methyl] -nitrobenzene (22) 4- (N-tert.butoxycarbonyl-3-amino-propyl) -N-methylaminomethyl] -nitrobenzene (23) 4- [(N-propyl-N-methyl-amino) -methyl] -nitrobenzene (24) 4- (2-dimethylamino-ethyl) -N-methyl-amino) -methyl] nitrobenzene 4- (3-dimethylamino-propyl) -N-methyl-amino) -methyl] nitrobenzene (26) 4- (2-methoxy-ethyl) -N-methyl-amino) -methyl] nitrobenzene (27) 4- (2-hydroxy-ethyl) -N-methyl-amino) -methyl] nitrobenzene (28) 4- (dioxolan-2-yl-methyl) -N-methyl-amino) -methyl] nitrobenzene (29) 4- (3-oxo-piperazine-1-yl-methyl) -nitrobenzene 89 Example XIII 4-[(N-carboxymethyl-N-methyl-amino)-methyl]-nitrobenzene 7.33 of 4 (N-ehoxycarbonylmethyl-N- meLhy l-amino) -methyl] nitrobenzene are dissolved in 140 ml of ethanol, 34.0 ml of IN sodium hydroxide solution are added and the mixture is stirred for half an hour at room temperature. After this time the mixture is neutralised with 34 ml of IN hydrochloric acid, the solvent removed, the residue taken up in methylene chloride and extracted with water. The aqueous phase is evaporated down and the residue is recrystallised from methylene chloride.
Yield: 5.43 g (84 of theory), Rf value: 0.4 (silica gel, methylene chloride/methanol 2:1) CIoHi2N,04 Mass spectrum: m/z 223 Example XIV 4-(N-ethyl-aminomethyl)-nitrobenzene g of 4-nitrobenzyl bromide are dissolved in 25 ml of ethanol, combined with 25 ml of 10% ethanolic ethylamine solution and refluxed for 2 hours. Then the solution is concentrated by rotary evaporation, the residue is taken up with methylene chloride and washed with dilute sodium hydroxide solution. Finally the organic phase is evaporated down.
Yield: 2.3 g (46 of theory), R, value: 0.2 (silica gel, methylene chloride/methanol 9:1)
CHIN
2 0 2 ESI mass spectrum: m/z 179 The following compounds are prepared analogously to Example
XIV:
4-[N-(4-chlorobenzyl)-aminomethyl]-nitrobenzene 90 4- (N-cyclohexyl-aminomethyl) -nitrobenzene A _nlIr- _nz-n (4N4 (-Lspropyl-aminomethyl) -nitrobenzene 4- (N-methyl-aminomethyl) -nitrobenzene 4- (N-butyl-amixomethyl) -nitrobenzene 4- (N-methoxycarboraylmethyl-aminomethyl) -nitrobenzene 4- (N-benzyl-aminomethyl) -nitrobenzene 4- (aminomethyl) -nitrobenzene 4- (pyrrolidin-1-yl-methyl) -nitrobenzene (11) 4- (morpholin-4-yl-methyl) -nitrobenzene (12) 4- (hexamethyleneiminomethyl) -nitrobenzene (13) 4- (4-hydroxy-piperidin-1-yl-methyl) -nitrobenzene (14) 4- (4-methoxy-piperidin-1-yl-methyl) -nitrobenzene 4- (4-methyl-piperidin-1-yl-methyl) -nitrobenzene (16) 4- (4-ethyl-piperidin-1-yl-methyl) -nitrobenzene (17) 4- (4-isopropyl-piperidin-1-yl-methyl) -nitrobenzene (18) 4- (4-phenyl-piperidin-1-y1-methyl) -nitrobenzene (19) 4- (4-benzyl-piperidin-1-yl-methyl) -nitrobenzene 91 4- (4-ethoxycarbonyl-piperidin-l-yl-methyl) -nitrobenzene '12 ,'prpy.-aLn1~Li-eL1 -IiiLrobenzene (22) 4- (4-tert.butoxycarbonyl-piperazin-1-yl-methyl) nitrobenzene (23) 4- (2-morpholin-4-y1-ethyl) -nitrobenzene (24) 4- (2-pyrrolidin-1-yl-ethyl) -nitrobenzene 4- (2-piperidin-1-yl-ethyl) -nitrobenzene (26) 4- (N-ethyl-N-benzyl-aminomethyl) -nitrobenzene (27) 4- (N-propyl-N-benzyl-aminomethyl) -nitrobenzene (28) 4- [N-methyl-N- (4-chlorobenzyl) -aminomethyl] -nitrobenzene (29) 4- [N-methyl-N- (4-bromobenzyl) -aminomethyl] -nitrobenzene 4- [N-methyl-N- (4-f luorobenzyl) -aminomethyl] -nitrobenzene (31) 4- [N-methyl-N- (4-methylbenzyl) -aminomethyl] -nitrobenzene (32) 4- [N-methyl-N- (3-chlorobenzyl) -aminomethyl] -nitrobenzene (33) 4- [N-methyl-N- (3,4-dimethoxybenzyl) -aminomethyl] nitrobenzene (34) 4- [N-methyl-N- (4-methoxybenzyl) -aminomethyl] -nitrobenzene 4- (N-2,2,2-trifluoroethyl-N-benzyl-aminomethyl) nitrobenzene 0 -92- (36) 4- [N-2,2,2-trifluoroethyl-N- (4-chlorobenzyl) aminomethyl] -nitrobenzene (37) 4- (Lhliororpholin-4-yi-methyl) -nitrobenzene (38) 4- (azetidion-1-yl-methyl) -nitrobenzene (39) 4- (3,4-dihydropyrrolidin-1-yl-methyl) -nitroberizene 4- (3,4-dihydropiperidin-1-yl-methyl) -nitrobenzene (41) 4- (2-methoxycarbonyl-pyrrolidin-1-yl-methyl) -nitrobenzene (42) 4- (3,5-dimethyl-piperidin-1-yl-methyl) -nitrobenzene (43) 4- (4-phenyl-piperazin-1-yl-methyl) -nitrobenzene (44) 4- (4-phenyl-4-hydroxy-piperidin-1-yl-methyl) -nitrobenzene 4- (3,4,5-trimethoxybenzyl-N-methyl-aminomethyl) nitrobenzene (46) 4-EN- (3,4-dimethoxybenzyl) -N-ethyl-aminomethyl] nitrobenzene (47) 4-EN- (2,6-dichlorobenzyl) -N-methyl) -aminomethyl] nitrobenzene (48) 4-EN- (4-trifluoromethylbenzyl) -N-methyl) -aminomethyl] nitrobenzene (49) 4- (N-benzyl-N-isopropyl-aminomethyl) -nitrobenzene 4- (N-benzyl-N-tert.butyl-aminomethyl) -nitrobenzeie (51) 4- (N,N-diisopropyl-aminomethyl) -nitrobenzene 0 -93 (52) 4- (N,N-diisobutyl-aminomethyl) -nitrobenzene (53) 4- (2,3,4,5-tetrahydro-benzo(d)azepin-3-y1-methyi)nitrobenzene (54) 4- (2,3-dihydro-isoindol-2-yl-methyl) -nitrobenzene 4-(6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -nitrobenzeie (56) 4-(1,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) nitrobenzene (57) 4- (2-hydroxyethyl) -N-benzyl-aminomethyl] -nitrobenzene (58) 4-EN- (1-ethyl-pentyl) (pyridin-2-yl-methyl) aminomethyl] -nitrobenzene (59) 4- (piperin-1-yl-methyl) -1,3-dinitrobenzene 4- (N-phenethyl-N-methyl-aminomethyl) -nitrobenzene (61) 4- (3,4-dihydroxy-phenethyl) -N-methyl-aminomethyl] nitrobenzene (62) 4-EN- (3,4,5-trimethoxy-phenethyl) -N-methyl-aminomethyl] nitrobenzene (63) 4-EN- (3,4-dimethoxy-phenethyl) -N-methyl-aminomethyl] nitrobenzene (64) 4-EN- (3,4-dimethoxy-benzyl) -N-methyl-aminomethyl] nitrobenzene 4- (4-chloro-benzyl) -N-methyl-aminomethyl] -nitrobenzene 0 -94 (66) 4- (4-bromo-benzyl) -N-methyl-aminomethyl] -nitrobenzene A .rM TI b A Phl-iinoehl -nIoez LIMk-, Luoo-eiizyl) -N-ei y-mioehl -ntoezn (68) 4- (4-methyl-benzyl) -N-methyl-aminomethyl] -nitrobenzene (69) 4- (4-nitro-phenethyl) -N-methyl-aminomethyl] nitrobenzene 4- (N-phenethyl-N-benzyl-aminomethyl) -nitrobenzene (71) 4- (N-phenethyl-N-cyclohexyl-aminomethyl) -nitrobenzene (72) 4- (pyridin-2-yl) -ethyl) -N-methyl-aminomethyl] nitrobenzene (73) 4- (pyridin-4-yl) -ethyl) -N-methyl-aminomethylJ nitrobenzene (74) 4- (pyridin-4-yl-methyl) -N-methyl-aminomethyl] nitrobenzene 4- (N,N-dibenzyl-aminomethyl) -nitrobenzene (76) 4- (4-nitro-phenethyl) -N-propyl-aminomethyl] nitrobenzene (77) 4- (N-benzyl-N- (3-cyano-propyl) -aminomethyl) -nitrobenzene (78) 4- (N-berzyl-N-allyl-aminomethyl) -nitrobenzene (79) 4- [N-benzyl-N- (2,2,2-trifluoroethyl) -aminomethyl] nitrobenzene 95 4-[N-(2-benzo(1,3)dioxol-5-yl-methyl)-N-methylaminomethyl] -nitrobenzene (81) 4-(7-chloro-2,3,4,5-tetrahydro--benzo(d)azepin-3-ylmethyl) -nitrobenzene (82) 4-(7,8-dichloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -nitrobenzene (83) 4-(7-methoxy-2,3,4,5-tetrahydro--benzo(d)azepin-3-ylmethyl) -nitrobenzene (84) 4-(7-methyl-2,3,4,5-tetrahydro-benzo~d)azepin-3-ylmethyl) -nitrobenzene 4-(7,8-dimethoxy--2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -nit robenzene (86) 4-(6,7-dichloro-l,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -nitrobenzene (87) 4-(6,7-dimethvl-l,2,3,4-tetrahvdro-isoquinolin-2-vlmethyl) -nitrobenzene (88) 4-(6-chloro-1,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)nitrobenzene (89) 4-(7-chloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)nitrobenzene 4-(6-methoxy-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)nitrobenzene (91) 4- (7-methoxy-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) nitrobenzene 96 (92) 4-[(2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-yl)methyl] -nitrobenzene (93) -[(7/-amit-no-2 ,3,4,5-tetrahydro-azepin-o(4,5-b)pyrazin-3yl) -methyl] -nitrobenzene (94) 4-[(2-amino-5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6yl) -methyl] -nitrobenzene 4-[(5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6-yl)methyl] -nitrobenzene Example XV 4- (1,1-dioxo-thiomorpholin-4-vl-methyl) -nitrobenzene g of 4-(thiomorpholin-4-yl-methyl)-nitrobenzene are dissolved in 100 ml of methylene chloride and 10.3 g of metachloroperbenzoic acid are slowly added. After a further 3 hours stirring at room temperature the precipitate obtained is filtered off.
Yield: 6.2 g (91 of theory) Rf value: 0.5 (silica gel, methylene chloride/methanol 1:1)
C
1
IH
14 N04S Mass spectrum: m/z 270 The following compound is prepared analogously to Example XV: 4- (l-oxo-thiomorpholin-4-yl-methyl) -nitrobenzene Example XVI 4- (3-amino-propyl) -N-methvlsulphonvl-aminol -nitrobenzene g of 4- (3-phthalimido-2-yl-propyl) -N-methylsulphonylamino] -nitrobenzene are dissolved in 200 ml of ethanol, 11.5 ml of hydrazine hydrate are added and the mixture is stirred for 1.5 hours at 50 OC. After cooling the residue is largely -97 evaporated down, water is added and the solution is extracted with methylene chloride. The organic phase is dried, evaporated down and purified over a silica gel column with methylene chloride/methanol/ammonia 9:1:0.1.
Yield: 2.5 g (39 of theory) R, value: 0.2 (silica gel, methylene chloride/methanol 9:1) ESI mass spectrum: m/z 272 The following compound is prepared analogously to Example XVI: 6-[N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino]-3amino-nitrobenzene Prepared from 6-[N-(2-dimethylamino-ethyl)-N-methylsulphonylamino]-3-phthalimido-2-yl-nitrobenzene Example XVII 4-(1-methyl-imidazol-2-vl)-nitrobenzene g of 4-(imidazol-2-yl)-nitrobenzene are dissolved in 50 ml of dimethylsulphoxide and at 0°C 5.0 g of potassium tert.butoxide are added. After one hour of stirring at room temperature 2.6 ml of methyl iodide are added dropwise and the mixture is stirred for one hour at room temperature. After this time the residue is poured onto ice water and the precipitate formed is suction filtered, washed with water and dried.
Yield: 6.1 g (76 of theory) Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1) Melting point: 186-187°C 98 The following compounds are prepared analogously to Example
XVII:
1) 4- 1 -ety-i miazol y-nitrobenzene Prepared from 4-(imidazol-2-yl)-nitrobenzene and ethyl iodide 4-(l-benzyl-imidazol-2-yl)-nitrobenzene Prepared from 4-(imidazol-2-yl)-nitrobenzene and benzyl bromide Example XVIII 4-[(N-(2-(2-methoxy-ethoxy)-ethyl)-N-methyl-amino)-methyl]nitrobenzene g of 4-methylaminomethyl-nitrobenzene are dissolved in ml of dimethylformamide and 4.6 g of 2-(2-methoxy-ethoxy)ethyl chloride are added. After six hours' stirring at 100 0
C
the solvent is removed and the residue is taken up in ethyl acetate. The organic phase is washed with water and dried over sodium sulphate. After the elimination of the solvent the residue is purified over an aluminium oxide column (activity 2-3) with toluene/ethyl acetate 5:1 as eluant.
Yield: 2.3 g (29 of theory) Rf value: 0.5 (aluminium oxide, toluene/ethyl acetate 5:1)
C
13
H
20
N
2 0 4 ESI mass spectrum: m/z 267 Example XIX 4-(N-ethyl-N-tert.butoxycarbonyl-aminomethyl)-nitrobenzene 2.2 g of 4-(ethylaminomethyl)-nitrobenzene are dissolved in ml of ethyl acetate and stirred with 2.6 g of di-tert-butyl.
dicarbonate (tert.butoxycarbonyl-anhydride) for 30 minutes at room temperature. Then the solution is washed with water and evaporated down.
Yield: 3.4 g of theory 99 Rf value: 0.3 (silica gel, methylene chloride/methanol 50:1) Melting point: 85 OC The following compounds are prepared analogously to Example
XIX:
4- (4-chlorophenyl-methyl) -N-tert.butoxycarbonylaminomethyl] -nitrobenzene 4- (N-tert .butoxycarbonyl-aminomethyl) -nitrobenzene 4- (N-cyclohexyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 4- (N-isopropyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 4- (N-methyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 4- (N-propyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 4- (N-butyl-N-tert.butoxycarbonyl-aminomethyl) -nitrobenzene 4- (N-methoxycarbonylmethyl-N-tert .butoxycarbonylaminomethyl) -nitrobenzene 4- (N-benzyl-N-tert.butoxycarbonyl-aminomethyl) nitrobenzene 100 4-[N-(3-trifluoroacetylamino-propyl)-N-methylsulphonylamino]-nitrobenzene Prepared from 4-[N-(3-amino-propyl)-N-methylsulphonyl-amino]nitrobenzene and trifluoroacetic acid anhydride (11) 4-[(4-tert.butoxycarbonyl-piperazin-1-yl)-methyl]nitrobenzene Example XX 4-(piperidin-l-yl-methyl)-aniline 37.0 g of 4-(piperidin-l-yl-methyl)-nitrobenzene are dissolved in 300 ml of methanol, 8.0 g of Raney nickel are added and the mixture is hydrogenated for 85 minutes with 3 bars of hydrogen at room temperature. The catalyst is filtered off and the filtrate is evaporated down.
Yield: 24.0 g (75 of theory), R, value: 0.4 (silica gel, methylene chloride/methanol 9:1)
C
12 Hs 1
N
2 ESI mass spectrum: m/z 191 The following compounds are prepared analogously to Example
VIII:
4-[(2,6-dimethyl-piperidin-l-yl)-methyl]-aniline N-(2-dimethylamino-ethyl)-N-methylsulphonyl-pphenylenediamine 3-(dimethylaminomethyl)-aniline 4-(dimethylaminomethyl)-aniline 4-(2-dimethylamino-ethyl)-aniline 4-[N-(2-dimethylamino-ethyl)-N-acetyl-amino]-aniline 101 4- (3-dimethylamino-propyl) -N-acetyl-amino] -aniline 8) 4- ti--dimethylamino-ethyl) -N-benzoyl-aminol -aniline 4- (2-dimethylamino-ethyl) -N-propionyl-aminol -aniline 4- (2-dimethylamino-ethyl) -N-butyryl-amino] -aniline (11) 4- (2-dimethylamino-ethyl) -N-isobutyryl-amino] -aniline (12) 4- (N-tert.butoxycarbonyl-aminomethyl) -aniline (13) 4- (N-ethyl-N-tert.butoxycarbonyl-aminomethyl) -aniline (14) 4-EN- (4-chlorophenyl-methyl) -N-tert.butoxycarbonylaminomethyl] -aniline 4- (N-cyclohexyl-N-tert.butoxycarbonyl-aminomethyl) aniline (16) 4- (N-isopropyl-N-tert .butoxycarbonyl-aminomethyl) -ani line (17) 4- (N-propyl-N-tert.butoxycarbonyl-aminomethyl) -aniline (18) 4- (N-methyl-N-tert.butoxycarbonyl-aminomethyl) -aniline (19) 4- (N-butyl-N-tert.butoxycarbonyl-aminomethyl) -aniline 4- (N-methoxycarbonyl-methyl-N-tert.butoxycarbonylaminomethyl) -aniline (21) 4- (N-benzyl-N-tert.butoxycarbonyl-aminomethyl) -aniline (22) 4- (pyrrolidin-l-yl-methyl) -aniline 102 (23) 4- (morpholin-4-yl -methyl) -aniline (24) 4- (hexamethyleneiminomethyl) -aniline 4- (4-hydroxy-piperidin-l-yl-methyl) -aniline (26) 4- (4-methoxy-piperidin-1-yl-methyl) -aniline (27) 4- (4-methyl-piperidin-1-yl-methyl) -aniline (28) 4- (4-ethyl-piperidin-l-yl-methyl) -aniline (29) 4- (4-isopropyl-piperidin-l-yl-methyl) -aniline 4- (4-phenyl-piperidin-l-yl-methyl) -aniline (31) 4- (4-benzyl-piperidin-1-yl-methyl) -aniline (32) 4- (4-ethoxycarbonyl-piperidin-1-yl-methyl) -aniline (33) 4- (N,N-dipropyl-aminomethyl) -aniline (34) 4- (4-tert.butoxycarbonyl-piperazin-l-yl-methyl) -aniline 4- (2-morpholin-4-yl-ethyl) -aniline (36) 4-(2-pyrrolidin-l-yl-ethyl)-aniline (37) 4- (2-piperidin-1-yl-ethyl) -aniline (38) 4- (N-propyl-N-benzyl-aminomethyl) -aniline (39) 4-EN- (n-hexyl) -N-methyl-aminomethyl] -aniline 4-EN-methyl-N- (4-chlorobenzyl) -aminomethyl] -aniline 103 (41) 4- (N-methyl-N- (4-bromobenzyl) -aminomethyl] -aniline (42) 4- (N-methyl-N- (4-methylbenzyl) -aminomethyl] -aniline (43) 4- [N-methyl-N- (4-f luorobenzyl) -aminomethyl] -aniline (44) 4- [N-methyl-N- (3-chlorobenzyl) -aminomethyl] -aniline 4- [N-methyl-N- (3,4-dimethoxybenzyl) -aminomethyl] -aniline (46) 4- [N-methyl-N- (4-methoxybenzyl) -aminomethyl] -aniline (47) 4- (N-2,2,2-trifluoroethyl-N-benzyl-aminomethyl) -aniline (48) 4-[N-2,2,2-trifluoroethyl-N-(4-chlorobenzyl)aminomethyl] -aniline (49) 4- (thiomorpholin-4-yl-methyl) -aniline 4- (l-oxo-thiomorpholin-4-yl-methyl) -aniline (51) 4- (l,1-dioxo-thiomorpholin-4-yl-methyl) -aniline (52) 4- (azetidion-1-yl-methyl) -aniline (53) 4- (3,4-dihydropyrrolidin-l-yl-methyl) -aniline (54) 4- (3.4-dihydropiperidin-l-yl-methyl) -aniline 4- (2-methoxycarbonyl-pyrrolidin-l-yl-methyl) -aniline (56) 4- (3,5-dimethyl-piperidin-1-yl-methyl) -aniline (57) 4- (4-phenyl-piperazin-l-yl-methyl) -aniline (58) 4- (4-phenyl-4-hydroxy-piperidin-1-yl-methyl) -aniline 104 (59) 4-EN- 5-trimethoxy-benzyl) -N-methyl-aminomethyl] aniline 4- (3,4-dimethoxy-benzyl) -N-ethyl-aminomethyl] -aniline (61) 4- (N-benzyl-N-ethyl-aminomethyl) -aniline (62) 4-E[N- 6-dichlorobenzyl) -N-methyl-aminomethyll -aniline (63) 4-EN- (4-trifluoromethylbenzyl) -N-methyl-aminomethyll aniline (64) 4- (N-benzyl-N-isopropyl-aminomethyl) -aniline 4- (N-benzyl-N-tert.butyl-aminomethyl) -aniline (66) 4- (diethylamino-methyl) -aniline (67) 4- (2-diethylamino-ethyl) -aniline (68) 4- (N,N-diisopropyl-aminomethyl) -aniline (69) 4- (N,N-diisobutyl-aminomethyl) -aniline 4- (2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-methyl) -aniline (71) 4- (2,3-dihydro-isoindol-2-yl-methyl) -aniline (72) 4-(6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (73) 4 4-tetrahydro-isoquinolin-2-yl-methyl) -aniline (74) 4-E[N- (2-hydroxy-ethyl) -N-benzyl-aminomethyl] -aniline 0 105 4- Ci-ethyl-pentyl) (pyridin-2-yl-methyl) aminomethyll -aniline (76) 4-('piperidin-1-yi-methyl) -3-nitro-aniline (77) 4- (piperidin-1-yl-methyl) -3-amino-aniline (78) 4- (N-benzyl-N-methyl-aminomethyl) -aniline (79) 4- (N-ethyl-N-methyl-aminomethyl) -aniline 4- (N-phenethyl-N-methyl-aminomethyl) -aniline (81) 4- (3,4-dihydroxy-phenethyl) -N-methyl-aminomethyl] aniline (82) 4- (3,4,5-trimethoxy-phenethyl) -N-methyl-aminomethyll aniline (83) 4- (3,4-dimethoxy-phenethyl) -N-methyl-aminomethyllaniline (84) 4- (3,4-dimethoxy-benzyl) -N-methyl-aminomethyl] -aniline 4- (4-chloro-benzyl) -N-methyl-aminomethyl] -aniline- (86) 4- (4-bromo-benzyl) -N-methyl-aminomethyl] -aniline (87) 4- (4-f luoro-benzyl) -N-methyl-aminomethyl] -aniline (88) 4- (4-methyl-benzyl) -N-methyl-aminomethyl] -aniline (89) 4-EN- (4-nitro-phenethyl) -N-methyl-aminomethyll -aniline 4- (N-phenethyl-N-benzyl-aminomethyl) -aniline 106 (91) 4- (N-phenethyl-N-cyclohexyl-aminomethyl) -aniline (92) 4- (pyridin-2-yl) -ethyl) -N-methyl-aminomethyl] a- 11 1 4 (93) 4- (pyridin-4-yl) -ethyl) -N-methyl-aminomethyl] aniline (94) 4- (pyridin-4-yl-methyl) -N-methyl-aminomethyll -aniline 4- (N,N-dibenzylaminomethyl) -aniline (96) 4- (4-nitro-benzyl) -N-propyl-aminomethyl] -aniline (97) 4- fN-benzyl-N- (3-cyano-propyl) -aminomethyl] -aniline (98) 4- (N-benzyl-N-allyl-aminomethyl) -aniline (99) 4- [N-benzyl-N- (2,2,2-trifluoroethyl) -aminomethyl] -aniline (100) 4- [(benzo(l,3)dioxol-5-yl-methyl) -methyl-aminomethyl] aniline (101) 4-(7-chloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline (102) 4-(7,8-dichloro-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline (103) 4- (7-methoxy-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline (104) 4-(7-methyl-2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline 107 (105) 4-(7,8-dimethoxy-2,3,4..5-tetrahydro-benzo(d)azepin-3-ylmethyl) -aniline (106) 4-(6,'/-dichloro-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (107) 4-(6,7-dimethyl-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (108) 4-(6-chloro-l,2,3,4-tetrahydro-isoquinolin-2-yl-methyl)aniline (109) 4- (7-chloro-1.2,3,4-tetrahydro-isoquinolin-2-yl-methyl) aniline (110) 4-(6-methoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (111) 4- (7-methoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline (112) 4-(2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-ylmethyl) -aniline (113) 4- (7-amino-2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3yl-methyl) -aniline (114) 4-(2-amino-5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6y1-methyl) -aniline (115) 4-(5,6,7,8-tetrahydro-azepino(4,5-d)thiazol-6-ylmethyl) -aniline (116) 4-(4-methyl-piperazin-1-yl)-aniline (117) 4- (2-dimethylamino-ethyl) -N-methyl-amino] -aniline 108 (118) 4- (3-dimethylamino-propyl) -N-methyl-amino] -aniline -119 "3-d"iethylamino-propyl) -N-methylsulphonyl -pphenylenediamine (120) 4- [(N-dimethylaminocarbonylmethyl-N-methylsulphonyl) amino] -aniline (121) N- (4-aminophenyl) -N-methyl-methanesulphonamide (122) 4- (imidazol-4-yl) -aniline (123) 4- (tetrazol-5-yl) -aniline (124) 4 (2 -dimethylamino-ethyl) -N-propionyl -amino] -aniline (125) N- (dimethylaminomethylcarbonyl) -N-methyl-pphenylenediamine (126) N- [(2-dimethylamino-ethyl) -carbonyl] -N-methyl-pphenylenediamine (127) 4- (N-acetyl-N-dimethylaminocarbonylmethyl) -amino) aniline (128) N-methylaminocarbonylmethyl-N-methylsulphonyl-pphenylenediamine (129) N-aminocarbonylmethyl-N-methylsulphonyl-pphenylenediamine (130) 4- (imidazolidin-2,4-dion-5-ylidene-methyl) -aniline (131) 4-(imidazolidin-2,4-dion-5-yl-methyl)-aniline -109 (132) 4-(2-oxo-pyrrolidin-l-yl-methyl) -aniline (133) N-cyanomethyl-N-methylsulphonyl-p-phenylenediamine (134) 4-[2-(imidazol-4-yl)-ethyl]-aniline (135) 4- [(4-methyl-piperazin-1-yl) -methyl] -aniline (136) 4-[IN-(2-(N-behzyl-N-methyl-amino)-ethyl)-Nmethylsulphonyl-amino] -aniline (137) 4- (N-benzyl-N-methyl-amino) -propyl) -Nmethylsulphonyl-amino] -aniline (138) N- cyclohexyl -p-phenylenediamine (139) 4- (pyridin-4-yl-methyl) -aniline (140) 4-(imidazol-1-yl-methyl)-aniline (141) 4-benzyl-aniline (142) N- (3-trifluoroacetylamino-propyl) -N-methylsulphonyl-pphenylenediamine (143) tert .butyl 4-amino-phenylacetate (144) 4- (imidazol-2-yl) -aniline (145) 4-(1-methyl-imidazol-2-yl)-aniline (146) 4- (l-ethyl-imidazol-2-yl) -aniline (147) 4-(1-benzyl-imidazol-2-yl)-aniline 110 (148) 4- (2-dimethylamino-ethyl) -N-methylsulphonyl-amino] -3amino-aniline (149) 4- (2-dimethylamino-ethyl) -N-methylsulphonyl-amino] -3chioro-aniline (150) 4-EN- (2-dimethylamino-ethyl) -N-acetyl-amino] -3-aminoaniline (151) 4- (2-dimethylamino-ethyl) -N-acetyl-amino] -3-bromoaniline (152) 4- (4-hydroxy-piperidin-1-yl) -ethyl-amino] -aniline (153) N- (2-dimethylamino-ethyl) -N-ethylsulphonyl-pphenylenediamine (154) N- (2-dimethylamino-ethyl) -N-propylsulphonyl-pphenylenediamine (155) N- (2-dimethylamino-ethyl) -N-isopropylsulphonyl-pphenylenediamine (156) N- (2-dimethylamino-ethyl) -N-butylsulphonyl-pphenylenediamine (157) N- (2-dimethylamino-ethyl) -N-benzylsulphonyl-pphenylenediamine (158) N- (2-dimethylamino-ethyl) -N-phenylsulphonyl-pphenylenediamine (159) 4- ((3-hydroxy-pyrrolidin-1-yl) -methyl) -aniline (160) 4-EN- (2-dimethylamino-ethyl) (furan-2-carbonyl) amino] -aniline (161) 4- (2-dimethylamino-ethyl) (2-methoxy-benzoyl) amino] -aniline (162) 4- (2-dimethylamino-ethyl) (pyridine-3-carbonyl) amino] -aniline (163) 4- (2-dimethylamino-ethyl) (phenyl-acetyl) -amino] aniline (164) N- (piperidin-1-yl-methylcarbonyl) -N-methyl-pphenylenediamine (165) N- (morpholin-4-yl-methylcarbonyl) -N-methyl-pphenylenediamine (166) N- [(4-benzyl-piperazin-1-y1) -methylcarbonyl] -N-methyl-pphenylenediamine (167) N- (pyrrolidin-l-yl-methylcarbonyl) -N-methyl-pphenylenediamine (168) 4-(5-methyl-imidazol-4-yl)-aniline (169) N-f (2-dimethylamino-ethyl) -carbonyl] -N-isopropyl-pphenylenediamine (170) N- [(2-dimethylamino-ethyl) -carbonyl] -N-benzyl-pphenylenediamine (171) N- (N-aminocarbonylmethyl-N-methyl-amino) methylcarbonyl) -N-methyl -p-phenylenediamine (172) N- [(N-benzyl-N-methyl-amino) -methylcarbonyl] -N-methyl-pphenyl enediamine 112 (173) N- [di- (2-methoxyethyl) -amino-methylcarbonyl] -N-methyl-pphenylenediamine (1-74 A ITtr~uxoroilpieai--i ehl carbonyl] -N-methyl -p-phenylenediamine (175) N- t(2-(piperidin-l-yl)-ethyl)-carbonyl] -N-methyl-pphenylenediamine (176) N- (N-benzyl-N-methyl-amino) -ethyl) -carbonyl] -Nmethyl -p-phenylenediamine (177) N- (dimethylaminomethylcarbonyl) -N-isopropyl-pphenylenediamine (178) N- (piperidin-l-yl-methylcarbonyl) -N-isopropyl-pphenylenediamine (179) N- [(4-tert.butoxycarbonyl-piperazin-l-yl) methylcarbonyl] -N-isopropyl-p-phenylenediamine (180) N- [(N-benzyl-N-methyl-amino) -methylcarbonyl] -N-benzyl-pphenylenediamine (181) N- (dimethylaminomethylcarbonyl) -N-benzyl-pphenylenediamine (182) N- (piperidin-l-yl-methylcarbonyl) -N-benzyl-pphenylenediamine (183) 4-(l,2,4-triazol-l-yl-methyl)-aniline (184) 4-(1,2,3-triazol-2-yl-methyl)-anilile (185) 4-(1,2,3-triazol-l-yl-methyl)-aniline -113 (186) 4-[(N-ethoxycarbonylmethyl-N-methyl-amino)-methyl]aniline (187) 4-[(N-aminocarbonylmethyl-N-methyl-amino)-methyl]aniline (188) 4-(azetidin-l-yl-methyl)-aniline (189) 4-[(di-(2-methoxy-ethyl)-amino)-methyl]-aniline (190) 4-[(N-(2-(2-methoxy-ethoxy)-ethyl)-N-methyl-amino)methyl]-aniline (191) 4-[N-(N-tert.butoxycarbonyl-3-amino-propyl)-N-methylaminomethyl]-aniline (192) 4-[(N-(methylcarbamoyl-methyl)-N-methyl-amino)-methyl]aniline (193) 4-[(N-(dimethylcarbamoyl-methyl)-N-methyl-amino)methyl]-aniline (194) 4-[(N-propyl-N-methyl-amino)-methyl]-aniline (195) 4-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)-methyl]aniline (196) 4-[(N-(3-dimethylamino-propyl)-N-methyl-amino)-methyl]aniline (197) 4-[(N-(2-methoxy-ethyl)-N-methyl-amino)-methyl]-aniline (198) 4-[(N-(2-hydroxy-ethyl)-N-methyl-amino)-methyl]-aniline (199) 4-[(N-(dioxolan-2-yl-methyl)-N-methyl-amino)-methyl]aniline 114 (200) 4-(3-oxo-piperazin-l-yl-methyl)-aniline 201) N-T di-(2-hydroxyethyl)-amino-methylcarbonyl]-N-methyl-pphenylenediamine (202) N-[(N-(2-methoxyethyl)-N-methyl-amino)-methylcarbonyl]- N-methyl-p-phenylenediamine (203) N-[(N-(2-dimethylamino-ethyl)-N-methyl-amino)methylcarbonyl]-N-methyl-p-phenylenediamine (204) N-[(4-methyl-piperazin-l-yl)-methylcarbonyl]-N-methyl-pphenylenediamine (205) N-[(imidazol-1-yl)-methylcarbonyl]-N-methyl-pphenylenediamine (206) N-[(phthalimido-2-yl)-methylcarbonyl]-N-methyl-pphenylenediamine Example XXI 4-(4-hydroxvmethvl-piperidin-l-yl-methyl-amino)-aniline 1.1 g of 4-(4-ethoxycarbonyl-piperidin-l-yl-methyl-amino)aniline are suspended in 15 ml of tetrahydrofuran. 175 mg of lithium borohydride are added at room temperature, stirred for 24 h, another 175 mg of lithium borohydride are added and after a further 7.5 hours 15 ml of water are added and the mixture is stirred for 10 minutes. It is extracted three times with 15 ml of ethyl acetate. The combined organic phases are washed with water and saturated saline solution, dried over sodium sulphate and concentrated by rotary evaporation. The residue is purified over a silica gel column with methylene chloride/methanol/ammonia 4:1:0.01 as eluant.
Yield: 200 mg (27 of theory) 115 Rf value: 0.4 (silica gel, methylene chloride/methanol/ammonia 4:1:0.01) Melting point: 1570C Example XXII methyl 4-methoxycarbonylmethyl-3-nitro-benzoate 54.3 g of methyl 3-nitro-benzoate and 29.0 g of methyl chloroacetate are dissolved in 100 ml of dimethylformamide and this solution is added dropwise at -10 0 C to a solution of 78.5 g of potassium-tert. butoxide in 500 ml of dimethylformamide.
The mixture is stirred for another 10 minutes at room temperature and after this time the solution is poured onto 350 ml of concentrated hydrochloric acid in 2 1 of ice water.
The solution is stirred for 0.5 hours, the precipitate obtained is suction filtered and washed with water. The product is recrystallised from 150 ml of methanol and dried at in vacuo.
Yield: 48.3 g of (51 of theory), contains about 20 of methyl 6-methoxycarbonylmethyl-3-nitro-benzoate R, value: 0.7 (silica gel, petroleum ether/ethyl acetate 1:1) Melting point: 65-73 °C The following compound is prepared analogously to Example
XXII:
ethyl 4-methoxycarbonylmethyl-3-nitro-benzoate Prepared from ethyl 4-thoxycarbonylmethyl-3-nitro-benzoate Example XXIII methyl 2-indolinone-6-carboxylate 48.3 g of methyl 4-methoxycarbonylmethyl-3-nitro-benzoate are dissolved in 800 ml of concentrated acetic acid, 5.0 g of 116 palladium on carbon are added and the solution is hydrogenated for 2.5 hours at room temperature and 50 psi. The catalyst is filtered off and the filtrate is evaporated down.
The residue is taken up in 150 ml of tert.-butylmethyl ether, filtered again and dried in vacuo at 100 0
C.
Yield: 28.6 g (98 of theory), R, value: 0.4 (silica gel, methylene chloride/methanol 10:1) Melting point: 208-211 °C The following compound is prepared analogously to Example
XXIII:
ethyl 2-indolinone-6-carboxylate Prepared from ethyl 4-methoxycarbonylmethyl-3-nitro-benzoate Example XXIV l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6-ethoxycarbonyl- 2-indolinone 15.0 g of ethyl 2-indolinone-6-carboxylate, 49.6 ml of triethyl orthobenzoate and 150 ml of acetic anhydride are stirred for 4 hours at 110 0 C. After this time the solvent is removed, the residue is recrystallised from petroleum ether and dried in vacuo at 50 0
C.
Yield: 16.9 g (61 of theory), Rf value: 0.5 (silica gel, petroleum ether/methylene chloride/ethyl acetate 5:4:1) Melting point: 98-100 0
C
C
22
H
21
NO,
The following compounds are prepared analogously to Example
XXIV:
l-acetyl-3-(1-ethoxy-l-phenylmethylene)-6-methoxycarbonyl- 2-indolinone -117 Prepared from methyl 2-indolinone-6-carboxylate, triethyl orthobenzoate and acetic anhydride 1 -ace tyl 3- (1i-eLioxy-i1-ethyl -methylene) 6- ethoxycarbonyl 2 -indolinone Prepared from ethyl 2-indolinone-6-carboxylate, triethyl orthopropionate and acetic anhydride 118 Preparation of the final compounds: Example 1 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene]- 6 -carbamoyl-2-indolinone-trifluoroacetate 300 mg of resin obtained according to Example II are suspended in 3 ml of dimethylformamide and shaken with 0.2 g of 4- (piperidin-1-yl-methyl)-aniline for 22 hours at 70 0 C. Then it is filtered off and the resin is washed several times with methylene chloride, methanol and dimethylformamide. Then 1 ml of methanolic ammonia is added for 2 hours in order to eliminate the acetyl group. Then after further washing 4 ml of trifluoroacetic acid in methylene chloride are added during another 60 minutes, the resin is separated off and the solution is evaporated down.
Yield: 69 mg Rf value: 0.1 (silica gel, methylene chloride/methanol 9:1)
C
28
H
28
N
4 0 2 Mass spectrum: m/z 452 The following compounds are prepared analogously to Example 1: 3-Z-(l-Anilino-l-phenyl-methylene)-6-carbamoyl-2indolinone Prepared from the resin obtained according to Example II and aniline
C
22
HI
7N 3 02 Mass spectrum: m/z 355 3-Z-[l-(4-dimethylaminomethyl-anilino)-l-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-dimethylaminomethyl-aniline
C
2 5H 24
N
4 02 Mass spectrum: m/z 412 119 3-Z-[1-(4-(2-diethylamino-ethyl)-anilino)-l-phenylmethylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared fromt Lhe resin obtained according to Example II and 4- (2-diethylamino-ethyl) -aniline
C
2 8 3 0 2 mass spectrum: m/z 454 3-Z-E1-(4-(morpholin-4-yl-methyl)-anilino)-1-phenylmethylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4- (morpholin-4-yl-methyl) -aniline Rf value: 0.50 (silica gel, methylene chloride/methanol 4:1)
C
2 7H 26
N
4
O
3 mass spectrum: m/z 454 3-Z-[1-(4-(1-oxo-thiomorpholin-4-yl-methyl)-anilino)- 1-phenyl-methylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4- (l-oxo-thiomorpholin-4-yl-methyl) -aniline Rf value: 0.30 (silica gel, methylene chloride/methanol 9:1)
C
27
H
26
N
4 0 3
S
Mass spectrum: m/z 486 3-Z-[l-(4-(1,1-dioxo-thiomorpholin-4-yl-methyl)-anilino)- 1-phenyl-methylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4- (1,l1-dioxo-thiomorpholin-4-yl-methyl) -aniline Rf value: 0.30 (silica gel, methylene chloride/methanol 9:1)
C
2 7H 26
N
4 0 4
S
Mass spectrum: m/z 502 3-Z- [1-(4-(benzylaminomethyl)-anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone-trifluoroacetate 120 Prepared from the resin obtained according to Example II and 4-[N-(phenyl-methyl)-N-tert.butoxycarbonyl-aminomethyl]aniline Rf value: 0.40 (silica gel, methylene chloride/methanol 4:1)
C
30
H
26
N
4 02 Mass spectrum: m/z 474 3-Z-[1-(4-(amino-methyl)-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(N-tert.butoxycarbonyl-aminomethyl)-aniline Rf value: 0.10 (silica gel, methylene chloride/methanol 4:1)
C
23
H
2 0N40 2 Mass spectrum: m/z 384 3-Z-[1-(4-(2,6-dimethylpiperidin-l-yl-methyl)-anilino)- 1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(2,6-dimethylpiperidin-l-yl-methyl)-aniline Rf value: 0.45 (silica gel, methylene chloride/methanol 4:1)
C
30
H
32
N
4 0 2 Mass spectrum: m/z 480 (m) 3-Z-[l-(4-(pyrrolidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(pyrrolidin-l-yl-methyl)-aniline R, value: 0.15 (silica gel, methylene chloride/methanol 4:1)
C
2 7H26N402 Mass spectrum: m/z 438 (m) (11) 3-Z-[1-(3-(dimethylaminomethyl)-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 3-dimethylaminomethyl-aniline R, value: 0.23 (silica gel, methylene chloride/methanol 4:1) 121
C
25
H
24
N
4 02 Mass spectrum: m/z 412 (12) 3-Z-[1-(3-(N-methyl-N-ethyl-aminomethyl)-anilino)- 1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 3-(N-methyl-N-ethyl-aminomethyl)-aniline R, value: 0.23 (silica gel, methylene chloride/methanol 4:1)
C
26
H
26 N402 Mass spectrum: m/z 426 (m (13) 3-Z-[l-(3-(methylaminomethyl)-anilino)-l-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(N-tert.butoxycarbonyl-N-methyl-aminomethyl)-aniline Rf value: 0.06 (silica gel, methylene chloride/methanol 4:1) C24H 22
N
4 02 Mass spectrum: m/z 399 (14) 3-Z-[l-(3-hydroxymethyl-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 3-amino-benzyl alcohol Rf value: 0.7 (silica gel, methylene chloride/methanol 4:1)
C
23
HIN
3
O,
Mass spectrum: m/z 385 3-Z-[1-(4-(methoxycarbonylmethyl-aminomethyl)-anilino)- 1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-(N-methoxycarbonylmethyl-N-tert.butoxycarbonyl-aminomethyl)aniline Rf value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
26
H
24
N
4 0 4 Mass spectrum: m/z 457 122 (16) 3-Z-[1-(4-(N-methylsulphonyl-N-(dimethylaminocarbonylmethyl)-amino)-anilino)-1-phenyl-methylene]-6-carbamoyl- 2-indolinone Prepared from the resin obtained according to Example II and 4-(N-methylsulphonyl-N-(dimethylaminocarbonylmethyl)-amino)aniline Rf value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
27
H
27
N
5 OsS Mass spectrum: m/z 533 (17) 3-Z-[l-(4-(N-acetyl-aminomethyl)-anilino)-l-phenylmethylene]-6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 4-(N-acetyl-aminomethyl)-aniline Rf value: 0.70 (silica gel, methylene chloride/methanol 4:1)
C
2
H
22
N
4 03 Mass spectrum: m/z 426 (18) 3-Z-[1-(3,4-dimethoxy-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 3,4-dimethoxy-aniline R, value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
24
H
21
N
3 0 4 Mass spectrum: m/z 415 (19) 3-Z-[l-(4-(morpholin-4-yl)-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-morpholin-4-yl-aniline R, value: 0.20 (silica gel, methylene chloride/methanol 9:1)
C
26
H
24 N403 Mass spectrum: m/z 440 3-Z-[1-(4-acetylamino-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone 123 Prepared from the resin obtained according to Example II and 4-acetylamino-aniline R, value: 0.25 (silica gel, methylene chloride/methanol 9:1) C24H2 0
N
4 0 3 Mass spectrum: m/z 412 (21) 3-Z-[l-(4-amino-anilino)-1-phenyl-methylene]-6-carbamoyl- 2-indolinone Prepared from the resin obtained according to Example II and 4-amino-aniline R, value: 0.40 (silica gel, methylene chloride/methanol 9:1)
C
22 H1N402 Mass spectrum: m/z 370 (22) 3-Z-[1-(4-N-methyl-N-acetyl-amino-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 4-(N-methyl-N-acetyl-amino)-aniline
C
2 sH 22
N
4 0 3 Mass spectrum: m/z 426 (23) 3-Z-[l-(4-ethoxycarbonyl-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and ethyl 4-amino-benzoate
C
2 5H 21 N30 4 Mass spectrum: m/z 427 (24) 3-Z-[l-(4-carboxy-anilino)-l-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 4-amino-benzoic acid Rf value: 0.11 (silica gel, methylene chloride/methanol 9:1)
C
23
H
17 N304 Mass spectrum: m/z 398 124 3-Z-[l-(4-benzylcarbamoyl-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and 4-amino-benzoic acid-bcnzylamide R, value: 0.21 (silica gel, methylene chloride/methanol 9:1)
C
30
H
24 N40 3 Mass spectrum: m/z 488 (26) 3-Z-[l-(cyclohexyl-amino)-1-phenyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example II and cyclohexylamine R, value: 0.60 (silica gel, methylene chloride/methanol 9:1)
C
22
H
23 N302 Mass spectrum: m/z 361 (m) (27) 3-Z-[1-(4-amino-cyclohexyl-amino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-amino-cyclohexylamine
C
22
H
24 N402 Mass spectrum: m/z 376 (28) 3-Z-[1-(N-methyl-piperidine-4-yl-amino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and 4-amino-l-methyl-piperidine R, value: 0.15 (silica gel, methylene chloride/methanol 4:1)
C
22
H
24 N402 Mass spectrum: m/z 376 (m (29) 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-methylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(2) and 4-(piperidin-l-yl-methyl)-aniline R, value: 0.30 (silica gel, methylene chloride/methanol 4:1) 0 125
C
2 3H 2 6
N
4 02 Mass spectrum: m/z 390 (3 7- r I -Ii A4 me h lamome 1 L..nL Ilyl methylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(2) and 3-dimethylaminomethyl-aniline Rf value: 0.51 (silica gel, methylene chloride/methanol 4:1)
C
2 0 2 2 4 2 Mass spectrum: m/z 351 (31) 3-Z- [l-(4-(N-methyl-N-benzyl-aminomethyl)-anilino) 1-methyl-methylene] -6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(2) and 4- (N-methyl-N-benzyl-aminomethyl) -aniline Rf value: 0.73 (silica gel, methylene chloride/methanol 4:1)
C
2 6
H
2 6 4 2 Mass spectrum: m/z 426 (32) 3-Z-[li- (N-methylsulphonyl-N- (2-dimethylamino-ethyl) amino) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinonetrifluoroacetate Prepared from the resin obtained according to Example 11(2) and 4- (N-methylsulphonyl-N- (2-dimethylamino-ethyl) -amino) aniline
C
22
H
2 7 N04S mass spectrum: m/z 458 (m+H2) (33) 3-Z- [l-(4-chloro-anilino)-1-methyl-methylene]-6carbamoyl indolinone Prepared from the resin obtained according to Example 11(2) and 4-chloro-aniline Rf value: 0.10 (silica gel, methylene chloride/methanol 9:1)
C
17 H 14 ClN 3 0 2 Mass spectrum: m/z 327/329 126 (34) 3-Z-[l-(3-chloro-anilino)-l-methyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(2) and 3-chloro-aniline R, value: 0.11 (silica gel, methylene chloride/methanol 9:1)
C
1
,H
7 1 C1N O, Mass spectrum: m/z 327/329 (m 3-Z-[1-(4-methoxycarbonyl-anilino)-1-methyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II(2) and methyl 4-amino-benzoate R, value: 0.11 (silica gel, methylene chloride/methanol 9:1)
C
19 H ,N 3 0 4 Mass spectrum: m/z 351 (36) 3-Z-[l-(4-carboxy-anilino)-l-methyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example II(2) and 4-amino-benzoic acid CisHiN O,4 Mass spectrum: m/z 336 (37) 3-Z-[1-(4-methyl-3-nitro-anilino)-1-methyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example II(2) and 4-methyl-3-nitro-aniline Rf value: 0.82 (silica gel, methylene chloride/methanol 4:1)
C
18
H
16
N
4 0 4 Mass spectrum: m/z 352 (38) 3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-1-propylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(4) and 4-(piperidin-l-yl-methyl)-aniline Rf value: 0.37 (silica gel, methylene chloride/methanol 4:1) 127
C
25
H
30
N
4 0 2 Mass spectrum: m/z 418 (39) 3-Z-[1-(3-dimethylaminomethyl-anilino)-1-propylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(4) and 3-dimethylaminomethyl-aniline R, value: 0.42 (silica gel, methylene chloride/methanol 4:1)
C
22
H
26
N
4 0 2 Mass spectrum: m/z 378 3-Z-[l-(4-(N-methyl-N-benzyl-aminomethyl)-anilino)-1-propyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example 11(4) and 4-(N-methyl-N-benzyl-aminomethyl)-aniline Rf value: 0.81 (silica gel, methylene chloride/methanol 4:1)
C
28 H30N40, Mass spectrum: m/z 454 (41) 3-Z-[1-(4-(N-methylsulphonyl-N-(2-dimethylamino-ethyl)amino)-anilino)-1-propyl-methylene]-6-carbamoyl-2-indolinonetrifluoroacetate Prepared from the resin obtained according to Example 11(4) and 4-(N-methylsulphonyl-N-(2-dimethylamino-ethyl)-amino)aniline Rf value: 0.59 (silica gel, methylene chloride/methanol 4:1)
C
24
H
31 N0O 4S Mass spectrum: m/z 486 (42) 3-Z-[l-(4-chloro-anilino)-l-propyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and 4-chloro-aniline R, value: 0.17 (silica gel, methylene chloride/methanol 9:1)
C
19 ,HC1N 3 02 Mass spectrum: m/z 355/357 128 (43) 3-Z-[1-(3-chloro-anilino)-1-propyl-methylene]-6carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and 3-chloro-aniline R, value: 0.12 (silica gel, methylene chloride/methanol 9:1)
C
19 ,,HC1N302 Mass spectrum: m/z 355/357 (44) 3-Z-[l-(4-methoxycarbonyl-anilino)-1-propyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and methyl 4-amino-benzoate R, value: 0.8 (silica gel, methylene chloride/methanol 4:1)
C
21
H
21
N
3 0 4 Mass spectrum: m/z 379 (mf) 3-Z-[1-(4-carboxy-anilino)-1-propyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and 4-amino-benzoic acid
C
20
H
19 N30 4 Mass spectrum: m/z 364 (46) 3-Z-[1-(4-methyl-3-nitro-anilino)-1-propyl-methylene]- 6-carbamoyl-2-indolinone Prepared from the resin obtained according to Example 11(4) and 4-methyl-3-nitro-aniline R, value: 0.86 (silica gel, methylene chloride/methanol 4:1)
C
20
H
20
N
4 0 4 Mass spectrum: m/z 380 (mf) 129 Example 2 3-Z-[1-(3-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-tritluoroacetate g of resin obtained according to Example II are reacted analogously to Example 1 with 2.0 g of 3-aminobenzyl alcohol in 20 ml of dimethylformamide for 22 hours at 700C. Then the solvent is suction filtered and the resin is washed several times with dimethylformamide and methylene chloride. Then 200 mg of the moist charged resin are suspended in 2 ml of methylene chloride and left to stand with 0.2 ml of methanesulphonic acid chloride and 0.1 ml of triethylamine for 2 hours at room temperature. Then the resin is washed several times with methylene chloride, suspended in 2 ml of methylene chloride and combined with 0.2 ml of piperidine. After 1 hour the resin is washed with methylene chloride and dimethylformamide and then treated with trifluoroacetic acid analogously to Example 1.
Yield: 15 mg Rf value: 0.30 (silica gel, methylene chloride/methanol 4:1)
C
28
H
28
N
4 0 2 Mass spectrum: m/z 452 The following compounds are prepared analogously to Example 2: 3-Z-[1-(3-(diethylaminomethyl)-anilino)-1-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and diethylamine R, value: 0.80 (silica gel, methylene chloride/methanol 4:1)
C
27
H
28 N402 Mass spectrum: m/z 440 3-Z-[l-(3-(benzylaminomethyl)-anilino)-l-phenylmethylene]-6-carbamoyl-2-indolinone-trifluoroacetate 130 Prepared from the resin obtained according to Example II and benzylamine R, value: 0.80 (silica gel, methylene chloride/methanol 4:1) 26
N
4 02 Mass spectrum: m/z 474 3-Z-[1-(3-(N-methyl-N-benzyl-aminomethyl)-anilino)- 1-phenyl-methylene]-6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and N-methyl-benzylamine Rf value: 0.80 (silica gel, methylene chloride/methanol 4:1)
C
31
H
28
N
4 0 2 Mass spectrum: m/z 488 3-Z-[1-(3-(butylaminomethyl)-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and butylamine R, value: 0.40 (silica gel, methylene chloride/methanol 4:1)
C
27
H
28
N
4 0 2 Mass spectrum: m/z 440 3-Z-[l-(3-(aminomethyl)-anilino)-1-phenyl-methylene]- 6-carbamoyl-2-indolinone-trifluoroacetate Prepared from the resin obtained according to Example II and ammonia
C
23
H
20
N
4 0 2 Mass spectrum: m/z 385 3-Z-[1-(3-(N-(3-dimethylaminopropyl)-N-methyl-aminomethyl)-anilino)-1-phenyl-methylene]-6-carbamoyl-2-indolinonetrifluoroacetate Prepared from the resin obtained according to Example II and l-dimethylamino-3-methylaminopropane R, value: 0.67 (silica gel, methylene chloride/methanol 4:1) C2 9
H
33 NsO2 131 Mass spectrum: m/z 484 3-Z-[1-(3-(N-(2-dimethylaminoethyl)-N-methyl-aminomethyl)anilino) -1-phenyl-miiethyiene -6-carbamoyi-2-indolinonetrifluoroacetate Prepared from the resin obtained according to Example II and 1-dimethylamino-2-methylaminoethane R, value: 0.40 (silica gel, methylene chloride/methanol 4:1) C28H31N5O2 Mass spectrum: m/z 470 Example 3 3-Z-[1-(4-(piperidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-ethoxycarbonyl-2-indolinone g of l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6ethoxycarbonyl-2-indolinone and 1.1 g of 4-(piperidin-1-ylmethyl)-aniline are dissolved in 15 ml of dimethylformamide and stirred for 45 minutes at 100 0 C. After cooling 5.0 ml of piperidine are added and the mixture is stirred for another 3 hours at room temperature. The solvent is removed and the residue purified over an aluminium oxide column (activity: 2-3) with methylene chloride/ethanol (100:3) as eluant.
Yield: 1.1 g (58% of theory), R, value: 0.5 (aluminium oxide, methylene chloride/ethanol 100:3)
C
3 oH 31
N
3 03 Mass spectrum: m/z 481 [M] The following compounds are prepared analogously to Example 3: 3-Z-[1-(4-bromo-anilino)-l-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6ethoxycarbonyl-2-indolinone and 4-bromoaniline R, value: 0.4 (silica gel, toluene/ethyl acetate 5:1) 132
C
24
H
19 BrN 2 03 Mass spectrum: m/z 462/464 2) 3-Z- Li-(3-(dimethylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l--phenylmethylene) -6ethoxycarbonyl-2-indolinone and 3- (dimethylaminomethyl) aniline Rf value: 0.5 (aluml'nium oxide, methylene chloride/ethanol= 30:1)
C
2 7
H
2 7N 3 0 3 ESI mass spectrum: m/z 442 iM+H~] 3-Z- (dimethylaminomethyl)-anilino)-l-phenylmethylene] -6-ethoxycarbonyl-2 -indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (dimethylaminomethyl) aniline Rf value: 0.7 (aluminium oxide, ethyl acetate/ethanol 20:1)
C
2 7
H
2 7
N
3 03 ESI mass spectrum: m/z 442 [M+H]1 3-Z-[l-(4-[(2,6-dimethyl-piperidin-1-yl)-methyl]-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4-1(2, 6-dimethyl-piperidin-1yl) -methyl] -aniline Rf value: 0.6 (silica gel, methylene chloride/ethanol 5:1)
C
32
H
3 5
N
3 03 Mass spectrum: m/z 509 [M'1 3-Z- [l-(4-(2-dimethylamino-ethyl)-anilino)-l-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) aniline -133 Rf value: 0.2 (silica gel, methylene chloride/ethanol =5:1)
C
2 8 2 9 3 Mass spectrum: m/z 455 [M'1 3-Z- (2-dimethylamino-ethyl) -N-acetyl-amino)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy--l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-acetyl-amino) -aniline Rf value: 0.4 (aluminium oxide, methylene chloride/ethanol= 20:1)
C
3 0 3 2 4 mass spectrum: m/z 512 [WI1 3-Z- [l-(4-tert.butyloxycarbonyl-anilino)-l-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4-tert .butyloxycarbonylaniline Rf value: 0.4 (aluminium oxide, methylene chloride/ethanol 40:1)
C
29
H
28
N
2 Mass spectrum: m/z 484 [M]1 3-Z- [l-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (3-dimethylamino-propyl) N-acetyl-amino) -aniline Rf value: 0.2 (aluminium oxide, methylene chloride/ethanol 40:1)
C
3 1 3 4 4 Mass spectrum: m/z 526 [M]1 -134 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Prepared from 1-acetyi-3- (1-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nmethylsuiphonyl -p-phenylenediamine Rf value: 0.3 (aluminium oxide, methylene chloride/ethanol 40:1)
C
29
H
32
N
4 0 5
S
Mass spectrum: m/z =548 3-Z-[1-(4-(4-methyl-piperazin-1-yl)-anilino)-l-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (4-methyl-piperazin-1-yl) aniline Rf value: 0.3 (aluminium oxide, ethyl acetate)
C
29
H
30
N
4 0 3 ESI mass spectrum: m/z 483 IM+H]l (11) 3-Z-[lI-(4-(N-(2-dimethylamino-ethyl)-N-methyl-amino)anilino) -1-phenyl-methylene] -6-ethoxvcarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-methyl-amino) -aniline Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol 20:1)
C
29
H
32
N
4 0 3 ESI mass spectrum: m/z 485 [M+H]1 (12) 3-Z- (3-dimethylamino-propyl) -N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (3-dimethylamino-propyl) N-methyl-amino) -aniline Rf value: 0.5 (aluminium oxide, ethyl acetate) 135
C
30 H 34
N
4 0 3 ESI mass spectrum: m/z 499 iM+H]1 (13) 3-Z-[l-(4-(N-methyl-acetylamino)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl--2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4-amino-N-methyl-acetanilide Rf value: 0.3 (silica gel, methylene chloride/ethanol 15:1)
C
2 7
H
2 5N 3 04 Mass spectrum: m/z 455 (14) 3-Z- (N-methyl-methylsulphonylamino) -anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and N- (4-aminophenyl) -N-methylmet hanesulphonamide Rf value: 0.8 (aluminium oxide, ethyl acetate)
C
26
H
25
N
3 0 5
S
Mass spectrum: m/z 491 [M'1 3-Z- (3-dimethylamino-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and N- (3-dimethylamino-propyl) -Nmethyl suiphonyl -p-phenylenediamine Rf value: 0.6 (silica gel, methylene chloride/ethanol/ammonia 5:2:0.01)
C
3 0
H
34
N
4 0 5
S
ESI mass spectrum: m/z 563 [M+H]1 (16) 3-Z- (N-dimethylaminocarbonylmethyl-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone -13G Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (Ndimethylaminocarbonylmethyl-N-methylsulphonyl) -amino) -aniline Rf value: 0.6 (silica gel, methylene chloride/ethanol 10:1)
C
29
H
30
N
4 0 6
S
ESI mass spectrum: m/z 561 EM-Hi1 (17) 3-Z-[1-(4-(imidazol-4-yl)-anilino)-l-phenyl-methylene]-6ethoxycarbonyl iniol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (imidazol-4-yl) -aniline Rf value: 0.5 (silica gel, methylene chloride/ethanol/ammonia 10:1:0.01)
C
27
H
22
N
4 0 3 Mass spectrum: m/z 450 [M*i (18) 3-Z-[1-(4-(tetrazol-5-yl)-anilino)-l-phenyl-methylene]-6ethoxycarbonyl indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (tetrazol-5-yl) -aniline Rf value: 0.5 (silica gel, methylene chloride/ethanol 5:1) C, H, 0 NF 0, ESI mass spectrum: m/z 451 [M-HA1 (19) 3-Z- [l-(4-(N-benzyl-N-methyl-aminomethyl)-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (N-benzyl-N-methylaminomethyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/ethanol 10:1)
C
3 3 3 1 3 ESI mass spectrum: m/z 516 [M-Hi1 3-Z- [l-(4-(N-(2-dimethylamino-ethyl) -N-propionyl-amino) aniline) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -137 Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-propionyl-aminol -aniline Rf value: 0.2 (silica gel, methylene chloride/ethanol 5:1)
C
3
H
34 4 ESI mass spectrum: m/z 525 [M-H]1 (21) 3-Z-[1-(4-(pyrrolidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (pyrrolidin-1-yl-methyl) aniline Rf value: 0.1 (silica gel, methylene chloride/ethanol 5:1)
C
2 9 2 9 3 ESI mass spectrum: m/z 466 [M-HA] (22) 3-Z- [1-(4-(N-methyl-N-phenethyl-aminomethyl)-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (N-phenethyl-N-methylaminomethyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/ethanol 10:1)
C
3 4 3 3 3 ESI mass spectrum: m/z 530 [M-Hi1 (23) 3 [1 (4 (N-dimethylaminomethylcarbonyl -N-methyl -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6ethoxycarbonyl -2-indolinone and N-dimethylaminomethylcarbonyl- N-methyl -p-phenylenediamine Rf value: 0.1 (silica gel, methylene chloride/ethanol 10:1) C2 9
H
3
N
0 4 EST mass spectrum: m/z 497 EM-Hi1 138 (24) 3-Z- El-(4-(N-(2-dimethylamino-ethyl)-N-ethylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Prepared fron. 1--acetL-y'l (1-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nethylsuiphonyl -p-phenylenediamine R, value: 0. 6 (silica gel, methylene chloride /ethanol 5: 1)
C
3 0H 34
N
4 ESI mass spectrum: rh/z 561 [M-H-1 3-Z- (N-tert.butoxycarbonyl-N-ethyl-aminomethyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and 4- (N-tert .butoxycarbonyl-Nethyl-aminonethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride /methanol 10:1)
C
32
H
3 5N 3 ESI mass spectrum: m/z 540 [M-Hi1 (26) 3-Z-[1-(4-(piperidin-l-yl-methyl)-anilino)-l-ethylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-ethyl-methylene) -6ethoxycarbonyl-2-indolinone and 4- (piperidin-l-yl-methyl) aniline Rf value: 0.9 (silica gel, methylene chloride/ethanol 5:1)
C
26
H
3 1
N
3 03 ESI mass spectrum: m/z 432 EM-Hi1 (27) 3-Z-[11- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-ethyl-methylene] -6-ethoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-l-ethyl-methylene) -6ethoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nmethyl sulphonyl -p-phenylenediamine Rf value: 0.3 (silica gel, methylene chloride/ethanol 5:1)
C
25
H
32
N
4 139 ESI mass spectrum: m/z 499 [M-Hi1 (28) 3-Z- [l-(4-(dimethylaminomethyl)-anilino) -1-phenylmethylenel -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (dimethylaminomethyl) aniline R, value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
26
H
25 N303 ESI mass spectrum: m/z 428 [M+H]l (29) 3-Z-tl-(4-[(2,6-dimethyl-piperidin-1-yl)-methyl]anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- 6-dimethyl-piperidin-1yl) -methyl] -aniline Rf value: 0.5 (RP 8, methanol/five percent saline solution= 4:1)
C
3 13 3
N
3 03 ESI mass spectrum: m/z 496 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nmethylsulphonyl -p-phenylenediamine R, value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
28
H
3 0
N
4 ESI mass spectrum: m/z 533 [M-HA1 (31) 3-Z-[Il- (3-dimethylamino-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone 140 Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (3-dimethylamino-propyl) -Nmethyl suiphonyl -p-phenylenediamine R, value: 0. 5 (aluminium oxide, methylene chloride/methanol 30:1)
C
29
H
32
N
4 0 5
S
ESI mass spectrum: m/z 547 EM-Hi1 (32) 3-Z- El- (N-dimethylaminocarbonylmethyl-Nmethylsulphonyl -amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl indol inone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-dimethylaminocarbonylmethyl-N-methylsulphonyl) -amino) -aniline Rf value: 0. 5 (aluminium oxide, methylene chloride /methanol 20:1)
C
28
H
28
N
4 0 6
S
ESI mass spectrum: m/z 547 EM-Hi1 (33) 3 [1 (4 (N-acetyl -N-dimethylaminocarbonylmethyl -amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxv-l-phenvlmethvlene)-6methoxycarbonyl-2-indolinone and 4- (N-acetyl -Ndimethylaminocarbonylmethyl) -amino) -aniline Rf value: 0. 6 (silica gel, methylene chloride /methanol 10: 1)
C
29
H
28
N
4 0 ESI mass spectrum: m/z 511 EM-Hi1 (34) 3-Z- (N-dimethylaminocarbonylmethyl -amino) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-dimethylaminocarbonylmethyl) -amino) -aniline Rf value: 0.6 (aluminium oxide, methylene chloride /methanol 30:1)
C
2 7H 26
N
4 0 4 -141 ESI mass spectrum: m/z 469 EM-Hi1 3-Z- (3-dimethylamino-propyl) -N-acetyl-amino) no J-lnl mLeLI: hyl ene -,Cmtreioxycarbuiiyi iridolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (3-dimethylamino-propyl) -Nacetyl -p-phenylenediamine Rf value: 0.5 (aluminium oxide, methylene chloride/methanol= 20:1)
C
30
H
32
N
4 0 4 ESI mass spectrum: m/z 511 [M-Hi1 (36) 3-Z- (N-methylaminocarbonylmethyl-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl indolinone and N-methylaminocarbonylmethyl N-methylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
2 7
H
26
N
4 0 6
S
ESI mass spectrum: m/z 533 [M-Hi1 (37) 3-Z-[l-(4-((imidazolidin-2,4-dion-5-ylidene)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((imidazolidin-2,4-dion-5ylidene) -methyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
27
H
20
N
4 ESI mass spectrum: m/z 479 [M-Hi1 (38) 3-Z- (2-dimethylamino-ethyl)-carbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone -142 Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N-C (2-dimethylamino-ethyl) carbonyl) -N-methyl -p-phenylenediamine Rf value: 0.5 (aluminium oxide, methylene chloride/methanol 20:1)
C
29
H
30
N
4 0 4 ESI mass spectrum: m/z 497 EM-Hi1 (39) 3-Z-[l-(4-(N-t~rt.butoxycarbony1-aminomethyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-tert .butoxycarbonylaminomethyl) -aniline Rf value: 0.3 (aluminium oxide, methylene chloride/methanol= 20:1)
C
29
H
29
N
3 0 EST mass spectrum: m/z 498 [M-Hi1 3-Z-(l-(4-(2-oxo-pyrrolidin-l-yl-methyl)-anilino)-lphenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-oxo-pyrrolidin-l-ylmethyl) -aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 20:1)
C
28
H
25
N
3 04 ESI mass spectrum: m/z 466 IM-Hi1 (41) (N-aminocarbonylmethyl-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl -2 -indolinone and N-aminocarbonylmethyl-Nmethylsulphonyl -p-phenylenediamine Rf value: 0.7 (silica gel, methylene chloride/methanol 5:1)
C
26
H
24
N
4 0 6
S
ESI mass spectrum: m/z 519 EM-Hi1 -143 (42) 3-Z-[l-(4-(thiomorpholin-4-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (thiomorpholin-4-ylmethyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 15:1)
C
28
H
2 7 N03S ESI mass spectrum: m/z 484 [M-Hi1 (43) 3-Z-[1-(4-(l,1-dioxo-thiomorpholin-4-yl-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- 1-dioxo-thiomorpholin-4yl-methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
28
H
27 ESI mass spectrum: m/z 516 IM-Hi1 (44) 3-Z- (N-cyanomethyl-N-methylsulphonyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N-cyanomethyl-N-methylsulphonyl -p-phenylenediamine Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
26 H22N405S ESI mass spectrum: m/z 501 fM-H-i 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-ethyl-Ntert .butoxycarbonyl-aminomethyl) -aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1) ESI mass spectrum: m/z 526 EM-Hi) -144 (46) 3-Z- [1-(4-(N-benzyl-N-methyl-aminomethyl) -anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared front l-acetyi-3- (1-ethoxy-i-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-benzyl-N-methylaminomethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
32
H
2 9
N
3 03 ESI mass spectrum: th/z 502 [M-Hi1 (47) 3-Z-[l-(4-(l-oxo-thiomorpholin-4-yl-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l-oxo-thiomorpholin-4-ylmethyl) -aniline Rf value: 0.7 (silica gel, methylene chloride/methanol 10:1)
C
28
H
27
N
3 0 4
S
ESI mass spectrum: m/z 500 EM-Hi1 (48) 3-Z-[l-(4-(2-(imidazol-4-yl)-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-4-yl) -ethyl) aniline Rf value: 0.4. (silica gel, methylene chloride/methanol 5:1)
C
28
H
24
N
4 0 3 ESI mass spectrum: m/z 463 EM-Hi1 (49) 3-Z-[l-(4-(morpholin-4-yl-methyl)-anilino)-l-phenylmethylenel -6 -methoxycarbonyl indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (morpholin-4-yl-methyl) aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
28
H
27
N
3 04 ESI mass spectrum: m/z 468 EM-Hi1 145 3-Z-t1-(4-((4-methyl-piperazin-l-yl)-methyl)-anilino)-iphenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((4-methyl-piperazin-l-yl) methyl) -aniline R, value: 0.4 (silica gel, methylene chloride/methanol 5:1)
C
2 9 3 0 3 EST mass spectrum: m/z 481 tM-Hi1 (51) 3-Z-t1-(4-((2-(N-benzyl-N-methyl-amino)-ethyl)-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6met hoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-benzyl-N-methylamino) -ethyl) -N-methylsulphonyl-amino) -aniline Rf value: 0.7 (silica gel, methylene chloride/methanol 10:1)
C
34
H
34 ESI mass spectrum: m/z 609 EM-Hi1 (52) 3-Z- (l-(4-cyclohexylamino-anilino)-l-phenyl-methylene -6methoxycarbonyl -2 -indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N-cyclohexyl-pphenylenediamine Rf value: 0.8 (silica gel, methylene chloride/methanol 10:1)
C
29
H
28 2 3 ESI mass spectrum: m/z 451 IM-Hi1 (53) 3-Z-[1-(4-(pyridin-4-yl-methyl)-anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (pyridin-4-yl-methyl) aniline Rf value: 0.6 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01) 146
C
29 H 2 3
N
3 0 3 ESI mass spectrum: m/z 460 EM-Hi1 (54) 3-Z-[1-(4-(imidazol-l-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-1-yl-methyl) aniline Rf value: 0.4 (silida gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
27 H 2 2
N
4 0 3 ESI mass spectrum: m/z 449 EM-Hi1 3-Z-[l-(4-(imidazol-1-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-1-yl-methyl) aniline Rf value: 0.4 (silica gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
2 7 2 2 4 3 ES! mass spectrum: m/z 449 [M-Hi1 (56) 3-Z- [1-(N-methyl-piperidine-4-yl-amino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4-amino-1-methyl-piperidine Rf value: 0.3 (silica gel, methylene chloride/methanol 5:1)
C
2 3
H
2 5
N
3 0 3 EST mass spectrum: m/z 390 EM-Hi1 (57) 3-Z-[l-(4-(imidazol-4-yl-methyl)-anilirlo)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-4-yl-methyl) aniline -147 R, value: 0.2 (silica gel, methylene chloride/methanol 5:1)
C
27
H
22
N
4 03 ESI mass spectrum: m/z 449 [M-Hi1 (58) 3-Z-[l-(4-((4-hydroxy-piperidin-l-yl)-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((4-hydroxy-piperidin-lyl) -methyl) -aniline Rf value: 0.1 (silica gel, methylene chloride/methanol 10:1)
C
2 9 2 9 3 ESI mass spectrum: m/z 482 [M-Hi1 (59) 3-Z-[1-(4-((4-methoxy-piperidin-1-yl)-methyl)-anilino)-1phenyl-methylenel -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((4-methoxy-piperidin-1yl) -methyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1) ESI mass spectrum: m/z 496 tM-Hi1 3-Z- [l-(4-benzyl-anilino)-l-phenyl-methylenel-6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (i-ethoxy-i-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4-benzyl-aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
30 H 24
N
2 0 3 Melting point: 224 0
C
(61) 3-Z-[1-(4-(N-(3-trifluoroacetylamilo-propyl)
-N-
methylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (3-trifluoroacetylaminopropyl) -N-methylsulphonyl-p-phenylenediamine 148 Rf value: 0.5 (aluminium oxide, methylene chloride/methanol 20:1)
C
2
,H
27
F
3
N
4 0 6
S
EST mass~ spectrum: -m/Z 615r (62) 3-Z- [1-(4-tert.butoxycarbonylmethyl-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6ethoxycarbonyl-2-indolinone and tert.butyl 4aminophenylacetate Rf value: 0.5 (aluminium oxide, ethyl acetate)
C
3 0
H
30
N
2 ESI mass spectrum: m/z 497 EM-Hi1 (63) 3-Z-[1-(4-tert.butoxycarbonyl-anilino)-1-ethylmethylene] -6 -ethoxycarbonyl -2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-ethylmethylen) -6ethoxycarbonyl-2-indolinone and 4-tert .butoxycarbonyl-aniline Rf value: 0.4 (aluminium oxide, methylene chloride/ethanol= 20:1)
C
2 5
H
2 8
N
2 0 ESI mass spectrum: m/z 435 EM-Hi1 (64) 3-Z-[lI-(4-(4-tert.butoxycarbonyl-piperazin-1-yl-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (4-tert .butoxycarbonylpiperazin-i-yl-methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
33
H
36
N
4 0 ESI mass spectrum: m/z 567 [M-Hi1 3-Z-[l-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone 149 Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l-methyl-imidazol-2-yl) aniline R, value: 0.6 (silica gel.. methylene chloride/methanol1 5:111
C
2 7 2 2 4 3 EST mass spectrum: m/z 449 EM-Hi1 (66) (2-dimethylamino-ethyl) -N-methylsulphonylamino) -3-nitro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone Prepared from l-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 6- (2-dimethylamino-ethyl) N-methylsulphonyl-amino) -3-amino-nitrobenzene Rf value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
28
H
29
N
5 0 7
S
ESI mass spectrum: m/z 578 [M-Hi1 (67) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -3-amino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indol inone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-methylsulphonyl-amino) -3-amino-aniline Rf value: 0.5 (aluminium oxide, methylene chloride/methanol= 20:1)
C
2 8H 31
NSO
5
S
ESI mass spectrum: m/z 548 EM-Hi1 (68) 3-Z- (N-benzyl-N-methyl-amino) -propyl) -N-methylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-benzyl-N-methylamino) -propyl) -N-methylsulphonyl-amino) -aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
35
H
36
N
4 0 5
S
150 ESI mass spectrum: m/z 623 [M-Hi1 (69) 3 Z- 1- (4 (2 -dimethylamino- ethyl) -N-methylsulphonyl ;qminr)-I3-rhlor-ilno-1 -phenyl-methylene]-cmethoxycarbonyl indol inane Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2 -dime thylamino -ethyl) N-methylsulphonyl-amino) -3-chioro-aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
28
H
2 9 C N 4 EST mass spectrum: m/z 567/569 [M-Hi1 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl indol inone and Ndimethylaminomethylcarbonyl -N-methyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
28
H
2 8N 4 0 4 ESI mass spectrum: m/z 483 jM-Hi1 (71) 3 (4 (2 -dimethylamino-ethyl) -N-acetyl -amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2 -dimethylamino- ethyl) N-acetyl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
2 9
H
3
N
0 4 ESI mass spectrum: m/z 497 [M-Hi1 (72) 3 [1l- (4 (2 -dimethylamino-ethyl) -N-propionyl -amino) anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2 -dimethylamino- ethyl) N-propionyl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1) 151
C
30 H32N404 ESI mass spectrum: m/z 511 [M-H-J (73) 3-Z- (2 -dime thylamcino -ethyl) -N-butyryl -amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-butyryl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3
H
34
N
4 04 ESI mass spectrum: m/z 525 EM-Hi1 (74) 3-Z-[li- (4-(N-(2-dimethylamino-ethyl) -N-isobutyryl-amino) anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-isobutyryl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 1 3 4 4 ESI mass spectrum: m/z 525 EM-Hi1 3-Z-[Il- (2-dimethylamino-ethyl) -N-benzovl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-benzoyl-amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
34
H
3 2
N
4 04 ESI mass spectrum: m/z 559 EM-Hi1 (76) 3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-3amino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-acetyl-amino) -3-amino-aniline 152 Rf value: 0.5 (aluminium oxide, methylene chloride/methanol 20:1)
C
29
H
31
N
5 0 4 ESI mass spectrum: m/z 512 EM-Hi1 (77) 3-Z-[l-(4-(4-hydroxymethyl-piperidin-l-yl-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-iidolinone and 4- (4-hydroxymethyl-piperidin- 1-yl-methyl-amino) -aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 5:1)
C
30
H
31
N
3 0 4 ESI mass spectrum: m/z 496 [M-Hi1 (78) 3-Z-[l-(4-(2-(4-hydroxy-piperidin-1-yl)-ethyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (4-hydroxy-piperidin-lyl) -ethyl-amino) -aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 5:1)
C
3 0
H
31
N
3 04 ESI mass spectrum: m/z 496 EM-HF] (79) 3-Z- (2-dimethylamino-ethyl) -N-propylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Npropylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
30
H
3 4 ESI mass spectrum: m/z 561 EM-Hi1 3-Z- El- (2-dimethylamino-ethyl) -N-butylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone 153 Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nbutylsuiphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 1 3 6 ESI mass spectrum: m/z 575 EM-Hi1 (81) 3-Z- (2-dimethylamino-ethyl) -N-phenylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nphenylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
33
H
32 ESI mass spectrum: m/z 595 [M-Hi1 (82) 3-Z- (2-dimethylamino-ethyl) -N-benzylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nbenzylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
34
H
34
N
4 0 5
S
ESI mass spectrum: m/z 609 (M-Hi1 (83) 3-Z- (2-dimethylamino-ethyl)-N-ethylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nethyl sulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
29
H
32
N
4 ESI mass spectrum: m/z 547 [M-H-i -154 (84) 3-Z-[l-(4-((imidazolidin-2,4-dion-5-yl)-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((imidazolidin-2,4-dion-5yl) -methyl) -aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
27
H
22
N
4 0 ESI mass spectrum: r'n/z 481 [M-Hi1 3-Z-[1-(4-((3-hydroxy-pyrrolidin-1-yl)-methyl)-anilino)- 1-phenyl-methylenel -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((3-hydroxy-pyrrolidin-1yl) -methyl) -aniline Rf value: 0.1 (silica gel, methylene chloride/methanol 10:1)
C
2 8 2 7 3 4 ESI mass spectrum: m/z 468 IM-HA1 (86) 3-Z- (cyclohexylyl-methyl) -anilino) -1-phenylmethylenel -6 -methoxycarbonyl indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (cyclohexyl-methyl) -aniline (Eur. J. Med. Chem. Chim. Ther. 1992, 27, 537-544) Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
30 H 30 N 2 0 3 ESI mass spectrum: m/z 465 [M-HWI (87) 3-Z- fl-(4-(cyclohexyl-carbonyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (cyclohexyl-carbonyl) aniline R, value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
30
H
28 4 ESI mass spectrum: m/z 479 EM-Hi1 -155 (88) 3-Z-(1-(4-diethylaminomethyl-anilino)-1-phenylmethylene] -6-rethoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (diethylamino-methyl) aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
28 H 29
N
3 0 3 ESI mass spectrum: m/z 454 [M-HA1 (89) 3-Z-[l-(4-(N-(n-hexyl)-N-methyl-aminomethyl)-anilino)-lphenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (n-hexyl) -N-methylaminomethyl) -aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 10:1)
C
31
H
35
N
3 0 3 ESI mass spectrum: m/z 496 tM-Hi1 3-Z- f1-(4-(N-(2-dimethylamino-ethyl)-N-(furan-2carbonyl) -amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N- (furan-2-carbonyl) -amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 2
H
3 0
N
4 ESI mass spectrum: m/z 549 [M-Hi1 (91) (2-dimethylamino-ethyl)-N-(2-methoxybenzoyl) -amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N- (2-methoxy-benzoyl) -amino) -aniline Rf value: 0.5 (silica gel,. methylene chloride/methanol 9:1) 156
C
3 5
H
34
N
4 ESI mass spectrum: m/z 589 [M-H-i (92) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N- (pyridine-3carbonyl) -amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N- (pyridine-3-carbohyl) -amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
33
H
31 NS0 4 ESI mass spectrum: m/z 560 [M-Hi1 (93) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) (phenyl-acetyl)amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N- (phenyl-acetyl) -amino) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 5 3 4 4 ESI mass spectrum: m/z 573 jM-Hi1 (94) 3-Z-[l-(4-(N-ethyl-N-methyl-aminomethyl)-anilino)-1phenyl-methylene] -6 -methoxycarbonyl-2 -indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-ethyl-N-methylaminomethyl) -aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 10:1)
C
27
H
27 N 03 ESI mass spectrum: m/z 440 EM-Hi1 3-Z- [l-(4-(imidazol-2-yl)-anilino)-l-phenyl-methylene] -6methoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (imidazol-2-yl) -aniline 157 R, value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
26 H 20
N
4 0 3 ESI mass spectrum: m/z 435 EM-Wi1 (96) 3-Z-[1-(4-(l-ethyl-imidazol-2-yl)-alililo)-1-phelylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l-ethyl-imidazol-2-yl) aniline R, value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
28
H
24
N
4 0 3 ESI mass spectrum: m/z 463 tM-Hi1 (97) 3-Z-t1-(4-(1-benzyl-imidazol-2-yl)-anililo)--phelylmethylene] -6 -methoxycarbonyl -2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (i-benzyl-imidazol-2-yl) aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 20:1)
C
3 3 2 6 4 3 ESI mass spectrum: m/z 525 EM-WI1 (98) 3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-Nisopropylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -Nisopropylsulphonyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
30
H
34
N
4 ESI mass spectrum: m/z 561 EM-Hi1 (99) 3-Z- (piperidin-l-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2indol inone 158 Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (piperidin-l-ylmethylcarbonyl) -N-methyl-p-phenylenediamine rf value: 0.5 (si±±Ud gel, methylene chloride/methanol 9:1)
C
31
H
32
N
4 0 4 ESI mass spectrum: m/z 523 [M-FV] (100) 3-Z- (morpholin-4-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phienyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (morpholin-4-ylmethylcarbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 0H 3
ON
4 0 ESI mass spectrum: m/z 525 [M-Hi1 (101) 3-Z- (4-benzyl-piperazin-l-yl) -methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((4-benzyl-piperazin-1-yl) methylcarbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 7
H
3 7N 5
O
4 ESI mass spectrum: m/z 614 [M-Hi1 (102) 3-Z- (pyrrolidin-l-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (pyrrolidin-l-ylmethylcarbonyl) -N-methyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 0
H
3 0
N
4 0 4 ESI mass spectrum: m/z 509 [M-Hi1 -159 (103) 3-Z- (2 -dimethylamino- ethyl) -N-acetyl -amino) -3bromo-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) N-acetyl-amino) -3-bromo-aniline Rf value: 0.6 (silica gel, methylene chloride/methanol 5:1)
C
29
H
29 BrN 4
O
4 ESI mass spectrum: m/z 575/577 EM-WI1 (104) 3-Z-[l-(4-(5-methyl-imidazol-4-yl)-anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (5-methyl-imidazol-4-yl) aniline R, value: 0.5 (silica gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
2 7 2 2 4 3 ESI mass spectrum: m/z 449 EM-WI1 (105) 3-Z- (2-dimethylamino-ethyl) -carbonyl) -Nisopropyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((2-dimethylamino-ethyl) carbonyl) isopropyl -p-phenylenediamine Rf value: 0.1 (silica gel, methylene chloride /methanol 10:1)
C
3
H
34 4 ESI mass spectrum: m/z 525 EM-Hi1 (106) 3-Z-El-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-Nbenzyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indolinone 160 Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((2-dimethylamino-ethyl) carbonyl) -N-benzyl -p-phenylenediamine value: 0.1 (silica ael- meithy-le-ne chlor--*-ide/lmeth-1-ano-l 1:1
C
3 1
H
34
N
4 04 ESI mass spectrum: m/z 525 EM-If] (107) 3-Z- Ii- (N-butyl-N-tert.butoxycarbonyl-aminomethyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-butyl-Ntert .butoxycarbonyl-aminomethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 3
H
37
N
3 0 ESI mass spectrum: m/z 554 EM-Hi1 (108) 3-Z- ((N-aminocarbonylmethyl-N-methyl-amino) methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (N-aminocarbonylmethyl -Nmethyl-amino) -methylcarbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
29
H
29
N
5 ESI mass spectrum: m/z 526 EM-Hi1 (109) 3-Z- ((N-benzyl-N-methyl-amino) -methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6met hoxycarbonyl indol inone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((N-benzyl-N-methyl-amino) methylcarbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
34
H
32
N
4 0 4 ESI mass spectrum: m/z 559 EM-Hi1 S 161 (110) 3-Z-E1- (4-(N-(di-(2-methoxyethyl)-amino-methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from l-acetyl-3- (1-ethoxy-i--phenylrnethylene) -6methoxycarbonyl-2-indolinone and N- (di- (2-methoxyethyl) -aminomethylcarbonyl) -N-methyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
32
H
36
N
4 0 6 ESI mass spectrum: m/z 571 EM-Hi1 (111) 3-Z-[1-(4-(N-((2-(4-tert.butoxycarbonyl-piperazin-l-yl)ethyl) -carbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6-me thoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (4-tert .butoxycarbonylpiperazin-l-yl) -ethyl) -carbonyl) -N-methyl-p-phenylenediamine Rf value: 0.8 (silica gel, methylene chloride/methanol 5:1)
C
36 41 5 6 ESI mass spectrum: m/z 638 EM-Hi1 (112) 3-Z-[l-(4-(N-((2-(piperidin-1-yl)-ethyl)-carbonyl)-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indol inone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (piperidin-1-yl) ethyl) -carbonyl) -N-methyl-p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 5:1)
C
32
H
34
N
4 0 4 EST mass spectrum: m/z 537 EM-Hi1 (113) 3-Z-E1-(4-(N-((2-(N-benzyl-N-methyl-amino)-ethyl)carbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (N-benzyl-N-methylamino) -ethyl) -carbonyl) -N-methyl-p-phenylenediamine 0 162 Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
35
H
34
N
4 0 4 ESI mass spectrum: m/z 573 EM-Hi1 (114) 3-Z- (N-dimethylaminomethylcarbonyl-N-isopropylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-iridolinone and N- (dimethylaminomethylcarbonyl) -N-isopropyl-p-phenylenediamine R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 0 3 2 4 ESI mass spectrum: m/z 511 EM-Hi1 (115) 3-Z- il- (4-(N-(piperidin-1-yl-methylcarbonyl)-Nisopropyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (piperidin-1-ylmethylcarbonyl) isopropyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 3 3 6 4 ESI mass spectrum: m/z 551 EM-Hi1 (116) 3-Z-E1-(4-(N-((4-tert.butoxycarbonyl-piperazin-1-yl)methylcarbonyl) -N-isopropyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from i-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- ((4-tert .butoxycarbonylpiperazin-1-yl) -methylcarbonyl) -N-isopropyl-p-phenylenediamine R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3 7 4 3 5 6 EST mass spectrum: m/z 652 EM-Hi1 163 (117) 3-Z- (N-benzyl-N-methyl-amino) -methylcarbonyl) N-benzyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N-C (N-benzyl-N-methyl-amino) methylcarbonyl) -N-benzyl -p-phenylenediamine Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
4 0 3 6 4 ESI mass spectrum: m/z 635 EM-Hi1 (118) 3-Z- (N-dimethylaminomethylcarbonyl-N-benzylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (i-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and N- (dimethylaminomethylcarbonyl) -N-benzyl-p-phenylenediamine R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
34
H
32
N
4 04 ESI mass spectrum: m/z 559 EM-Hi1 (119) 3-Z- (piperidin-l-yl-methylcarbonyl) -N-benzylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (5-methyl-imidazol-4-yl) aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
3
?H
36
N
4
O
4 ESI mass spectrum: m/z 559 EM-Hi1 (120) 3-Z-[l-(4-(l,2,4-triazol-2-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l.2,4-triazol-l-ylmethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride /methanol 10:1) 0 164-
C
26
H
21
N
5 0 3 ESI mass spectrum: m/z 450 [M-Hi1 (121) 3-Z-E1-(4-(1,2,3-triazol-2-yl-methyl.)-anilino)-1-phenvlmethylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (1,2,3-triazol-2-ylmethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol =20:1)
C
26
H
2
IN
5 0 3 ESI mass spectrum: m/z 450 EM-Hi1 (122) 3-Z-[1-(4-(l,2,3-triazol-l-yl-methyl)-anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (l,2,3-triazol-1-ylmethyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 9:1)
C
2 6
H
2 1
N
5 0 3 ES1 mass spectrum: m/z 450 EM-Hi1 (123) 3-Z- ((N-aminocarbonylmethyl-N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Prepared from l-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((N-aminocarbonylmethyl-Nmethyl-amino) -methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
27
H
2 6
N
4 04 ES1 mass spectrum: m/z 469 EM-Hi1 (124) 3-Z-(1-(4-((di-(2-methoxy-ethyl)-amino)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-methoxy-ethyl) amino) -methyl) -aniline 165 R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
30 H 33
N
3 0 ESI mass spectrum: m/z 514 [M-Hi1 (125) 3-Z-E1-(4-(pyrrolidin-l-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (pyrrolidin-1-yl-methyl) aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
28
H
2 7N 3
O
3 ESI mass spectrum: m/z 452 EM-Hi) (126) 3-Z-[1-(4-((di-(2-hydroxy-ethyl)-amino)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-hydroxy-ethyl) amino) -methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
2 8 2 9 3 ESI mass spectrum: m/z 486 EM-Hi] (127) 3-Z- ((N-ethoxycarbonylmethyl-N-methyl-amino) methyl) -anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- ((N-ethoxycarbonylmethyl-Nmethyl-amino) -methyl) -aniline Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol= 40:1)
C
2 9
H
2 9
N
3 ESI mass spectrum: m/z 498 EM-Hi1 (128) 3-Z-[l-(4-(azetidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone 0 166 Prepared from l-acetyl-3- (1-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (azetidin-1-yl-methyl) aniline Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia 9:1:0.5)
C
27
H
25 3 ESI mass spectrum: m/z 438 EM-Hi) (129) 3-Z- El- (N-propyl-N-tert.butoxycarbonyl-aminomethyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-propyl-Ntert .butoxycarbonyl-aminomethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
32
H
3 5
N
3 ESI mass spectrum: m/z 540 EM-Hi1 (130) 3-Z-[l-(4((N-(2-(2-methoxy-ethoxy)-ethyl)-N-methylamino) -methyl) -anilino) -1-phenyl-methylenel -6-methoxycarbonyl- 2- indolinone Prepared from 1-acetyl-3- (l-ethoxy-l-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-methoxy-ethoxy) ethyl) -N-methyl-amino) -methyl) -aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 9:1)
C
30
H
3 3 3 ESI mass spectrum: m/z 514 [M-Hi1 (131) 3-Z- [l-(4-((N-(tert.butoxycarbonyl-3-amino-propyl)-Nmethyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl indol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (N-tert.butoxycarbonyl- 3-amino-propyl) -N-methyl-aminomethyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
33 H 8
N
4 ESI mass spectrum: m/z 571 [M+H]l 167 (132) 3-Z-[l-(4-((N-(methylcarbamoyl-methyl)-N-methyl-amino)methyl) -anilino) -1-phenyl.-methylene -6-methoxycarbonyl-2indolinane Prepared from l-acetyl-3-(l-ethoxy-l-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-((N-(methylcarbamoylmethyl) -N-methyl-amino)-methyl)-aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
28
H
28
N
4 0 4 ESI mass spectrum: m/z 483 EM-WI (133) 3-Z-[l-(4-((N-(dimethylcarbamoyl-methyl)-N-methylamino)-methyl)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl- 2-indolinone Prepared from l-acetyl-3-(l-ethoxy-1-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-((N-(dimethylcarbamoylmethyl) -N-methyl-amino)-methyl)-aniline Rf value: 0.3 (silica gel, methylene chloride/methanol 10:1)
C
29
H
30
N
4 0 4 EST mass spectrum: m/z 497 EM-Hi1 (134) 3-Z-l-(4-methyl-anilino)-l-phenyl-methylene]-6methoxycarbonyl-2-indolinone Prepared from 1-acetyl-3-(l-ethoxy-1-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-methyl-aniline Rf value: 0.4 (silica gel, methylene chloride/methanol 9:1)
C
24
H
20 N203 ESI mass spectrum: m/z 383 EM-Hi1 (135) 3-Z-[l-(4-((N-propyl-N-methyl-amino)-methyl)-anilino)-1phenyl-methylene]-6-methoxycarbonyl-2-indolinone Prepared from i-acetyl-3-(i-ethoxy-1-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-((N-propyl-N-methyl-amino)methyl) -aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
28 29 3 03 168 ESI mass spectrum: m/z 454 EM-Hi1 (136) 3 (2 -hydroxy-ethyl) -N-methyl -amino) -methyl) anilino) -1--den'rl-me',hyIene]j -6D-metihoxycarbonyl-2-indolinone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-hydroxy-ethyl) -Nmethyl-amino) -methyl) -aniline Rf value: 0.5 (aluminium oxide, methylene chloride /ethanol= 40:1)
C
2 7
H
2 7
N
3 04 ESI mass spectrum: m/z 456 fM-Hi1 (137) 3-Z- II-(4-((N-(2-dimethylamino-ethyl) -N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (2-dimethylaminoethyl) -N-methyl-amino) -methyl) -aniline R, value: 0.5 (silica gel, methylene chloride /methanol 9:1)
C
2 9
H
32
N
4 0 3 ESI mass spectrum: m/z 483 tM-Hi1 (138) 3 (4 (3 -dimethylamino-propyl) -N-methyl -amino) methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from l-acetyl-3- (l-ethoxy-1-phenylmethylene) -6methoxycarbonyl-2-indolinone and 4- (3-dimethylaminopropyl) -N-methyl-amino) -methyl) -aniline aniline Rf value: 0.5 (silica gel, methylene chloride /methanol 9:1) C 30 34 0 3 ESI mass spectrum: m/z 497 tM-Hi1 (139) 3-Z-[l-(4-(3-oxo-piperazin-1-yl-methyl)-anilino)-lphenyl-methylene] -6-methoxycarbonyl-2-indolinone 169 Prepared from 1-acetyl-3-(l-ethoxy-l-phenylmethylene)-6methoxycarbonyl-2-indolinone and 4-(3-oxo-piperazin-l-ylmethyl)-aniline aniline R, value: 0.46 (silica gel, methylene chloride/methanol 9:1)
C
28
H
26
N
4 04 ESI mass spectrum: m/z 481 Example 4 3-Z-[1-(4-carboxy-anilino)-1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone 485 mg of 3-Z-[l-(4-tert.butoxycarbonyl-anilino)-l-phenylmethylene]-6-ethoxycarbonyl-2-indolinone are dissolved in ml of methylene chloride and 6.0 ml of trifluoroacetic acid are added. The mixture is stirred for 2 hours at room temperature. Then the solvent is removed and the residue recrystallised from ether.
Yield: 375 mg (87 of theory), Rf value: 0.3 (silica gel, methylene chloride/methanol 10:1)
C
25
H
20
N
2 0O Mass spectrum: m/z 428 The following compounds are prepared analogously to Example 4: 3-Z-[1-(4-aminomethyl-anilino)-l-phenyl-methylene]-6methoxycarbonyl-2-indolinone Prepared from 3-Z-[1-(4-(N-tert.butoxycarbonyl-aminomethyl)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone Rf value: 0.5 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01)
C
24 H,,N,03 ESI mass spectrum: m/z 398 3-Z-[1-(4-ethylaminomethyl-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone 170 Prepared from 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane vau: .silica gel, methylene chloride /met hanolI/ammonia -10:1:0.01)
C
26
H
25
N
3 0 3 ESI mass spectrum: m/z 426 EM-Hi1 3-Z- [l-(4-carbokymethyl-anilino)-1-phenyl-methylene] -6ethoxycarbonyl indol inane Prepared from 3-Z- [1-(4-tert.butoxycarbonylmethyl-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone Rf value: 0.1 (aluminium oxide, methylene chloride/ethanol/ammonia 5:1:0.01)
C
2 6
H
2 2
N
2 ESI mass spectrum: m/z 441 tM-Hi1 3-Z-[II-(4-carboxy-anilino)-1-ethyl-methylene] -6-ethoxycarbonyl indol inane Prepared from 3-Z- [1-(4-tert.butoxycarbonyl-anilino) -1-ethylmethylene] -6-ethoxycarbonyl-2-indolinone Rf value: 0.1 (aluminium oxide, methylene chloride/ethanol= 20:1)
C
2 1
H
2 0
N
2 0 ESI mass spectrum: m/z 379 tM-Hi] 3-Z- (piperazin-1-yl-methyl) -anilino) -1-phenylmethylene] -6 -methoxycarbonyl indol inane Prepared from 3-Z- (4-tert.butoxycarbonyl-piperazin-1-ylmethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Rf value: 0.1 (silica gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
28
H
28
N
4 0 3 ESI mass spectrum: m/z 469 [M+H]1 -171 3-Z- [l-(4-butylaminomethyl-anilino)-l-phenyl-methylenel -6methoxycarbonyl -2-indcl inone Prepared from 3-Z- (N-butyl-N-tert.butoxycarbonylaminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone R, value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
2 8
H
2 9
N
3 0 3 EST mass spectrum: m/z 454 EM-Hi1 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6ethoxycarbonyl -2 -indol inone Prepared from 3-Z- (N-tert.butoxycarbonyl-N-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone R, value: 0.3 (silica gel, methylene chloride /methanol /ammonia 10:1:0.01)
C
2 7 2 7 3 ESI mass spectrum: m/z 442 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6carbamoyl indolinone Prepared from 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone Rf value: 0.2 (silica gel, methylene chloride /methanol /ammonia 5:1:0.01)
C
2 5
H
2 4 0 2 ESI mass spectrum: m/z 411 [M-H]1 3-Z- (piperazin-l-yl-methylcarbonyl) -N-isopropylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 3-Z- ((4-tert.butoxycarbonyl-piperazin- 1-yl) -methylcarbonyl) -N-isopropyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2 -indolinone 172 Rf value: 0.35 (silica gel, methylene chloride/methanol 9:1)
C
3 2 3
N
4 ESI mass spectrum: m/z 552 EM-Hi1 3-Z-(l-(4-(N-((2-(piperazin-l-yl)-ethyl)-carbonyl)-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indolinone Prepared from 3-Z- (4-tert.butoxycarbonylpiperazin-l-yl) -eth'l) -carbonyl) -N-methyl-amino) -anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Rf value: 0.4 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01) ESI mass spectrum: m/z 540 (11) 3-Z-[l-(4-(N-propyl-aminomethyl)-anilino)-l-phenylmethylene] -6 -methoxycarbonyl-2-indolinone Prepared from 3-Z-[li- (N-propyl-N-tert.butoxycarbonylaminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone Rf value: 0.35 (silica gel, methylene chloride/methanol 9:1)
C
27
H
27
N
3 03 EST mass spectrum: m/z 440 EM-Hi1 (12) 3-Z- (N-(3-amino-propyl)-N-methyl-amino)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 3-Z- (tert.butoxycarbonyl-3-aminopropyl) -N-methyl-amino) -methyl) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl -2 -indol inone Rf value: 0.35 (silica gel, methylene chloride/methanol 9:1)
C
28
H
3 0
N
4 03 ESI mass spectrum: m/z 471 [M+H]1 173 Example 3-Z-[l-(4-methylaminomethyl-anilino)-1-phenyl-methylene]-6ethoxvcarbonyl-2-indolinone 100 mg of 3-Z-[1-(4-(N-benzyl-N-methyl-aminomethyl)-anilino)- 1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone are dissolved in 20 ml of ethanol, 0.2 ml of IN hydrochloric acid are added and the mixture is hydrogenated for 70 minutes at room temperature and 50 psi hydrogen pressure. The reaction solution is filtered and the filtrate concentrated by rotary evaporation. The residue is dried in vacuo at 100 0
C.
Yield: 50 mg (53 of theory), Rf value: 0.3 (silica gel, methylene chloride/ethanol/ammonia 5:1:0.01)
C
26
H
25 N303 ESI mass spectrum: m/z 426 The following compounds are prepared analogously to Example 3-Z-[l-(4-methylaminomethyl-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone Prepared from 3-Z-[1-(4-(N-benzyl-N-methyl-aminomethyl)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone Rf value: 0.2 (silica gel, methylene chloride/methanol/ammonia 10:1:0.01)
C
25
H
23
N
3 0 3 ESI mass spectrum: m/z 412 [M-H] 3-Z-[1-(4-(N-(2-methylamino-ethyl)-N-methylsulphonylamino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2indolinone Prepared from 3-Z-[1-(4-((2-(N-benzyl-N-methyl-amino)-ethyl)- N-methylsulphonyl-amino)-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone -174 Rf value: 0.3 (silica gel, methylene chloride/methanol/ammonia 10:1:0.01)
C
27
H-
28
N
4 0 5
S
EST mass spectrum: L/ =59[-H]1 3-Z- (N-(2-amino-ethyl)-N-methylsulphonyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 3-Z- (N-cyanomethyl-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone R, value: 0.5 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01)
C
26
H
26
N
4 0 5
S
ESI mass spectrum: m/z 505 [M-Hj1 3-Z- (3-methylamino-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 3-Z- [1-(4-(N-(3--(N-benzyl-N-methyl-amino) propyl) -N-methylsulphonyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone Rf value: 0.3 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01)
C
28
H
30
N
4 0 5
S
ESI mass spectrum: m/z 533 [M-HKI 3-Z- (piperazin-l-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 3-Z-[l-(4-(N-((4-benzyl-piperazin-l-yl)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone Rf value: 0.5 (silica gel, methylene chloride/methanol 9:1)
C
30
H
3
IN
5 0' ESI mass spectrum: m/z 524 [M-Hi1 175 3-Z-[1-(4-(N-(methylamino-methylcarbonyl)-N-methyl-amino)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone Prepared from 3-Z-[1-(4-(N-((N-benzyl-N-methyl-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6-methoxycarbonyl-2-indolinone Rf value: 0.3 (silica gel, methylene chloride/methanol 9:1)
C
27
H
26
N
4 0 4 ESI mass spectrum: m/z 469 3-Z-[1-(4-(N-((2-methylamino-ethyl)-carbonyl)-N-methylamino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2indolinone Prepared from 3-Z-[1-(4-(N-((2-(N-benzyl-N-methyl-amino)ethyl)-carbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone R, value: 0.3 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01)
C
28
H
28
N
4 04 ESI mass spectrum: m/z 483 Example 6 3-Z-[1-(4-ureidomethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone 300 mg of 3-Z-[1-(4-aminomethyl-anilino)-l-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone are dissolved in 15 ml of methanol and 200 ml of triethylamine are added. Then 400 mg of potassium cyanate in 5 ml of water are added. After 2 days of stirring at room temperature the reaction solution is concentrated by rotary evaporation, the residue taken up in methylene chloride and washed once with water and once with saturated sodium chloride solution. The organic phase is dried over sodium sulphate and concentrated by rotary evaporation. The residue is dried in vacuo at 100 0
C.
Yield: 100 mg of (21 of theory), 176 Rf value: 0.7 (silica gel, methylene chloride/methanol 5:1)
C
2 H22N404 ESI mass spectrum: m/z 441 Example 7 3-Z-[1-(4-guanidinomethyl-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone 300 mg of 3-Z- [1-(4-aminomethyl-anilino)-1-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone are dissolved in 5 ml of dimethylformamide and 300 ml of triethylamine are added. Then 700 mg of 3,5-dimethylpyrazol-l-carboxylic acid amidine in ml of dimethylformamide are added. After one day of stirring at room temperature the reaction solution is concentrated by rotary evaporation. The residue is dried at 100 0 C in vacuo.
Yield: 200 mg (87 of theory), R, value: 0.1 (Reversed phase RP 8, methanol/five percent saline solution 6:4)
C
2 sH 23 Ns0 3 Mass spectrum: m/z 441 Example 8 3-Z-[1-(4-acetylaminomethyl-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone 100 mg of 3-Z-[l-(4-aminomethyl-anilino)-l-phenyl-methylene]- 6-methoxycarbonyl-2-indolinone are dissolved in 5 ml of glacial acetic acid, 0.1 ml of acetic anhydride is added and the mixture is stirred for 10 minutes at room temperature.
After this time the reaction solution is poured onto saturated soda solution and extracted four times with methylene chloride. The combined organic phases are washed with saturated saline solution, dried over sodium sulphate and concentrated by rotary evaporation. The residue is dried at 1000C in vacuo.
177 Yield: 20 mg (23 01 of theory), Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
2 6 2 3 3 4 £31L mass spectrum: m/z 440 [M-Hij The following compounds are prepared analogously to Example 8: 3-Z- El-(4- (N-methylsulphonyl-aminomethyl)-anilino)-lphenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 3-Z- [1-(4-aminomethyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone and methanesulphonyl chloride/triethylamine Rf value: 0.7 (silica gel, methylene chloride/methanol 5:1)
C
2 5H 23
N
3 0 5
S
ESI mass spectrum: m/z 476 EM-WI1 3-Z-E1-(4-(4-benzoyl-piperazin-1-yl-methyl)-anilino)-1phenyl-methylene] -6 -methoxycarbonyl-2-indolinone Prepared from 3-Z-[1-(4-(piperazin-l-yl-methyl) -anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone and benzoyl chloride Rf value: 0.7 (silica gel, methylene chloride/methanol 10:1)
C
3 5H 32
N
4 0 4 ESI mass spectrum: m/z 571 EM-Hi1 3-Z-El-(4- ((N-(3-acetylamino-propyl)-N-methyl-amino)methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Prepared from 3-Z- El- (3-amino-propyl) -N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone Rf value: 0.3 (silica gel, methylene chloride/methanol 9:1)
C
3 0
H
32
N
4 0 4 ES1 mass spectrum: m/z 511 [M-H-i 178 Example 9 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethvlene] -6--carboxy-2-indolinone 0.8 g of 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene]-6-ethoxycarbonyl-2-indolinone are dissolved in ml of ethanol, 8.3 ml of IN sodium hydroxide solution are added and the mixture is stirred for 1 hour at 80 0 C. After cooling, it is neutralised with 8.3 ml of lN hydrochloric acid. The precipitate formed is suction filtered, washed with water, ethanol and ether and dried in vacuo at 100 0
C.
Yield: 0.7 g of (89 of theory), R, value: 0.2 (silica gel, methylene chloride/methanol 5:2)
C
28
H
27 N303 Mass spectrum: m/z 453 The following compounds are prepared analogously to Example 9: 3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene]-6-carboxy- 2-indolinone Prepared from 3-Z-[1-(4-bromo-anilino)-1-phenyl-methylene]- 6-ethoxycarbonyl-2-indolinone R, value: 0.4 (silica gel, toluene/ethyl acetate 5:1)
C
22
H
1 ,BrN 2 03 ESI mass spectrum: m/z 435/437 3-Z-[l-(3-(dimethylaminomethyl)-anilino)-1-phenylmethylene]-6-carboxy-2-indolinone Prepared from 3-Z-[1-(3-(dimethylaminomethyl)-anilino)- 1-phenyl-methylene]-6-ethoxycarbonyl-2-indolinone R, value: 0.7 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
25
H
23
N
3 03 ESI mass spectrum: m/z 414 -179 3-Z- (dimethylaminomethyl) -anilino)-1-phenylmethylene] -6-carboxy-2-indolinone Prepared from 3-Z- El- (dimethylaminomethyl) -anilino) 1-phenyll-methylene -6o- ethoxycarbonyl-2-indoiinone Rf value: 0.7 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
2 5
H
23
N
3 0 3 ESI mass spectrum: m/z 412 EM-Hi1 3-Z-El-(4-E(2,6-dimethyl-piperidin-1-yl)-methyl]-anilino)- 1-phenyl-methylene] -6-carboxy-2-indolinone Prepared from 3-Z- El-(4- [12,6-dimethyl-piperidin-1-yl) methyl] -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Rf value: 0.6 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
30
H
31
N
3 0 3 ESI mass spectrum: m/z 482 EM+H]l 3-Z-El-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-carboxy-2-indolinone Prepared from 3-Z-E1-(4-(1-methyl-imidazol-2-yl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone Rf value: 0.6 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
2 6
H
20
N
4 03 EST mass spectrum: m/z 435 EM-Hi1 (N-acetyl-N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone Prepared from 3-Z- El- (N-acetyl -Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Rf value: 0.3 (silica gel, methylene chloride/methanol 10:1)
C
2 8H26N40 ESI mass spectrum: m/z 497 EM-If] 180 3-Z-[li- (4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6carboxy- 2- indol inone Prepared from t- (4,-ethy'Laiiinomet-hyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone Rf value: 0.6 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
2 5 2 3 3 ESI mass spectrum: r i/z 412 [M-Hi1 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone Prepared from 3-Z-li- (N-dimethylaminomethylcarbonyl-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone Rf value: 0.6 (Reversed phase RP 8, methanol/five percent saline solution 4:1)
C
2 7 2 6 4 ESI mass spectrum: m/z 469 EM-Hi1 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone Prepared from 3-Z-[li- (N-tert .butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone Rf value: 0.4 (silica gel, methylene chloride/methanol 10:1)
C
3 0
H
3 1
N
3 ESI mass spectrum: m/z 512 tM-Hi1 3-Z- ((N-carboxymethyl-N-methyl-amino) -methyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone Prepared from 3-Z- ((N-ethoxycarbonylmethyl-N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl indolinone 181 R, value: 0.4 (silica gel, methylene chloride/methanol 6:1)
C
27
H
2
,N
3 0 ESI mass spectrum: m/z 470 Example 3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-methoxycarbonyl-2-indolinone 0.9 g of 3-Z-[1-(4-(piperidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-carboxy-2-indolinone are suspended in 35 ml of dimethylformamide and 0.4 g of carbonyldiimidazole are added.
The mixture is stirred for 14 hours at 80 0 C. After this time ml of methanol are added and the mixture is stirred for another 3 hours at 50 0 C. The solvent is removed and the residue is purified over a silica gel column with methylene chloride/methanol as eluant.
Yield: 0.5 g of (49% of theory), R, value: 0.5 (aluminium oxide, methylene chloride/methanol 30:1)
C
29
H
29
N
3 0 3 ESI mass spectrum: m/z 468 The following compounds are prepared analogously to Example 3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-1-phenylmethylene]-6-benzyloxycarbonyl-2-indolinone Prepared from 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)- 1-phenyl-methylene]-6-carboxy-2-indolinone and benzyl alcohol R, value: 0.6 (aluminium oxide, methylene chloride/methanol 30:1)
C
35
H
33
N
3 0 3 Mass spectrum: m/z 543 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene]-6-isopropyloxycarbonyl-2-indolinone -182 Prepared from 3-Z-[l-(4-(piperidin-l-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and isopropanol Rf value: 0.4 (aluminium oxide, methylene chloride/ isopropanol =30:1)
C
3 1 3303 Mass spectrum: m/z 495 [M]1 3-Z-[l-(4-(piperidin--l-yl-methyl)-anilino)-l-phenylmethylene] -6-propyloxycarbonyl-2-indolinone Prepared from 3-Z- Il- (piperidin-l-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and n-propanol Rf value: 0.7 (silica gel, methylene chloride/methanol 5:1)
C
3 1 3 3 3 Mass spectrum: m/z 495 [M*i 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-l-phenylmethylene] -6-butyloxycarbonyl-2-indolinone Prepared from 3-Z- (piperidin-l-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and n-butanol Rf value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
3 2
H
3 5
N
3 0 3 Mass spectrum: m/z 509 3-Z- [1-(4-bromo-anilino) -1-phenyl-methylene] -6-carbamoyl- 2 -indolinone Prepared from 3-Z- [1-(4-bromo-anilino) -1-phenyl-methylene] 6 -carboxy- 2- indolinone and ammonia R, value: 0.5 (silica gel, methylene chloride/methanol 10:1)
C
22
H
16 BrN 2 03 Mass spectrum: m/z 432/434 EM-WI1 3-Z-(1-(4-(piperidin-l-yl-methyl)-anilino)-l-phenylmethylene] -6 -ethylcarbamoyl-2-indolinone Prepared from 3-Z- (piperidin-1-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and ethylamine gas Rf value: 0.6 (silica gel, methylene chloride/methanol 5:1) 183
C
3 0
H
32
N
4 02 mass spectrum: m/z 480 [M*i n, 1hr ntb' nlno' -1-phenaylmethylene] -6-[E(2-methoxy-ethoxy) -carbonyl] -2-indolinone Prepared from 3-Z- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and methyiglycol Rf value: 0.8 (silica gel, methylene chloride/methanol 4:1)
C
25
H
23
N
3 0 3 ESI mass spectrum: m/z 470 [M-Hi1 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-l-phenylmethylene] [(2-dimethylamino-ethoxy) -carbonyl] -2-indolinone Prepared from 3-Z- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and 2-dimethylaminoethanol aniline Rf value: 0.5 (silica gel, methylene chloride/methanol 5:2)
C
2 9
H
32 4 3 ESI mass spectrum: m/z 483 EM-Hi1 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-l-phenylmethylene] -6-[E(2-N-tert.butoxycarbonyl-amino-ethoxy) carbonyl] -2-indolinone Prepared from 3-Z- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and 2-Ntert .butoxycarbonyl-amino-ethanol aniline Rf value: 0.8 (silica gel, methylene chloride/methanol 5:2)
C
3 2 3 6 4 ESI mass spectrum: m/z 412 EM-H-I 3-Z-[l-(4-(dimethylaminomethyl)-anilino)-l-phenylmethylene] ((2,2,2-trifluoroethoxy) -carbonyl] -2-indolinone 184 Prepared from 3-Z- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carbaxy-2-indolinone and 2,2,2trifluoroethanol aniline R, value: 0. -t silica gemcthylene chloride/rieLhaxiol 5:1)
C
27
H
24
F
3
N
3 0 3 ESI mass spectrum: m/z 494 [M-HKI Example 11
I
3-Z- Ii- (piperidin-1-yl-methyl) -anilino) -1-phenylmethylene] -6-carbamoyl-2-indol inane 0.9 g of 3-Z-[l-(4-(piperidin-l-yl-methyl)-anilino)-l-phenylmethylenel-6-carbaxy-2-indolinane, 0.8 g of TBTU and 0.4 g of HOBT are suspended in 25 ml of dimethylformamide and 1.0 ml of triethylamine are added. The mixture is stirred for minutes at room temperature. After this time ammonia gas is introduced at 10-15 0 C over a period of 15 minutes and the mixture is stirred for 1.5 hours at room temperature. The precipitate formed is suction filtered, washed with water, ethanol and ether and dried at 100 0 C in vacua.
Yield: 0.6 g (64 0- of theory), Rf value: 0.4 (Reversed phase RP 8, methanol/five percent saline solution 6:4)
C
2 8
H
2 8
N
4 02 ESI mass spectrum: m/z 453 [M+H]l The following compounds are prepared analogously to Example 11: 3-Z-[il- (4-(piperidin-l-yl-methyl)-anilina)-1-phenylmethylene] -6-dimethylcarbamayl-2-indolinone Prepared from 3-Z- (piperidin-1-yl-methyl) -anilino) 1-phenyl-methylene] -6-carbaxy-2-indolinone and dimethylamine hydrochloride/diisopropylethylamine -185 Rf value: 0.5 (silica gel, methylene chloride/methanol 5:1)
C
30
H
32
N
4 02 ESI mass spectrum: m/z 481 [M+H+1 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene] (N-ethyl-N-methyl-carbamoyl) -2-indolinone Prepared from (piperidin-1-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and N-ethyl- N-methyl -amine Rf value: 0.5 (aluminium oxide, methylene chloride/ethanol 20:1)
C
31 H 34
N
4 0 2 ESI mass spectrum: m/z 495 [M+H]I 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6-methylcarbamoyl-2-indolinone Prepared from 3-Z-[11- (piperidin-l-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and methylamine hydrochloride/di isopropylethylamine Rf value: 0.3 (aluminium oxide, methylene chloride/ethanol 20:1)
C
29
H
30
N
4 0 2 ESI mass spectrum: m/z 467 [M+H1j 3-Z- (dimethylaminomethyl)-anilino) -1-phenylmethylene] -6-methylcarbamoyl-2 -indolinone Prepared from 3-Z-[Il- (dimethylaminomethyl) -anilino) 1-phenyl-methylene] -6-carboxyl-2-indolinone and methylamine hydrochloride/triethylamine Rf value: 0.3 (silica gel, methylene chloride /ethanol 2:1)
C
26
H
26
N
4 0 2 Mass spectrum: m/z 426 3-Z- (piperidin-l-yl-methyl)-anilino) -1-phenylmethylene] (2-hydroxyethyl-carbamoyl) -2-indolinone 186 Prepared from 3-Z-[1-(4-(piperidin-1-yl-methyl) -anilino)- 1-phenyl-methylenel -6-carboxy-2-indolinone and ethanolamine/di isopropylethylamine R. value: 0. 5 (aluminium oxdmeth-'ene chl or-*de/'metharnoi 20:1)
C
30
H
32
N
4 03 ESI mass spectrum: m/z 495 EM-Hi1 3-Z-(l-(4-(pipei idin-1-yl-methyl)-anilino)-l-phenylmethylene] -6-diethylcarbamoyl-2-indolinone Prepared from 3-Z- (piperidin-1-yl-methyl) -anilino) 1-phenyl-methylene] -6-carboxy-2-indolinone and diethylamine hydrochloride/diisopropylethylamine R, value: 0.8 (aluminium oxide, methylene chloride /methanol 10:1)
C
3 2 3 6 4 2 EST mass spectrum: m/z 509 [M+H]l 3-Z- (N-tert.butoxycarbonyl-ethylaminomethyl) anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone Prepared from 3-Z- (N-tert.butoxycarbonylethylaminomethyl) -anilino) -1-phenyl-methylene] -6-carboxy-2indol inone Rf value: 0.3 (silica gel, toluene/ethyl acetate/ethanol- 4:2:1)
C
3 0
H
32
N
4 04 ESI mass spectrum: m/z 511 EM-Hi1 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone Prepared from 3-Z- (N-dimethylaminomethylcarbonyl-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-carboxy-2indolinone Rf value: 0.5 (silica gel, methylene chloride /methanol /ammonia 5:1:0.01) 187
C
27
H
27
N
5 03 ESI mass spectrum: m/z 468 ExamDle 12 3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone x citric acid 3.25 g of citric acid monohydrate are placed in 50 ml of methanol and 5.0 g of 3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl-methylene]-6methoxycarbonyl-2-indolinone are added at room temperature.
The solution formed is evaporated down, the residue is washed with ether and recrystallised from ethyl acetate.
Yield: 6.3 g (90 of theory), Rf value: 0.6 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01) Melting point: 198 0
C
C
28
H
28 N4Os x C 6
H
8 0, ESI mass spectrum: m/z 483 Elemental analysis: calc.: C 60.34 H 5.37 N 8.28 found: 59.98 5.25 8.13 The following compound is prepared analogously to Example 12: 3-Z-[l-(4-(dimethylaminomethyl)-anilino)-l-phenylmethylene]-6-methoxycarbonyl-2-indolinone x methanesulphonic acid Prepared from 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1phenyl-methylene]-6-methoxycarbonyl-2-indolinone and methanesulphonic acid Rf value: 0.6 (silica gel, methylene chloride/methanol/ammonia 5:1:0.01) Melting point: 275 0
C
C,
2
H
25
N
3 0, x CH40 3
S
ESI mass spectrum: m/z 426 188 Elemental analysis: caic. C 61.92 H 5.59 N 8.03 S 6.12 found: 61.43 5.87 7.85 5.39 The following compouinds may be prepared analogously to the foregoing Examples: 3-Z- (1-anilino-l-phenyl-methylene) -6-ethoxycarbonyl- 2-indolinone 3-Z-[l-(4-nitro-anilino)-l-phenyl-methylenej-6ethoxycarbonyl indol inone 3-Z- [l-(4-fluoro-anilino)-1-phenyl-methylene] -6-ethoxycarbonyl indol inone 3-Z-[il- (4-chloro-anilino)-l-phenyl-methylene] -6-ethoxycarbonyl indol inone 3-Z-[1-(4-iodo-anilino)-1-phenyl-methylene]-6ethoxycarbonyl indol inone 3-Z- [1-(4-cyano-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl indolinone 3-Z-[l-(4-methoxy-anilino)-l-phenyl-methylenel-6ethoxycarbonyl indolinone 3-Z-[l-(4-ethoxy-anilino)-l-phenyl-methylene]-6ethoxycarbonyl indolinone 3-Z- [1-(4-trifluoromethyl-anilino) -1-phenyl-methylene] 6- ethoxycarbonyl indol inone 3-Z-[l-(4-methyl-anilino)-l-phenyl-methylene]-6ethoxycarbonyl indolinone -189 (11) 3-Z- II-(4-methylmercapto-anilino)-1-phenyl-methylene] 6 -ethoxycarbonyl indol inone (12) 3-Z- il- (4-aminornethvl-anilino) -1-pheny!-meithylene] -6ethaxycarbonyl indolinone (13) 3-Z- (isopropylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (14) 3-Z- [1-(4-(anilinomethyl)-anilino)-1-phenyl-methylene] 6- ethoxycarbonyl indol inane 3-Z- [1-(4-(propylaminomethyl) -anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (16) 3-Z- (butylaminomethyl) -anilino) -1-phenylmethyleie] -6-ethoxycarbonyl-2-indolinone (17) 3-Z- fl-(4-(isobutylaminomethyl)-anilino)-1-phenylmethylene] ethoxycarbonyl indolinone (18) 3-Z- [1-(4-(cyclohexylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2 -indol inane (19) 3-Z- [l-(4-(benzylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (N-ethyl-N-methyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (21) 3-Z- (N-methyl-N-propyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (22) 3-Z- (N-isopropyl-N-methyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -190 (23) 3-Z--(-(4-((N-ethyl-N-propyl-amino)-methyl)-anilino)- 1-phenyl-methylenel -6-ethoxycarbonyl-2-indolinone (24) 3-Z-fl-(4-((N-ethyl,-NT-isopro---pyl -ami no) -methyl) -anilino)- 1-phenyl-methylenel -6-ethoxycarbonyl-2-indolinone 3-Z-fl-(4-(dipropylaminomethyl)--anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2--indolinone (26) 3-Z-[II-(4-(diisopropylaminomethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (27) 3-Z-[1-(4-((N-benzyl-N-ethyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (28) 3-Z-[lI-(4-(dibenzylaminomethyl)-anilino)-1-phenylmethylene] -6 -ethoxycarbonyl-2-indolinone (29) 3-Z-[1-(4-(3,6-dihydro-2H-pyridin-1-yl-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 3-Z-[1-(4-(3,5-dimethyl-piperidin-1-yl-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (31) 3-Z-[1-(4-(azepan-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (32) 3-Z-[1-(4-(piperazin-1-yl-methyl)-anilino)--phelylmethylene] -6 -ethoxycarbonyl indolinone (33) 3-Z-[1-(4-(morpholin-4-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (34) 3-Z- [1-(4-(thiomorpholin-4-yl-methyl)-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone 191 3-Z-[l-(4-(1-oxo-thiomorpholin-4-yl-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (36) -ey)-anili.no) 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (37) 3-Z-[l-(4-(acetylamino-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (38) 3-Z-[l-(4-(2-amino-ethyl)-anilino)-1-phenyl-methylenel 6- ethoxycarbonyl indolinone (39) 3-Z-[1-(4-(2-methylamino-ethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone 3-Z-[1-(4-(2-ethylamino-ethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (41) 3-Z-[1-(4-(2-diethylamino-ethyl)-anilino)-1-phenylmethylene] ethoxycarbonyl indolinone (42) 3-Z-[l-(4-(2-piperidin-1-yl-ethyl)-anilino)-1-phelylmethylene] -6-ethoxycarbonyl-2 -indolinone (43) 3-Z- [l-(4-(2-acetylamino-ethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (44) 3-Z- II-(4- (3-amino-propyl) -anilino)-1-phenyl-methylene] 6 -ethoxycarbonyl indolinone 3-Z- (3-dimethylamino-propyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolilofe (46) (N-aminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 192 (47) 3-Z- (N-methylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (43) 3-Z-F- A1 (IT- ethy'aminoii-e Liycarbonyi -N-me thy! -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (49) 3-Z-[li- (N-diethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 3-Z- (piperidin-1-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (51) 3-Z- [l-(4-(N-(morpholin-4-yl-methylcarbanyl)-N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone (52) 3-Z- (piperazin-1-yIl-methylcarbonyl) -N-methylamino] -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (53) 3-Z- (2-amino-ethylcarbonyl)-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (54) 3-Z- (2-methylamino-ethylcarbanyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane 3-Z- (2-diethylamino-ethylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (56) 3-Z- [1-(4-(N-acetyl-N-(2-aminoethyl)-amino)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 193 (57) 3-Z- [1-(4-(N-acetyl-N- (2-methylamino-ethyl) -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (58) 3Z 1 4 Naey--(-ehlmn-rpl aro anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (59) 3-Z-[l-(4-(N-acetyl-N-(2-piperidin-1-yl-ethyl)-amino)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 3-Z- (N-acetyl-N- (aminocarbonylmethyl) -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (61) 3-Z- (N-acetyl-N- (dimethylaminocarbonylmethyl) amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone (62) 3-Z- (N-acetyl-N- (piperidin-l-yl-carbonylmethyl) amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone (63) 3-Z-[l-(4-(N-methyl-N-(aminocarbonyl)-amino)-alililo)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (64) 3-Z- (N-methyl-N- (methylaminocarbonyl) -amino) anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 3-Z- (N-methyl-N- (dimethylaminocarbonyl) -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinole (66) 3-Z- (N-methyl-N- (piperidin-l-yl-carbonyl) -amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (67) 3-Z- [l-(4-(N-(2-aminoethyl)-N-methylsulphonyl-amino)anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 194 (68) 3-Z- (2-methylamino-ethyl) -N-methylsulphanylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (69) 3-Z- [1-(4-(N-(2-ethylamino-ethyl)-N-methylsulphonylamino) -anilina) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane 3-Z-[li- (.-diethylamino-ethy1) -N-methylsulphonylamino) -anilina) -1-phenyl-methylene] -6-ethoxycarbanyl-2ndol inane (71) 3-Z-[l-(4-(N-(2-pyrrolidin-1-yl-ethyl)-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2ndol inane (72) 3-Z- (2-piperidin-l-yl-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbanyl-2indolinane (73) 3-Z- (1-(4-(N-(2-piperazin-l-yl-ethyl)-N-methylsulphanylamino) -anilino) -1-phenyl-methylene] -6-ethaxycarbonyl-2indal inane (74) 3-Z- (marphalin-4-yl) -ethyl) -Nmethylsuiphonyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indal inane 3-Z-[li- (aminacarbanylmethyl) -N-methylsulphanylamino) -anilina) -1-phenyl-methylene] -6-ethoxycarbanyl-2ndol inane (76) 3-Z- (methylaminacarbanylmethyl) -Nmethylsuiphanyl -amino) -anilina) -1-phenyl-methylene] -6ethoxycarbonyl indalinone 195 (77) 3-Z- (ethylaminacarbanylmethyl)
-N-
methylsuiphonyl-amina) -anilino) -1-phenyl-methylene] -6ethaxycarbonyl indal inane (78) 3-Z- (N-(N-(2-dimethylamina-ethyl) -N-methyl-amino)carbonylmethyl) -N-methylsulphonyl-amina) -anilino) -1-phenylmethylene] -6-ethoxycarbanyl-2-indolinone (79) 3-Z- (diethylaminacarbanylmethyl)
-N-
methylsuiphanyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indalinane 3-Z- (pyrrolidin-1-yl-carbanylmethyl) -N-methylsuiphonyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbonyl indal inane (81) 3-Z- (piperidin-1-yl-carbonylmethyl)
-N-
methylsuiphanyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indal inane (82) 3-Z-[1-(4-(N-(piperazin-1-y1-carbonylmethy1-Nmethylsuiphanyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indal inane (83) 3-Z- 1- ((marphalin-4-yl) -carbanylmethyl) -N-methylsuiphanyl-amina) -anilina) -1-phenyl-methylene] -6ethaxycarbanyl indal inane (84) (2-dimethylamin-ethxy)-anilina-i-phenylmethylene] -6-ethaxycarbanyl-2-indalinane 3-Z- (3-dimethylamina-praPaxy) -anilina) -1-phenylmethylene] -6-ethaxycarbanyl-2-indolinane (86) 3-Z- (aminacarbanylmethyl)-anilino)-J--phenylmethylene] -6 -ethaxycarbanyl-2-iridalinane -196- (87) 3-Z-[1-(4-(2-aminocarbanyl-ethyl)-anilina)-1-phenylmethylene] -6-ethoxycarbanyl-2-indolinone (88) 3-Z-[1-(4-(pyridin-2-yl)-anilina)-1-phenyl-methylene]- 6- ethaxycarbonyl indal inone (89) 3-Z-[1-(4-(pyridine-3-yl)-anilino)-1-phenyl-methylene]- 6- ethaxycarbanyl -2 indol inane 3-Z- [1-(4-(pyridin-4-yl)-anilina)-1-phenyl-methylene] 6- ethaxycarbanyl indal inane (91) 3-Z-[1-(4-(N-acetyl-N-methyl-amina)-anilino)-1-phenylmethylene] -6-ethaxycarbonyl-2-indolinane (92) 3-Z- (N-ethylcarbonyl-N- (dimethylaminacarbanylmethyl) -amino) -anilino) -1-phenyl-methylene] -6-ethaxycarbanyl- 2-indol inane (93) 3-Z- [1-(carbamoylmethyl-anilina) -1-phenyl-methylene] 6- ethaxycarbanyl indal inane (94) 3-Z- [1-(4-dimethylcarbamaylmethyl-anilina) -1-phenylmethylene] -6-ethoxycarbanyl-2-indolinone 3-Z-[l-(4-(piperidin-1-yl-methyl)-anilino)-methylene] 6 -ethoxycarbanyl indol inane (96) 3-Z- [1-(4-(piperidin-1-yl-methyl)-anilino)-prapylidene] 6- ethaxycarbanyl indal inane (97) 3-Z- [l-(4-(piperidin-1-yl-methyl)-anilina)-butylidene] 6 -ethaxycarbanyl-2-indalinone 197 (98) 3-Z- (3-dimethylamino-propyl) -N-acetyl-amino) anilino) -methylene] -6-ethoxycarbonyl-2-indalinone (99) 3-Z-(1-(4-(N-(3-dimethvlamino-Dropy1vl)-N-acety-aincanilino) -ethylidene] -6-ethoxycarbonyl-2-indolinone (100) 3-Z- [1-(4-(N-(3-dimethylamino-propyl) -N-acetyl-amino) anilina) -propylidene] -6-ethoxycarbonyl-2-indolinone (101) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino) anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone (102) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonylamino) -anilino) -methylene] -6-ethoxycarbonyl-2-indolinone (103) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -propylidene] -6-ethoxycarbonyl-2-indolinone (104) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone (105) 3-Z-[1-(4-tetrazol-5-yl-anilino)-methylene]-6ethoxycarbonyl -2 -indol inane (106) 3-Z- [1-(4-tetrazol-5-yl-anilino)-ethylidene] -6-ethoxycarbonyl -2-indol inane (107) 3-Z-[1-(4-tetrazol-5-yl-anilino)-propylidene]-6-ethoxycarbonyl indol inane (108) 3-Z-[l-(4-tetrazol-5-yl-anilino)-butylidene]-6ethoxycarbonyl indol inane (109) 3-Z- [1-(4-carbaxy-anilina)-methylene] -6-ethaxycarbanyl- 2- indol inane 198 (110) 3-Z-[1-(4-carboxy-anilino)-propylidene]-6ethoxycarbonyl indolinone (111) 3 (4 -carboxy-anil inn) -butylidene] 6-ehxcrc 2- indolinone (112) 3-Z-[1-(4-(N-(3-dimethylamino-propionyl) -Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] ethoxy~arbony1 indol inone (113) 3-Z-[1-(4-(N-(4-dimethylamino-butyryl)-Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] ethoxycarbonyl indol inane (114) 3-Z- (N-dimethylaminocarbonylmethyl-N- (2dimethylamino-ethylsulphonyl) -amino) -anilino) -1-phenylmethylene] -6 -ethoxycarbonyl-2-indol inane (115) 3-Z-[li- (N-dimethylaminocarbonylmethyl-N- (3dimethylamino-propylsulphonyl) -amino) -anilino) -1-phenylmethylene] -6 -ethoxycarbonyl-2-indolinone (116) 3-Z- (2-hydroxy-ethyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (117) 3-Z-[1-(4-((2-methoxy-ethyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (118) 3-Z-[1-(4-((2-dimethylamino-ethyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (119) 3-Z- [1-(4-((3-dimethylamino-propyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 199 (120) 3-Z- tert. butoxycarbonyl 2-amino -ethyl) -aminomethyl) -anilina) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (121) 3-Z- (N-tert.butaxycarbanyl-3-amino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (122) 3-Z-[l-(4-((2-amino-ethyl)-amino-methyl)-anilino)-lphenyl-methylene] -6-ethoxycarbonyl-2-indolinone (123) 3-Z-[1-(4-((3-amino-propyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (124) 3-Z- [1-(4-((2-acetylamino-ethyl)-amino-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (125) 3-Z-[1-(4-((3-acetylamino-propyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (126) 3 1- (4 (2 -methylsulphonylamino- ethyl) amino-methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (127) 3-Z- ((3-methylsulphonylamino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inane (128) 3-Z-[l-(4-(N-(N-tert.butoxycarbonyl-2-amino-ethyl)-Nmethyl-amino-methyl) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (129) 3-Z- [1-(4-(N-(2-amino-ethyl)-N-methyl-amino-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -200 (130) 3-Z- (2-acetylamino-ethyl) -N-methyl-aminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone (131) 3-Z- (2-methylsulphonylamino-ethyl) -N-methylamino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone (132) 3-Z-[1-(4-(ca~rboxymethy1-amino-methy1)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (133) 3-Z- El-(4-(ethoxycarbonylmethyl-amino-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (134) 3-Z-[lI-(4-(carbamoylmethyl-amino-methyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (135) 3-Z- (dimethylcarbamoyl-methyl-amino-methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (136) 3-Z- (methylcarbamoyl-methyl-amino-methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (137) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-amino-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indolinone (138) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-nitro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (139) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-acetylamino-anilino) -1-phenyl-methylene] -6ethoxycarbonyl -2 -indol inone 201 (140) (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methylsulphonylamino-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (141) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-cyano-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (142) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-hydroxy-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (143) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methoxy-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inone (144) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-ethoxycarbonyl-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (145) 3-Z-[li- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-carboxy-anilino) -1-phenyl-methylene] -6ethoxycarbonyl -2 -indol inane (146) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-carbamoyl-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (147) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-chioro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indol inane (148) 3-Z-[li- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-f luoro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane 202 (149) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-bromo-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (150) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (151) 3-Z- (N-aimethylaminomethylcarbonyl-N-methylamino) -3-trifluoromethyl-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (152) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino)-3,5-dibromo-anilino)-1-phenyl-methylene] -6ethoxycarbonyl indolinone (153) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) 5-dichioro-anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inone (154) 3-Z-(1-(4-(dimethylaminomethyl)-3-amino-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (155) 3-Z-[1-(4-(dimethylaminomethyl)-3-nitro-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (156) 3-Z- (dimethylaminomethyl) -3-acetylamino-anilino) 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (157) 3-Z-[Il- (dimethylaminomethyl) -3- (methylsuiphonylamino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inone (158) 3-Z-[1-(4-(dimethylaminomethyl)-3-cyano-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -203 (159) 3-Z-tl-(4-(dimethylaminomethyl)-3-hydroxy-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (160) 3-Z- (dimethyiauiinomiDiethyiL) -3-meth'oxy-anilin'-O) phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (161) 3-Z- (dimethylaminomethyl)-3- (ethoxycarbonyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (162) 3-Z- [1-(4-(dimethylaminomethyl)-3-carboxy-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (163) (4-(dimethylaminomethyl)-3-carbamoyl-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (164) 3-Z- [1-(4-(dimethylaminomethyl)-3-chloro-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (165) 3-Z- [1-(4-(dimethylaminomethyl) -3-fluoro-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (166) 3-Z- [1-(4-(dimethylaminomethyl)-3-bromo-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (167) 3-Z- [l-(4-(dimethylaminomethyl)-3-methyl-anilino) -1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (168) 3-Z- (dimethylaminomethyl) -3-trifluoromethylanilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (169) 3-Z- II-(4-(dimethylaminomethyl)-3,5-dibromo-aliliflo)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (170) 3-Z- [1-(4-(dimethylaminomethyl)-3,5-dichloro-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone 204 (171) (4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)- N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indolinone (172) 3-Z- [1-(4-(N-(imidazo-1-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indol inone (173) 3-Z-[li- (N-.(phthalimido-2-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2ndcl inone (174) 3-Z- Ii- (N-aminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (175) 3-Z- (N-acetylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (176) 3-Z-[li- (N-methylsulphonylaminomethylcarbonyl-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2indolinone (177) 3-Z- [1-(4-(N-((N-(2-methoxyethyl)-N-methyl-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6- ethoxycarbonyl -2 -indol inone (178) 3-Z- (2-dimethylaminoethyl) -N-methyl-amino) methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -ethoxycarbonyl indolinone (179) 3-Z-[1-(4-(N-((di-(2-hydroxyethyl)-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6- ethoxycarbonyl indol inone (180) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -methylene] -6-ethoxycarbonyl-2-indolinone 205 (181) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -ethylidene] -6-ethoxycarbonyl-2-indolinone (182) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -propylidene] -6-ethoxycarbonyl-2-indolinone (183) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone (184) 3-Z-[l1-(4-(dimethylaminomethyl)-anilino)-methylene] -6ethoxycarbonyl indolinone (185) 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-ethylidene]-6ethoxycarbonyl -2 -indol inane (186) 3-Z- [1-(4-(dimethylaminomethyl) -anilino) -propylidene] -6ethoxycarbonyl indolinone (187) 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-butylidene]-6ethoxycarbonyl -2 -indol inane (188) 3-Z- (N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (189) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (190) 3-Z-[1-(4-((imidazolidin-2,4-dion-5-ylidene)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (191) 3-Z- [1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane 206 (192) 3-Z- El- (4-(N-tert.butoxycarbonyl-aminomethyl) -anilino) 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (193) 3-Z- (2-oxo-pyrrolidinr-1 -y 1 -methyl -a-41inolphenyl-methylene] -6-ethoxycarbonyl-2-indolinone (194) 3-Z- CN-aminocarbonylmethyl-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone (195) 3-Z- (N-cyanomethyl-N-methylsulphonyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (196) 3-Z-[1-(4-(2-(imidazol-4-yl)-ethyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (197) 3-Z-(1-(4-((2-(N-benzyl-N-methyl-amino)-ethyl)-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (198) 3-Z-[1-(4-cyclohexylamino-anilino)-1-phenyl-methylene] 6 -ethoxycarbonyl indol inane (199) 3-Z-[l-(4-(imidazol-1-yl-methyl)-anilino)-1-phenylmethylene] -6 -ethoxycarbonyl-2-indolinone (200) 3-Z-(1-(4-(imidazol-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (201) 3-Z- [1-(N-methyl-piperidine-4-yl-amino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (202) 3-Z-(1-(4-(imidazol-4-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbony1-2-indolinone -207 (203) 3-Z-[l-(4-((4-hydroxy-piperidin-1-yl)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (204) 3-Z- ((4-rm-ethoxy-piLperiLdi'n-I,-yl), -Me-thyl) -mni Iin',) 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (205) 3-Z-(1-(4-benzyl-anilino)-l-phenyl-methylene]-6ethoxycarbonyl -2-indol inane (206) (N-(3-trifluoroacetylamino-propyl)-Nmethylsuiphonyl-amino) -anilino) -1-phenyl-methylenel -6ethoxycarbonyl -2-indol inane (207) 3-Z-[l-(4-(4-tert.butoxycarbonyl-piperazin-1-yl-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (208) 3-Z-[1-(4-(l-methyl-imidazol-2-yl)-anilino)-l-phelylmethylene] -6-ethoxycarbonyl-2-indolinone (209) 3-Z-[1-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (210) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -3-amino-aniline) -1-phenyl-methylenel -6-ethoxycarbenyl- 2 -indelinone (211) ((3-(N-benzyl-N-methyl-amino)-propyl)-Nmethylsuiphenyl-amine) -aniline) -1-phenyl-methylene] -6ethexycarbenyl indelinene (212) 3-Z- [l-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amie) aniline) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (213) 3-Z- [1-(4-(N-(2-dimethylamine-ethyl)-N-butyryl-amine) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -208 (214) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl)--N-isobutyrylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inone (215) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) -N-benzoyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (216) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-3amino-anilino) -1-ph~ny1-methylene] -6-ethoxycarbonyl- 2-indol inane (217) (4-(4-hydroxymethyl-piperidin-1-yl-methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (218) 3-Z-[1-(4-(2-(4-hydroxy-piperidin-1-yl)--ethyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (219) 3-Z- (2-dimethylamino-ethyl) -N-propylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indol inane (220) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) -N-butylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indol inane (221) 3-Z- (2-dimethylamino-ethyl) -N-phenylsulphonylamino) -aniline) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (222) 3-Z- (2-dimethylamino-ethyl) -N-benzylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indol inane (223) 3-Z-[1-(4-((imidazolidin-2,4-dion-5-yl)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinane 0 209 (224) 3-Z-[1-(4-((3-hydroxy-pyrrolidin-1-yl)-methyl)-anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (cylol1 xly-methyl) -anilin-l-1-pheny-,, methylene] -6-ethoxycarbonyl-2-indolinone (226) 3-Z-[1-(4-(cyclohexyl-carbonyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (227) 3-Z- [1-(4-diethylaminomethyl-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (228) 3-Z-[1-(4-(N-(n-hexyl)-N-methyl-aminomethyl)-anilino)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (229) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(furan-2carbonyl) -amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl -2 -indolinone (230) 3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-N-(2-methoxybenzoyl) -amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indol inane (231) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-(pyridine-3carbonyl) -amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (232) 3-Z-[l-(4-(N-(2-dimethylamino-ethyl)-N-(phenyl-acetyl)amino) -aniline) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone (233) 3-Z-[1-(4-(imidazol-2-yl)-anilino)-l-phenyl-methylene]- 6- ethoxycarbonyl indolinone (234) 3-Z-[l-(4-(l-ethyl-imidazol-2-yl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2 -indolinone -210 (235) 3-Z-[l-(4-(l-benzyl-imidazol-2-yl)-anilino)-l-phenylmethylenel -6-ethaxycarbonyl-2-indolinone (236) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-Nisoprapylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (237) 3-Z- [l-(4-(N-.(4-benzy1-piperazin-1-y1)-methylcarbonyl)- N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (238) 3-Z- (pyrrolidin-1-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (239) 3-Z- [1-(4-(N-(2-dimethylamino-ethyl) -N-acetyl-amino) -3broma-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinane (240) 3-Z-[l-(4-(5-methyl-imidazol-4-yl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2--indolinone (241) 3-Z-[lI-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-Nisopropyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (242) 3-Z- (2-dimethylamino-ethyl)-carbonyl)-Nbenzyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbanyl- 2- indol inane (243) 3-Z- (N-butyl-N-tert.butoxycarbonyl-aminomethyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -211 (244) (N-((N-aminocarbonylmethyl-N-methyl-amino) methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -ethoxycarbonyl indolinone (245) 3-Z- ((N-benzyl-N-methyl-amino) -methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (246) 3-Z- [1-(4-(N-(di-(2-methoxyethyl)-amino-methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indcl inone (247) 3-Z-[l-(4-(N-((2-(4-tert.butoxycarbonyl-piperazin-1-yl)ethyl) -carbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6- ethoxycarbonyl indol inone (248) 3-Z-[l-(4-(N-((2-(piperidin-l-yl)-ethyl)-carboflyl)-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inone (249) 3-Z-[1-(4-(N-((2-(N-benzyl-N-methyl-amino)-ethyl)carbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indolinone (250) 3-Z- (N-dimethylaminomethylcarbonyl-N-isopropylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inone (251) 3-Z- (piperidin-l-yl-methylcarbonyl) -Nisopropyl -amino) -anilino) -l-phenyl -methylene] -6ethoxycarbonyl indolinone (252) 3-Z-[l-(4-(N-((4-tert.butoxycarbonyl-piperazifl-l-yl)V methylcarbonyl) -N-isopropyl-amino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone -212 (253) 3-Z- (N-benzyl-N-methyl-amino) -methylcarbonyl) N-benzyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone (254) 3-Z- (N-dimethylaminomethylcarbonyl-N-benzylamino) -anilino) -1-phenyl-methylenel-6-ethoxycarbonyl- 2- indolinone (255) 3-Z- piperidin-1-y1-methylcarbonyl) -N-benzylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (256) 3-Z-[1-(4-(1,2,4-triazol-2-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (257) 3-Z-[1-(4-(1,2,3-triazol-2-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (258) 3-Z-[1-(4-(1,2,3-triazol-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (259) 3-Z- ((N-aminocarbonylmethyl-N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indol inane (260) 3-Z-[1-(4-((di-(2-methoxy-ethyl)-amino)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (261) 3-Z-[l-(4-((di-(2-hydroxy-ethyl)-amino)-methyl)aniline) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (262) 3-Z- 1- ((N-ethoxycarbonylmethyl-N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane S 213 (263) 3-Z-[l-(4-(azetidin-1-yl-methyl)-anilino)-1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (24)3-r7 rI (4 (N -propyl tert. but xycarbcny1 -ami 1-met hy I~ anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (265) 3-Z-[l-(4-((N-(2-(2-methoxy-ethoxy)-ethyl)-N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (266) 3-Z-[1-(4-((N-(tert.butoxycarbonyl-3-amino-propyl)-Nmethyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (267) 3-Z- (methylcarbamoyl-methyl) -N-methyl-amino) methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indol inane (268) 3-Z- (dimethylcarbamoyl-methyl) -N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indolinone (269) 3-Z-[l-(4-((N-propyl-N-methyl-amino)-methyl)-anilino)phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (270) 3-Z-[l-(4-((N-(2-dimethylamino-ethyl)-N-methyl-amino)-_ methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (271) 3-Z-[Il-(4-((N-(3-dimethylamino-propyl)-N-methyl-amino)methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indolinone (272) 3-Z- (l-(4-((N-(2-methoxy-ethyl)-N-methyl-amino)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -214 (273) 3-Z-[1-(4-((N-(2-hydroxy-ethyl)-N-methyl-amino)-methyl)anilino) -1-phenyl-methylenel -6-ethoxycarbonyl-2-indolinone (274) 3 (4 (dioxolan-2-yl-methyi) -N-methyl -amino) methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (275) 3-Z-[l-(4-(3-oxo-piperazin-1-yl-methyl)-anilino)-lphenyl-methylene] -G.'thoxycarbonyl-2-indolinone (276) 3-Z- E1-(4-(N-(piperazin-1-yl-methylcarbonyl)-Nisopropyl-amina) -anilino) -1-phenyl-methylene] -6ethoxycarbonyl indol inane (277) 3-Z-[l-(4-(N-((2-(piperazin-l-yl)-ethyl)-carbonyl)-Nmethyl-amino) -anilino) -1-phenyl-methylenel -6-ethoxycarbonyl- 2-indcl inane (278) 3 [1 (3 -amino-propyl) -N-methyl -amino) -methyl) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (279) 3-Z- (3-methylamina-propyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2 -indol inane (280) 3-Z- [1-(4-Ureidomethyl-anilino)-l-phenyl-methylene]-6ethoxycarbonyl indol inane (281) (4-guanidinomethyl-anilina) -1-phenyl-methylene] 6- ethoxycarbonyl -2 -indol inane (282) 3-Z-[1-(4-(N-methylsulphonyl-aminomethyl)-anilina)-1phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (283) 3-Z-[l-(4-(4-benzoyl-piperazin-1-yl-methyl)-anilino)-lphenyl-methylene] -6-ethoxycarbonyl-2-indolinone 215 (284) 3-Z-[1-(4-((N-(3-acetylamino-propyl)-N-methyl-amino)methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- (285) 3-Z- (3-methylsulphonylamino-propyl) -N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2- indol inane (286) 3-Z- [1-(4-((N-carbaxymethyl-N-methyl-amino)-methyl)anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (287)3-Z- (l-anilino-1-phenyl-methylene) -6-methoxycarbonyl- 2-indolinone (288) 3-Z- [1-(4-nitro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl indolinone (289) 3-Z- [1-(4-fluoro-anilino)-1-phenyl-methylene] -6-methoxycarbonyl indolinone (290) 3-Z- [l-(4-chloro-anilina)-l-phenyl-methylene] -6-methoxycarbonyl -2 -indolinone (291) 3-Z- [1-(4-bromo-anilino)-l-phenyl-methylene] -6-methoxycarbonyl indol inane (292) 3-Z-[l-(4-iodo-anilino)-1-phenyl-methylene]-6methoxycarbonyl -2 -indol inane (293) 3-Z- Ll-(4-cyano-anilino)-1-phenyl-methylene] -6-methoxycarbonyl -2-indol inane (294) 3-Z- El- (4-carboxy-anilino)-1-phenyl-methylene]-6methoxycarbonyl indol inane 216 (295) 3-Z-[1-(4-methoxy-anilino)-1-phenyl-methylene]-6methoxycarbonyl -2-indol inane (296) 3-.F-(-toyanln)i pey-mae-thy-lenel -6-raetfioxycarbonyl indol inone (297) 3-Z- [1-(4-trifluoromethyl-anilino)-1-phenyl-methylene] 6 -methoxycarbonyl indolinone (298) 3-Z- [1-(4-methylmercapto-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl -2-indol inane (299) 3-Z- [l-(4-(isopropylaminomethyl)-anilino)-i-phenylmethylene] -6 -methoxycarbonyl indolinone (300) 3-Z- [1-(4-(anilinomethyl)-anilino)-1-phenyl-methylene] 6 -methoxycarbonyl -2-indol inane (301) 3-Z- (isobutylaminomethyl)-anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone (302) (cyclohexylaminomethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (303) (benzylaminomethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2 -indolinone (304) 3-Z- 11- ((N-methyl-N-propyl-amino)-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (305) 3-Z- (N-isopropyl-N-methyl-amino) -methyl) aniline) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (306) (N-ethyl-N-propyl-amino)-methyl)-aniiino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone -217- (307) 3-Z-[1-(4-((N-ethyl-N-isopropyl-amino)-methyl)-anilino)- 1-phenyl--methylene] -6-methoxycarbonyl-2-indolinone (308) methylene] -6-methoxycarbonyl-2-indolinone (309) 3-Z- [1-(4-(diisopropylaminomethyl)-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (310) 3-Z- (N-benzyl-N-ethyl-amino) -methyl) -anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (311) 3-Z-[l-(4-(dibenzylaminomethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl -2-indolinone (312) 3-Z-[l-(4-(3,6-dihydro-2H--pyridin-1-yl-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (313) 3-Z-[1-(4-(3,5-dimethyl-piperidin-1-yl-methyl)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (314) 3-Z-[1-(4-(azepan-1-yl-methyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (315) 3-Z-[1-(4-(2-amino-ethyl)-anilino)-1-phenyl-methylene]- 6 -methoxycarbonyl -2-indolinone (316) 3-Z-(1-(4-(2-methylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbony1-2-indolinone (317) 3-Z-[1-(4-(2-ethylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (318) 3-Z- [1-(4-(2-dimethylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone -218 (319) 3-Z-[1-(4-(2-diethylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (320) 3-Z- (2-piperidin-1-yl-ethyi,-) -anilino)l- I-phlenylmethylene] -6-methoxycarbonyl-2-indolinone (321) 3-Z-[1-(4-(2-acetylamino-ethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (322) 3-Z- E1-(4-(3-amino-propyl)-anilino)-1-phenyl-methylene 6 -methoxycarbonyl indolinone (323) 3-Z-[1-(4-(3-dimethylamino-propyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (324) 3-Z- El- (4-(N-aminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (325) 3-Z- (N-ethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (326) (N-diethylaminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (327) (N-dipropylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2ndol inane (328) 3-Z- ((N-ethyl-N-methyl-amino) -methylcarbonyl) N-methyl-amino) -aniline) -1-phenyl-methylene] -6methoxycarbonyl indol inone (329) 3-Z- (N-ethyl-N-propyl-amino) -methylcarbonyl)- N-methyl-amino) -anilino) -1-phenyl-methylenel -6methoxycarbonyl -2-indol inane -219 (330) 3-Z- (N-methyl-N-propyl-amino)-methylcarbonyl)- N-methyl-amino) -anilino) -1-phenyl-methylene] -6met hoxycarbonyl -2-indcl inane (331) 3-Z- I (N-dimethylaminomethylcarbonyl-N-ethyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (332) 3-Z- (N-dimethylaminomethylcarbonyl-N-propylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane (333) 3-Z- 1- (N-dimethylaminomethylcarbonyl-N-butyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (334) 3-Z- (N-(2-amino-ethylcarbonyl)-N-methyl-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (335) 3-Z- (2-diethylamino-ethylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2indol inane (336) 3-Z-[l-(4-(N-acetyl-N-(2-aminoethyl)-amino)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (337) 3-Z-[l-(4-(N-acetyl-N-(2-methylamino-ethyl)-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (338) 3-Z-[l-(4-(N-acetyl-N-(3-methylamino-propyl)-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (339) 3-Z-[1-(4-(N-acetyl-N-(2-piperidin-1-yl-ethyl)-amino)aniline) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (340) 3-Z-[II-(4-(N-acetyl-N-(aminocarbonylmethyl)-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone -220 (341) 3-Z- E1-(4-(N-acetyl-N- (piperidin-1-yl-carbonylmethyl) amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone (342) 3-Z-[1-(4-(N-methyl-N-(aminocarbonyl)-amino)-anilino)- 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (343) 3-Z- 11- (N-methyl-N- (methylaminocarbonyl) -amino) anilino) -l-phenyl-m6thylene] -6-methoxycarbonyl-2-indolinone (344) 3-Z- (N-methyl-N- (dimethylaminocarbonyl) -amino) anilino) -1-phenyl-methylenel -6-methoxycarbonyl-2-indolinone (345) 3-Z-[1-(4-(N-methyl-N-(piperidin-l-yl-carbonyl)-amino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (346) 3-Z-[Il-(4-(N-(2-ethylamino-ethyl)-N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone (347) 3-Z- (2-diethylamino-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone (348) 3-Z-[l-(4-(N-(2-pyrrolidin-1-yl-ethyl)-Nmethylsulphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (349) 3-Z- Ii- (2-piperidin-1-yl-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone (350) 3-Z- (2-piperazin-1-yl-ethyl) -N-methylsulphonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone 221 (351) 3-Z-[1-(4-(N-(2-(4-morpholin-1-yl)-ethyl)-Nmethylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (352) 3-Z- [1-(4-(N-(ethylaminocarbonylmethyl)-Nmethylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (353) 3-Z- (diethylaminocarbonylmethyl)
-N-
methylsuiphonyl-amino) -anilino) -1-phenyl-methylenel -6methoxycarbonyl indol inone (354) 3-Z- (pyriolidin-1-yl-carbonylmethyl) -N-methylsuiphonyl -amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone (355) 3-Z- (piperidin-1-yl-carbonylmethyl) -N-methylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6iethoxycarbonyl indolinone (356) (piperazin-1-yl-carbonylmethyl) -N-methylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inane (357) 3-Z- [1-(4-(N-((morpholin-4-yl)-carbonylmethyl)-N-methylsuiphonyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (358) 3-Z- [1-(4-(2-dimethylamino-ethoxy)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (359) 3-Z- [l-(4-(3-dimethylamino-propoxy)-anilino)-1-phenylmethylene] -6 -methoxycarbonyl indolinone (360) 3-Z-[II-(4-(aminocarbonylmethyl)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone 222 (361) 3 -Z-[l-(4-(2-aminocarbonyl-ethyl).anilino)-l-phenylmethylene] -6-methoxycarbonyl-2-indolinone (362) 3-Z- [1-(4-(pyridin-2-yl)-anilino)-1-phenyl-methylene] 6-me thoxycarbonyl indol inane (363) 3-Z- (pyridine-3-yl)-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl -2.k -indol inane (364) 3-Z- ((N-phenethyl-N-methyl-amino) -methyl) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (365) 3-Z-[lI-(4-(N-acetyl-N-methyl-amino)-anilino-l-phenylmethylene] -6-methoxycarbonyl-2-indalinone (366) 3-Z- (N-ethylcarbonyl-N- (dimethylaminocarbanylmethyl) -amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indolinone (367) 3-Z- (N-methyl-N-methylsulphonyl-amino) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (368) 3-Z- [1-(4-carboxymethyl-anilino)-1-phenyl-methylene].6methoxycarbonyl indolinone (369) 3-Z- [1-(4-carbamoylmethyl-anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indolinone (370) 3-Z- [1-(4-dimethylcarbamoylmethyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (371) 3-Z-[1-(4-tetrazol-5-yl-anilino)-1-phenyl-methylene]- 6 -methoxycarbonyl indol inane -223 (372) 3-Z- (piperidin-1-yl-methyl) -anilino) -methylene] 6 -methoxycarbonyl indol inane (373) 3-Z-[1.-(4-(piperidin-1-l-rnethl,)-anilino)-eth,,licien-,-jl 6 -methoxycarbonyl indolinone (374) 3-Z- II-(4-(piperidin-1-yl-methyl)-anilino) -propylidenel 6 -methoxycarbonyl indolinone (375) 3-Z- [l-(4-(piperidin-1-yl-methyl)-anilino)-butylidene] 6 -methoxycarbonyl indol inane (376) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino) anilino) -methylene] -6-methoxycarbonyl-2-indolinone (377) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino) anilino) -ethylidenel -6-methoxycarbonyl-2-indolinone (378) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)anilino) -propylidene] -6-methoxycarbonyl-2-indolinone (379) 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)anilino) -butylidene] -6-methoxycarbonyl-2-indolinone (380) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -methylene] -6-methoxycarbonyl-2-indolinone (381) 3-Z- (N-(2-dimethylamino-ethyl)-N-methylsulphonylamino) -anilino) -ethylidene] -6-methoxycarbonyl-2-indolinone (382) 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -propylidene] -6-methoxycarbonyl-2-indolinone (383) 3-Z-[li- (2-dimethylamino-ethyl) -N-methylsulphonylamino) -anilino) -butylidene] -6-methoxycarbonyl-2-indolinone -224 (384) 3-Z-[l-(4-tetrazol-5-yl-anilino)-methylene]-6-methoxycarbonyl indol inone (385 3-Z [1-(4-ttraz~1-~"l e-y'iaene'-6-methoxycarbonyl indolinone (386) 3-Z-[l-(4-tetrazol-5-yl-anilino)-propylidenel-6-methoxycarbonyl indol inane (387) 3-Z-[1-(4-tetrazol-5-yl-anilino)-butylidene]-6-methoxycarbonyl -2-indol inane (388) 3-Z- [1-(4-carboxy-anilino) -methylene] -6-methoxycarbonyl- 2- indolinone (389) 3-Z-[1-(4-carboxy-anilino)-ethylidene]-6methoxycarbonyl indol inane (390) 3-Z- [1-(4-carboxy-anilino)-propylidene]-6-methoxycarbonyl indolinone (391) 3-Z- [1-(4-carboxy-anilino) -butylidene] -6methoxycarbonyl -2 -indal inane (392) 3-Z-[l-(4-(N-benzyl-N-methyl-aminomethyl)-anilino)-1methyl-methylene] -6-methoxycarbonyl-2-indolinone (393) 3-Z-[1-(4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-ylmethyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2ndol inane (394) 3-Z-[l-(4-((benzo(1,3)dioxol-5-yl-methyl)-methyl-aminomethyl) -anilino) -1-methyl-methylene] -6-methoxycarbanyl-2ndol inone 0 225 (395) 3-Z- [1-(4-(N-phenethyl-N-methyl-aminomethyl) -anilino) -1methyl-methylene] -6-methoxycarbonyl-2-indolinone (396) 3-Z- (3.,4-dimethoxv-benzvl) -N-methyl-aminomethyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2indol inane (397) 3-Z-[1-(4-(N-(4-Chloro-benzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone (398) 3-Z-[l-(4-(N--(4-methylbenzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone (399) 3-Z-[l-(4-(N-(4-fluoro-benzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone (400) 3-Z-[l-(4-(N-(4-bromo-benzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylenel-6-methoxycarbonyl-2-indolinone (401) 3-Z-[l-(4-(N-(3-dimethylamino-propionyl)-Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (402) 3-Z-[1-(4-(N-(4-dimethylamino-butyryl)-Ndimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (403) 3-Z- (N-dimethylaminocarbonylmethyl-N- (2dimethylamino-ethylsulphonyl) -amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2 -indolinone (404) 3-Z- (N-dimethylaminocarbonylmethyl-N- (3dimethylamino-propylsulphonyl) -amino) -anilino) -1-phenylmethylene] -6 -methoxycarbonyl indolinone 0 226 (405) 3-Z-[1-(4-((2-hydroxy-ethyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (406) 3-Z-[l-(4-((2-methoxy-ethyl)-amino-meth1)-anilinphenyl-methylene] -6-methoxycarbonyl-2-indolinone (407) 3-Z- [1-(4-((2-dimethylamino-ethyl) -amino-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (408) 3-Z-[l-(4-((3-dimethylamino-propyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (409) 3-Z- (N-tert.butoxycarbonyl-2-amino-ethyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone (410) (N-tert.butoxycarbonyl-3--amino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2ndcl inane (411) 3-Z-[1-(4-((2-amino-ethyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (412) 3-Z-[l-(4-((3-amino-propyl)-amino-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (413) 3-Z- [1-(4-((2-acetylamino-ethyl)-amino-methyl) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (414) 3-Z- [1-(4-((3-acetylamino-propyl)-amino-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (415) ((2-methylsulphonylamino-ethyl) -amino-methyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone 0 227 (416) 3-Z- (3-methylsulphonylamino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inone (417) 3-Z-(l-(4-(N-(N-tert.butoxycarbonyl-2-amino-ethyl)-Nmethyl-amino-methyl) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inone (418) 3-Z-[1-(4-(N-(2-amino-ethyl)-N-methyl-amino-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (419) 3-Z-[1-(4-(N-(2-acetylamino-ethyl)-N-methyl-aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indolinone (420) 3-Z- (2-methylsulphonylamino-ethyl) -N-methylamino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indcl inone (421) 3-Z-[1-(4-(carboxymethyl-amino-methyl)-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (422) 3-Z- [1-(4-(ethoxycarbonylmethyl-amino-methyl) -anilino) 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (423) 3-Z-[Il-(4-(carbamoylmethyl-amino-methyl) -anilino) -1phenyl-methylene] -6 -methoxycarbonyl-2 -indolinone (424) 3-Z- (dimethylcarbamoyl-methyl-amino-methyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (425) 3-Z- (methylcarbamoyl-methyl-amino-methyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone 228 (426) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-amino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone (427) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-nitro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone (428) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-acetylamino-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inone (429) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methylsuiphonylamino-anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone (430) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-cyano-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indol inone (431) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-hydroxy-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inone (432) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methoxy-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inone (433) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-ethoxycarbonyl-anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone (434) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-carboxy-anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone 0 229 (435) (N-dimethylaminomethylcarbonyl-N-methylamino) -3-carbamayl-anilina) -1-phenyl-methylene] -6methoxycarbonyl indol inane (436) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-chiara-anilina) -1-phenyl-methylene] -6methoxycarbonyl indol inane (437) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-f luoro-anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inane (438) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-bromo-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2- indolinone (439) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-methyl-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2-indol inane (440) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-trifluoromethyl-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inane (441) 3-Z-[li- (N-dimethylaminomethylcarbonyl-N-methylamino) -3,5-dibromo-anilino) -1-phenyl-methylene] -6methoxycarbonyl -2 -indol inane (442) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -3,5-dichioro-anilino) -1-phenyl-methylene] -6methoxycarbonyl indol inane (443) 3-Z- (dimethylaminomethyl)-3-amino-anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone 230 (444) 3-Z-[1-(4-(dimethylaminomethyl)-3-nitro-anilino)-iphenyl-methylene] -6-methoxycarbonyl-2-indolinone (445) -[1(-dehyaiimhy)--etlin-riic 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (446) 3-Z- (dimethylaminomethyl) -3-methylsuiphonylaminoanilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (447) 3-Z- [1-(4-(dimethylaminomethyl)-3-cyano-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (448) 3-Z-(1-(4-(dimethylaminomethyl)-3-hydroxy-anilino)-iphenyl-methylene] -6-methoxycarbonyl-2-indolinone (449) 3-Z- [l-(4-(dimethylaminomethyl)-3-methoxy-anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (450) 3-Z- (dimethylaminomethyl) -3-ethoxycarbonylanilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (451) 3-Z-[1-(4-(dimethylaminomethyl)-3-carboxy-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (452) 3-Z-[lI-(4-(dimethylaminomethyl)-3-carbamoyl-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (453) 3-Z- [1-(4-(dimethylaminomethyl)-3-chloro-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (454) 3-Z- [l-(4-(dimethylaminomethyl)-3-fluoro-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (455) 3-Z- [l-(4-(dimethylaminomethyl)-3-bromo-anilino) -1phenyl-methylene] -6-methoxycarbonyl-2-indolinone S 231 (456) 3-Z-[1-(4-(dimethylaminomethyl)-3-methyl-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (457) 3-Z- (dimethyl;a=mintnethvl) -3-trifluro--me-t-tylanilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (458) 3-Z-[1-(4-dimethylaminomethyl-3,5-dibromo-anilino)-1phenyl-methylene] -6-methoxycarbonyl-2-indolinone (459) 3-Z- E1-(4-(dimethylaminomethyl)-3,5-dichloro-anilino)-iphenyl-methylene] -6-methoxycarbonyl-2-indolinone (460) 3-Z-t1-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] [(2-hydroxy-ethoxy) -carbonyl] -2-indolinone (461) 3-Z-[l-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] [(ethoxycarbonyl-methoxy) -carbonyll -2-indolinone (462) 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-1-phenylmethylene] [(carboxy-methoxy) -carbonyl] -2-indolinone (463) 3-Z- [l-(4-(dimethylaminomethyl)-anilino) -1-phenylmethylene] [(carbamoyl-methoxy) -carbonyl] -2-indolinone (464) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] Ii(2-hydroxy-ethoxy) carbonyl] -2 -indolinone (465) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(ethoxycarbonylmethoxy) -carbonyl] -2-indolinone (466) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(carboxy-methoxy) carbonyl] indol inane 232 (467) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(carbamoyl-methoxy) carbonyl] -2 -indol inane (468) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(2-methoxy-ethoxy) carbonyl] -2-indolinone (469) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] [(2-dimethylaminoethoxy) -carbonyl] -2-indolinone (470) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] 1(2- (Ntert .butoxycarbonyl-amino) -ethoxy) -carbonyl] -2-indolinone (471) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] -6-[(2-amino-ethoxy) carbonyl] -2-indolinone (472) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenyl-methylene] trifluoroethoxy) -carbonyl] -2-indolinone (473) 3-Z- ((4-methyl-piperazin-1-yl) -methylcarbonyl) N-methyl-amino) -anilino) -1-phenyl-methylene] -6methoxycarbonyl indolinone (474) 3-Z- (imidazo-1-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane (475) 3-Z- (phthalimido-2-yl-methylcarbonyl) -N-methylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2indol inane 233 (476) 3-Z- (N-aminomethylcarbonyl-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (477) 3-Z -L -1 %I N ac t T m -1-1r -a-ino)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (478) 3-Z- (N-methylsulphonylaminomethylcarbonyl-Nmethyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone (479) 3-Z-[l-(4-(N-((N-(2-methoxyethyl)-N-methyl-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] *6 -methoxycarbonyl indolinone (480) 3-Z- [l-(4-(N-((N-(2-dimethylaminoethyl)-N-methyl-amino) methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indol inane (481) 3-Z-[1-(4-(N-((di-(2-hydroxyethyl)-amino)methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] 6 -methoxycarbonyl indol inane (482) 3-Z-[l-(4-tert.butoxycarbonylmethyl-anilino)-1-phenylmethylene] -6 -methoxycarbonyl -2-indol inane (483) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -methylene] -6-methoxycarbonyl-2-indolinone (484) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -aniline) -ethylidene] -6-methoxycarbonyl-2-indolinone (485) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -aniline) -propylidene] -6-methoxycarbonyl-2-indolinone (486) 3-Z- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -butylidene] -6-methoxycarbonyl-2-indolinone 0 234 (487) 3-Z- [l-(4-(dimethylaminomethyl)-anilino)-methylene] -6methoxycarbonyl indol inane (488) 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-ethylidene]-6methoxycarbonyl indol inane (489) 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-propylidene] -6methoxycarbonyl ijdo1 inone (490) 3-Z- [1-(4-(dimethylaminomethylL)-anilino)-butylidene] -6methoxycarbonyl -2 -indol inane (491) 3-Z-[1-(4-tert.butyloxycarbonyl-anilino)-1-phenylmethylene] -6 -methoxycarbonyl indolinone (492) 3-Z- [l-(4-(N-(2-dimethylamino-ethyl)-N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (493) 3-Z- (3-dimethylamino-propyl) -N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (494) 3-Z- [1-(4-(N-methyl-acetylamino)-anilino)-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (495) 3-Z-[1-(4-(imidazol-4-yl)-anilino)-1-phenyl-methylene]- 6 -methoxycarbonyl-2-indolinone (496) 3-Z-[1-(4-((N-(dioxolan-2-yl-methyl)-N-methyl-amino)methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2 -indol inane (497) 3-Z-[l-(4-(N-benzyl-N-methyl-amino-methyl)-anilino)-lmethyl-methylene] -6-carbamoyl-2-indolinone 0 235 (498) 3-Z-[1-(4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-yl.
methyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (499) -3-Z-[1I-(4-((benzo(l,3)dioxol-5-vl-methvl) -methyl-arn-no methyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (500) 3-Z- El-(4-(N-phenethyl-N-methyl-amino-methyl)-anilino) 1-methyl-methylene] -6-carbamoyl-2-indolinone (501) 3-Z-[l-(4-(N-(3,4-dimethoxy-benzyl)-N-methyl-aminomethyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (502) 3-Z- [1-(4-(N-(4-Chloro-benzyl)-N-methyl-amino-methyl) anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (503) 3-Z- (4-methyl-benzyl) -N-methyl-amino-methyl) anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (504) (4-fluoro-benzyl) -N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (505) (4-(N-(4-bromo-benzyl)-N-methyl-amino-methyl)anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone (506) 3-Z-[1-(4-((N-(2-methoxy-ethyl)-N-methyl-amino)-methyl)anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (507) 3-Z-[lI-(4-(dimethylaminomethyl)-anilino) -1-phenylmethylene] [(2-amino-ethoxy) -carbonyl] -2-indolinone (508) 3-Z- (3-methylsulfonylamino-propyl) -N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone 0 236 Example 13 Dry ampoule containing 75 mg of active substance per 10 ml Composition: Active substance Mannitol water for injections 75.0 mg 50.0 mg ad 10.0 ml Preparation: Active substance and mannitol are dissolved in water. After packaging the solution is freeze-dried. To produce the solution ready for use, the product is dissolved in water for injections.
Example 14 Dry ampoule containing 35 mg of active substance per 2 ml Composition: Active substance Mannitol water for injections 35.0 mg 100.0 mg ad 2.0 ml Preparation: Active substance and mannitol are dissolved in water. After packaging, the solution is freeze-dried.
To produce the solution ready for use, the product is dissolved in water for injections.
0 237 Example Tablet containing 50 mg of active substance Composition: Active substance Lactose Maize starch Polyvinylpyrrolidone Magnesium stearate 50.0 mg 98.0 mg 50.0 mg 15.0 mg 2.0 mq 215.0 mg Preparation: and are mixed together and granulated with an aqueous solution of is added to the dried granulated material. From this mixture tablets are pressed, biplanar, faceted on both sides and with a dividing notch on one side.
Diameter of the tablets: 9 mm.
Example 16 Tablet containing 350 mg of active substance Composition: Active substance Lactose Maize starch Polyvinylpyrrolidone Magnesium stearate 350.0 mg 136.0 mg 80.0 mg 30.0 mg 4.0 mq 600.0 mg 238 Preparation: and are mixed together and granulated with an aqueous solution of is added to the dried granulated material. From this mixture tablets are pressed, biplanar, faceted on both sides and with a dividing notch on one side.
Diameter of the tablets: 12 mm.
Example 17 Capsules containing 50 mg of active substance Composition: Active substance Dried maize starch Powdered lactose Magnesium stearate 50.0 mg 58.0 mg 50.0 mg 2.0 mg 160.0 mg Preparation: is triturated with This trituration is added to the mixture of and with vigorous mixing.
This powder mixture is packed into size 3 hard gelatine capsules in a capsule filling machine.
Example 18 Capsules containing 350 mg of active substance 239 Composition: Active substance Dried maize starch Powdered lactose Magnesium stearate 350.0 mg 46.0 mg 30.0 mg 4.0 mg 430.0 mg Preparation: is triturated with This trituration is added to the mixture of and with vigorous mixing.
This powder mixture is packed into size 0 hard gelatine capsules in a capsule filling machine.
Example 19 Suppositories containing 100 mg of active substance 1 suppository contains: Active substance 100.0 mg Polyethyleneglycol 1500) 600.0 mg Polyethyleneglycol 6000) 460.0 mg Polyethylenesorbitan monostearate 840.0 mg 2,000.0 mg Preparation: The polyethyleneglycol is melted together with polyethylene sorbitan monostearate. At 40 0 C the ground active substance is homogeneously dispersed in the melt. It is cooled to 38 0 C and poured into slightly chilled suppository moulds.
PAOPER'JgOIO233Ol- dcImsdmc.I14J4 -239A- Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form or suggestion that that prior art forms part of the common general knowledge in Australia.
boo.
S
S.
S

Claims (7)

1. Indolinones of general formula R 3 R 4 -N X R2 I Rz substituted in the 6 position, wherein X denotes an oxygen or sulphur atom, RI denotes a hydrogen atom or a C 1 4 -alkoxycarbonyl or C 2 4 alkanoyl group, R 2 denotes a carboxy group, a straight-chain or branched C 1 -6-alkoxy-carbonyl group, a C 4 7 -cycloalkoxy-carbonyl or an aryloxycarbonyl group, a straight-chain or branched Cl-6-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a 15 phenyl, heteroaryl, carboxy, C1- 3 -alkoxy-carbonyl, aminocarbonyl, C 1 3 -alkylamino-carbonyl or di-(Cz- 3 -alkyl) aminocarbonyl group, a straight-chain or branched C 2 6 -alkoxy-carbonyl group, **which is terminally substituted in the alkyl moiety by a 20 chlorine atom or a hydroxy, C 1 -3-alkoxy, amino, C 1 3 -alkylamino or di-(C 1 3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 241 position of the ethyl group by a hydroxy or C 13 ,-alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or N-(C 1-alkyl) -C,-,-alkylaminocarbonyl-phenyl group, it may also denote a di- 1- 2 -alkYl -aminocarbonyl gop R 3 denotes a hydrogen atom, a C 1 6 -al kyl, C 37 ,-cycloalkyl, trifluoromethyl or heteroaryl group, a phenyl or naphthyl group, a phenyl or naphthyl group mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, C 1 3 -alkyl or C 13 ,-alkoxy group, whilst in the event of disubstitution the substituents may be identical or different and wherein the abovementioned unsubstituted as well as the mono- and disubstituted phenyl and naphthyl groups may additionally be substituted by a hydroxy, hydroxy-C- 3 -alkyl or C- alkoxy- C 1 3 -al kyl group, by a cyano, carboxy, carboxy- C- 3 -alkyl, C- 3 -alkoxycarbonyl, aminocarbonyl, C'3 alkylamino-carbonyl or di- (C- 3 alkyl) -aminocarbonyl group, by a nitro group, by an amino, C1--alkylamino, di- 3 -alkyl) -amino or amino-C 13 ,-alkyl group, by a C1- -alkylcarbonylamino, N- (Cl- -alkyl) -C- 3 -alkyl- carbonylamino, C 1 3 -alkylcarbonylamino-C 13 ,-alkyl, N- (C 1 3 -alkyl) -Cl- 3 -alkylcarbonylamino-C 1 3 -alkyl, C 1 3 -alkyl- sulphonylamino, C- 3 -alkylsulphonylamino-Cl 1 3 -alkyl, N- (C- 3 alkyl) -C 13 -alkylsulphonylamino-Cl 1 3 -alkyl or aryl -Cl- 3 -alkylsulphonylamino group, 242 by a cycloalkylamino, cycloalkyleneimino, cyclo- alkyleneiminocarbonyl, cycloalkyleneimino-C 1 3 -alkyl, cycloalkyleneiminocarbonyl-C 1 3 -alkyl or cycloalkyleneiminosulphonyl-C, 3 -alkyl group having 4 to 7 ring members in each case, whilst in each case the methylene group in position 4 of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or -N(C- 3 -alkyl) group, or by a heteroaryl or heteroaryl-C,_ 3 -alkyl group, R 4 denotes a C 3 _.-cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7- membered cycloalkyl group may be substituted by an amino, C, 3 alkylamino or di-(C_3-alkyl)-amino group or replaced by an -NH or -N(CI 3 -alkyl) group, or a phenyl group substituted by the group Rg, which may additionally be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C,_ 5 -alkyl, trifluoromethyl, hydroxy, C 1 3 -alkoxy, carboxy, C13_-alkoxycarbonyl, amino, acetylamino, C 1 3 -alkyl-sulphonylamino, aminocarbonyl, C_ 1 3 -alkyl-aminocarbonyl, di-(C 3 -alkyl)-aminocarbonyl, aminosulphonyl, C 1 _3-alkyl-aminosulphonyl, di-(C_3-alkyl)-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein R denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, C_-s-alkyl, C3_,-cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, the group of formula 0 243 0 NH wherein the hydrogen atoms bound to a nitrogen atom may in each case be replaced independently of one another by a C 1 3 -alkyl group, a C- 3 -alkoxy group, a C 1 3 -alkoxy-C 1 I 3 -alkoxy, phenyl-C- 3 -alkoxy, amino- C 2 3 -alkoxy, C 1-3-a lkylamino-C 2 3 -alkoxy, di- (CI- 3 -alkyl) amino- C 2 alkoxy, phenyl-C 1 3 ,-alkylamino- C 2 3 -alkoxy, N- (Cl- 3 -alkyl) -phenyl-C 1 3 -alkylamino-C 2 3 -alkoxy, C 5 -,-cycloalkyleneimino-C 2 3 -alkoxy or CI-3-al kylmercapto group, a carboxy, C, 4 -alkoxycarbonyl, aminocarbonyl, C 1 3 -alkyl- amino-carbonyl, N- (C,-,-alkyl) -C,-,-alkylaminocarbonyl, phenyl-Cl- 3 -alkylamino-carbonyl, N-(C- 3 -alkyl) -phenyl-Cl- 3 -alkylamino-carbonyl, piperazinocarbonyl or N- (Cl 1 3 -alkyl) -piperazinocarbonyl group, a C 1 3 -alkylaminocarbonyl or N- (C 1 -5-alkyl) Cl- 3 -alkylaminocarbonyl group wherein an alkyl moiety is substituted by a carboxy or C 1 3 -alkoxycarbonyl group or in the 2 or 3 position by a di- (Cl 1 3 -alkyl) -amino, piperazino, N-(C- 3 -alkyl) -piperazino or a 4- to 7-membered cycloalkyleneimino group, a C 3 7 -cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or
7-membered cycloalkyl moiety may be substituted by an *amino, Cl- 3 -alkylamino or di- (Cl 1 3 -alkyl) -amino group or replaced by an -NH or -N(C. 3 -alkyl) group, a 4- to 7-membered cycloalkyleneimino group wherein 244 a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or the cycloalkylene moiety may be fused to a phenyl ring or one or two hydrogen atoms may each be replaced by a C,_3- alkyl group and/or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C 1 3 ,-alkoxycarbonyl, aminocarbonyl, Cl. 3 -alkylaminocarbonyl, di- (C 1 3 -alkyl) -aminocarbonyl, phenyl-C 1 -3-alkylamino or N-(C- 3 -alkyl)- phenyl-C, 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 .3-alkyl), -N(phenyl), -N(C- 3 -alkyl-carbonyl) or -N(benzoyl) group, a C- 4 -alkyl group substituted by the group R 7 wherein R, denotes a C 3 7 -cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be substituted by an amino, C 1 3 -alkylamino or di-(C,~-alkyl)-amino group or replaced by an -NH or -N(C 1 3 -alkyl) group or in a 5- to 7-membered cycloalkyl group a 2 group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by a -NH-CO-NH or -CO-NH-CO group or a -(CH 2 4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C1-3-alkyl group, 245 an aryl or heteroaryl group, a hydroxy or C,- 3 -al koxy group, an amino, Cl- 7 -alkylamino, di- 7 -alkyl) -amino, phenylamino, N-phenyl-C 13 ,-alkyl-amino, phenyl-C,- -alkyl- amino, N- (Cl-3-alkyl) -phenyl-C,,3-alkylamino or di- (phenyl-Cl-3-alkyl) -amino group, an o-hydroxy-C 2 -3-alkyl-amino, N- 3 -alkyl) -aw-hydroxy- C 2 -3-al kyl-amino, di- (&-hydroxy-C 2 3 -alkyl) -amino, di- (Cl-3-alkoxy) -C2- 3 -alkyl) -amino or N- (dioxolan- 2-yl) 3 -alkyl-amino group, a C -alkylcarbonylamino-C2- -alkylaioo C,-3-al kylcarbonylamino-C 2 -3-alkyl-N- (C,-,-alkyl) -amino group, aC,-3 alkylsuiphonylamino, N- (C,,3-alkyl) -C,,3-alkyl- suiphonylamino, C,,3-alkylsulphonylamino-C2- 3 -alkyl-amino or Cl-3-alkylsulphonylamino-C2-3-alkyl-N- (C,,3-alkyl) -amino group, a hydroxycarbonyl-C,-,-alkylamino or N- (C- 3 -alkyl)- hydroxycarbonyl -C,-,-alkyl-amino group, a guanidino group wherein one or two hydrogen atoms may each be replaced by a C1- alkyl group, a group of formula N(R 8 )-C0(CH 2 )n-R 9 I) wherein R. denotes a hydrogen atom or a C 1 3 alkyl group, 246 n denotes one of the numbers 0, 1, 2 or 3 and R9 denotes an amino, C, 4 -alkylamino, di- (C 14 -alkyl)-amino, phenylamino, N- (C- 4 -alkyl) -phenylamino, benzylamino, N-(C. 4 -alkyl)-benzylamino or C 1 4 -alkoxy group, a 4- to 7-membered cycloalkyleneimino group, whilst in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C.3-alkyl), -N(phenyl), -N(C_ 3 -alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula -N(Rio)-(CH 2 )m-(CO)o-R11 (III), wherein Rio denotes a hydrogen atom, a C,_3-alkyl group, a C_.3-alkylcarbonyl, arylcarbonyl, phenyl-C 1 3 -alkyl- carbonyl, C_3-alkylsulphonyl, arylsulphonyl or phenyl-C_ 3 -alkylsulphonyl group, m denotes one of the numbers 1, 2, 3 or 4, o denotes the number 1 or, if m denotes one of the numbers 2, 3 or 4, o may also denote the number 0 and R 1 denotes an amino, C, 4 -alkylamino, di-(Cl_ 4 -alkyl)-amino, phenylamino, N-(Cl. 4 -alkyl)-phenylamino, benzylamino, N- (C- 4 -alkyl) -benzylamino, C-. 4 -alkoxy or C,.3-alkoxy-C_ 3 -alkoxy group, a di-(C,--alkyl)-amino-C_- 3 247 alkylamino group optionally substituted in the 1 position by a C 1 3 -alkyl group or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7- membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, 3 -alkyl), -N(phenyl), -N(C_ 3 -alkyl-carbonyl) or -N(benzoyl) group, a C 4 7 -cycloalkylamino, C 4 cycloalkyl-CI_3-alkylamino or C 4 7 -cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a Cs,-cycloalkyl, C 2 -4-alkenyl or C, 4 -alkyl group, a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, C 1 3 -alkyl, C 1 _3-alkoxy or amino group, and/or one or two hydrogen atoms may each be replaced by a C_.3-alkyl, Cs-7-cycloalkyl or phenyl group and/or the methylene group in the 3 position of a cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C. 3 -alkyl, Ci-3-alkoxy or C 1 .3-alkoxy-C 1 .3-alkyl group, the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may in each case be substituted by a hydroxy, hydroxy-C 1 3 -alkyl, 248 C,- 3 -alkoxy, C 1 3 -alkoxy-C. 3 -alkyl, carboxy, C- 4 -alkoxycarbonyl, aminocarbonyl, C,- 3 -alkylaminocarbonyl, di- (CI- 3 -alkyl) -aminocarbonyl, phenyl-C 1 3 -aikyiamino or N4- (C -alkyl) -pril -C- 1 3 -alkyl amino group or may be replaced by an oxygen or sulphur atom, by a suiphinyl, suiphonyl, -NH, -N(C 1 3 -alkyl-), -N(phenyl), -N(phenyl-Cj -alkyl-) -N(Cl 1 3 -alkyl-carbonyl-) -N(Cl- 4 -hydroxy-carbonyl-) -N(Cl 1 4 -alkoxy-carbonyl-), -N(benzoyl-) or -N(phenyl-C 1 3 -alkyl-carbonyl-) group, wherein a methylene group linked to an imino- nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino- nitrogen atom may each be replaced by a carbonyl group, or R 6 denotes a C 1 4 -alkyl group which is substituted by a carboxy, C- 3 -alkoxycarbonyl, aminocarbonyl, C- 3 -alkylaminocarbonyl or di-(CI- 3 -alkyl) -aminocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, an N-(Cl- 3 -alkyl)-C,.-alkanoylamino group which is additionally substituted in the alkyl moiety by a carboxy or C -3-alkoxycarbonyl group, a group of formula -N(R2)-CO-(CH2)p- R13 (IV), wherein 249 R 12 denotes a hydrogen atom, a C 1 6 -alkyl or C 3 .,-cycloalkyl group or a C 1 _-alkyl group terminally substituted by a phenyl, heteroaryl, triflucromethyl, hydroxy, C- 3 arlkoxy, aminocarbonyl, C 1 4 -alkylamino-carbonyl, di-(C,--alkyl)- amino-carbonyl, Ci. 3 -alkyl-carbonyl, C. 3 -alkyl-sulphonyl- amino, N- (C, 3 -alkyl)-C~ 3 -alkyl-sulphonylamino, Cl- 3 -alkyl-aminosulphonyl or di- (Ci.3-alkyl) -aminosulphonyl group and p denotes one of the numbers 0, 1, 2 or 3 and R, 3 assumes the meanings of the abovementioned group R,, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula -N(R 4 -(CH2)q-(CO)r-Rl5 wherein R, 4 denotes a hydrogen atom, a C 1 4-alkyl group, a Cl. 3 -alkylcarbonyl, arylcarbonyl, phenyl-C_-3-alkylcarbonyl, heteroarylcarbonyl, heteroaryl-C,~ 3 -alkylcarbonyl, C,. 4 -alkylsulphonyl, arylsulphonyl, phenyl-Ci.3-alkylsulphonyl, heteroarylsulphonyl or heteroaryl-C 1 3 -alkyl-sulphonyl group, q denotes one of the numbers 1, 2, 3 or 4, r denotes the number 1 or, if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and Ri 5 assumes the meanings of the abovementioned group R,, 250 a group of formula -N(Ri6)-SO2-R17 (VI), wherein R16 denotes a hydrogen atom or a C 1 _4-alkyl group optionally terminally substituted by a cyano, trifluoromethyl-carbonylamino or N-(C 1 3 -alkyl)-trifluoromethyl-carbonyl-amino group and R 1 denotes a C 1 3 -alkyl group, an amino group substituted by a di-(C_3-alkyl)- amino-C_-3-alkyl-carbonyl or di-(C_3-alkyl)- amino-C-_3-alkyl-sulphonyl group and a di-(C, 3 -alkyl)- aminocarbonyl-C_3-alkyl group, or an 3 -alkyl)-C 15 s-alkylsulphonylamino or N-(C 1 3 -alkyl)-phenylsulphonylamino group wherein the alkyl moiety is additionally substituted by a cyano or carboxy group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R, may be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C,_-alkyl, trifluoromethyl, hydroxy, C _3-alkoxy, carboxy, C, 3 -alkoxycarbonyl, aminocarbonyl, C,_4-alkylamino-carbonyl, di-(C-_4-alkyl)-amino-carbonyl, aminosulphonyl, C_3-alkyl-aminosulphonyl, di-(Cl--alkyl)-aminosulphonyl, C-_-alkyl-sulphonylamino, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, 251 and R, denotes a hydrogen atom or a C,.3-alkyl group, wherein by an aryl group is meant a phenyl or naphthyl group optionally mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a cyano, trifluoromethyl, nitro, carboxy, aminocarbonyl, C_3-alkyl or C 13 -alkoxy group and by a heteroaryl group is meant a monocyclic 5- or 6-membered heteroaryl group optionally substituted by a C 1,-alkyl group in the carbon skeleton, wherein the 6-membered heteroaryl group contains one, two or three nitrogen atoms and the 5-membered heteroaryl group contains an imino group optionally substituted by a C 1 3-alkyl or phenyl-C 1 -alkyl group, an oxygen or sulphur atom or an imino group optionally substituted by a Ci. 3 -alkyl or phenyl-C_-3-alkyl group or an oxygen or sulphur atom and additionally a nitrogen atom or an imino group optionally substituted by a C 1 3 -alkyl or phenyl-C 1 3 -alkyl group and two nitrogen atoms, and moreover a phenyl ring may be fused to the abovementioned monocyclic heterocyclic groups via two adjacent carbon atoms and the bonding takes place via a nitrogen atom or via a carbon atom of the heterocyclic moiety or a fused phenyl ring, some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the P.OPERVg\IO033.41 -252- above-defined groups of formula I may be replaced by fluorine atoms, and the hydrogen atom of any carboxy group present or a hydrogen atom bound to a nitrogen atom may each be replaced by a hydroxy group, an acyl group, an allyloxycarbonyl group, a C 1 16 -alkoxycarbonyl group, a phenyl-Ci- 6 alkoxycarbonyl group, a Ci- 3 -alkylsulfonyl-C 2 4 alkoxycarbonyl, C 1 -3-alkoxy-C 2 4 -alkoxy-C 2 -4-alkoxycarbonyl or RcCO-O-RfCRg) CO-group wherein Re denotes a Ci- 8 -alkyl, C5- 7 -cycloalkyl, phenyl or phenyl-C1- 3 alkyl group, Rf denotes a hydrogen atom, a Cj- 3 -alkyl, C5-7-cycloalkyl or phenyl group, and Rg denotes a hydrogen atom, a C 1 3 alkyl, or Re-CO-O-(RfCRh)-O- group, wherein Re and Rf are as hereinbefore defined and Rh is a hydrogen atom or a C1- 3 alkyl group, 20 the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof. 2. Indolinones of general formula I according to claim 1, wherein S RI and R 3 are as hereinbefore defined and X denotes an oxygen atom, R 2 denotes a carboxy group, a straight-chain or branched C 1 -6-alkoxy-carbonyl group, a C5- 7 -cycloalkoxycarbonyl or a phenoxycarbonyl group, P.OPER VJc0233.O1 cltmidoc.1404A5 -252A- a straight-chain or branched C 1 3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, Cl- 3 -alkoxycarbonyl, aminocarbonyl, C 1 3 -alkylaminocarbonyl or di-(C 1 3 -alkyl)-aminocarbonyl group, a straight-chain or branched C2-3-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom, by a hydroxy, C 1 3 -alkoxy, amino, C 1 3 -alkylamino or di-(Ci- 3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C1- 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or **o o•* *oo oooo* *oo 253 N- (C-s-alkyl)-C 1 3 -alkylaminocarbonyl-phenyl group, it may also denote a di-(C 1 -2-alkyl)-aminocarbonyl group, R denotes a C, ,-cycloalkl group, whilst the methylene group in the 4 position of a 6- or 7- membered cycloalkyl group may be substituted by an amino, C 1 3 alkylamino or di- 3-alkyl)-amino group or replaced by an -NH or -N(CI--alkyl) group, or a phenyl group substituted by the group which may additionally be mono- or disubstituted by fluorine, chlorine or bromine atoms, by C. 3-alkyl, trifluoromethyl, hydroxy, C 1 3 -alkoxy, carboxy, C_ 3 -alkoxycarbonyl, amino, acetylamino, aminocarbonyl, Ci.3-alkyl-aminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein R 6 denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, C 1 _s-alkyl, C 3 _,-cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, the group of formula 0 NH -CH N O H wherein a hydrogen atom bound to the nitrogen atom may be replaced by a C I3-alkyl group, a C 1 3-alkoxy group, an amino-C 2 3 -alkoxy, C 1 _3-alkylamino- C 2 3 -alkoxy, di-(C_-3-alkyl)-amino-C 2 -3-alkoxy, phenyl- C 3 -alkylamino-C 2 ,3-alkoxy, N-(Cl 3 -alkyl)-phenyl- 254 CI 3 -alkylamino-C2-3-alkoxy, pyrrolidino-C 2 3 -alkoxy, piperidino-C 2 3 -alkoxy or C,_3-alkylmercapto group, a carboxy, C _--alkoxycarbonyl, aminocarbonyl, C 1 _3-alkyl- amino-carbonyl, phenyl-C 1 _3-alkylamino-carbonyl or N-(C 1 3 -alkyl) -phenyl-C, 3 -alkylamino-carbonyl group, a C 3 ,_-cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be replaced by an -NH or -N(C 1 3 -alkyl) group, a 4- to 7-membered cycloalkyleneimino group, wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or one or two hydrogen atoms may each be replaced by a C 1 -3-alkyl group and/or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a carboxy, Cl_ 3 -alkoxycarbonyl, aminocarbonyl, C 1 3 -alkylaminocarbonyl, di-( CC 3 -alkyl) -aminocarbonyl, phenyl-C 1 _3-alkylamino or N-(C 1 3 -alkyl)- phenyl-C,_,-alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH or -N(C,_3-alkyl) group, a C,_ 4 -alkyl group terminally substituted by the group R,, wherein R, denotes a Cs,_-cycloalkyl group, 255 whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be replaced by an -NH or -N(C 1 3 -alkyl) group or in a 5 to 7 -membered cycloalkyl group a (CH 2 2 group may be replaced by a -CO-NH group, a (CH 2 3 group may be replaced by a -NH-CO-NH- or a (CH 2 4 group may be replaced by a -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl group, a phenyl or heteroaryl group, a hydroxy or C 1 3 -al koxy group, an amino, Cl- 6 -alkylamino, di- (Cl 1 6 -alkyl) -amino, phenylamino, N-phenyl -C 1 3 -alkyl -amino, phenyl-C 1 3 -alkylamino, N- (C 1 3 -alkyl) -phenyl-C 1 3 -alkylamino or di- (phenyl-C 1 3 -alkyl) -amino group, a co-hydroxy-C 2 3 -alkyl -amino, N- (C- 3 -alkyl) -co-hydroxy- -C 2 3 -alkyl -amino, di- ((o-hydroxy-C 2 3 -alkyl) -amino, di- (Cl- 3 -alkoxy) -C 2 3 -alkyl) -amino or N- (dioxolan-2-yl) -Cl 1 3 -alkyl-amino group, a Cl- 3 -alkylcarbonylamino-C 2 -alkyl -amino or C 1 3 -al kylcarbonylamino-C 2 3 -alkyl-N- (C 1 3 -alkyl) -amino group, a C 1 3 -al kyl sulphonyl amino, N- (C 1 3 -alkyl) Cl- 3 -al kylsulphonylamino, CI- 3 -alkylsulphonylamino- -C 2 3 -alkyl -amino or C,- 3 -alkylsulphonylamino-C 2 3 -alkyl- (Cl- 3 -alkyl) -amino group, a hydroxycarbonyl-C 1 3 -alkylamino or N- (Cl- 3 -alkyl) -hydroxycarbonyl -C 1 3 -alkyl -amino group -256 a guanidino group wherein a hydrogen atom may be replaced by a C .3-alkyl group, a group of formula -N(R8)-CO-(CH 2 )n-R 9 (II), wherein R, denotes a hydrogen atom or a C,13-alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and R 9 denotes an amino, C, 3 -alkylamino, di-(C 1 3 -alkyl)- amino, phenylamino, benzylamino or C 14 -alkoxy group, a to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH, -N(C 1 3 -alkyl), -N(phenyl), -N(Cl_ 3 -alkyl-carbonyl) or -N(benzoyl) group, or, if n denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula -N(R 1 0 )-(CH2)m-(CO)o-R 11 (III), wherein Rio denotes a hydrogen atom, a C,3-alkyl group, a C 1 .3-alkylcarbonyl or C_ 3 -alkylsulphonyl group, m denotes one of the numbers 1, 2 or 3, o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and 257 R11 denotes an amino, C 1 3 -alkylamino, di- (C- 3 -alkyl)-amino, C. 4 -alkoxy or C 1 3 -alkoxy-C_ 3 -alkoxy group or a 5- to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH, -N(C 1 3 -alkyl), -N(phenyl), -N(C_ 3 -alkyl-carbonyl) or -N(benzoyl) group, a C 4 .,-cycloalkylamino or C,,-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond, a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or one or two hydrogen atoms may each be replaced by a C, _-alkyl group and/or the methylene group in position 3 of the pyrrolidino group may be substituted by a hydroxy or C_3-alkoxy group, in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl, C 1 .3-alkoxy, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl, C_ 3 -alkylaminocarbonyl, di-(C 1 3 -alkyl)-aminocarbonyl, phenyl-C_.3-alkylamino or N-(Ci_ 3 -alkyl)-phenyl-C_ 3 -alkyl- amino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 .3-alkyl), -N(phenyl), 258 -N(phenyl-C 1 3 -alkyl), -N(C, 1 3 -alkyl-carbonyl), -N(C 1 4 -alkoxy-carbonyl), -N(benzoyl) or -N(phenyl-C 1 3-alkyl-carbonyl) group, wherein a methylene group linked to an imino- nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 6-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino- nitrogen atom may each be replaced by a carbonyl group, or R, denotes a C 1 4 -alkyl group which is terminally substituted by a carboxy, C 1 _3-alkoxycarbonyl, aminocarbonyl, C 1 3 -alkylaminocarbonyl or di-(CI- 3 -alkyl)-aminocarbonyl group or by a 4- to 7-membered cycloalkyleneiminocarbonyl group, a group of formula -N(RI 2 )-CO-(CH 2 )p-R 1 3 (IV), wherein R 12 denotes a hydrogen atom, a C 1 _-alkyl, Cs,_-cycloalkyl, phenyl-C 1 3 -alkyl or heteroaryl-Cl_ 3 -alkyl group and p denotes one of the numbers 0, 1, 2 or 3 and R, 3 assumes the meanings of the abovementioned group R,, or, if p denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula 259 -N(R 1 4 )-(CH2)q-(CO)r-R15 wherein R 14 denotes a hydrogen atom, a C 1 4 -alkyl group, a C 1 _3-alkylcarbonyl, phenylcarbonyl, phenyl-C 1 3 -alkyl- carbonyl, heteroarylcarbonyl, heteroaryl-C 1 .3-alkylcarbonyl, C 4 -alkylsulphonyl, phenylsulphonyl, phenyl-C 1 -_-alkylsulphonyl- heteroarylsulphonyl or heteroaryl-C 1 3 -alkyl-sulphonyl group, q denotes one of the numbers 1, 2, 3 or 4, r denotes the number 1 or, if q is one of the numbers 2, 3 or 4, it may also denote the number 0 and RIs assumes the meanings of the abovementioned group R,, a group of formula -N(R 1 6 )-S0 2 -R 17 (VI), wherein R 16 denotes a hydrogen atom or a C, 4 -alkyl group optionally terminally substituted by a cyano, trifluoromethyl- carbonylamino or N-(C 1 3 -alkyl)-trifluoromethyl- -carbonyl-amino group and denotes a C-_3-alkyl group, an amino group substituted by a di-(C 1 3 -alkyl)- amino-C 1 3 -alkyl-carbonyl or di-(Cl_ 3 -alkyl)- amino-C,.3-alkyl-sulphonyl group and a di-(C 1 -3-alkyl)- aminocarbonyl-Cl--alkyl group, P.AOPERUliO0233.41 dimdoc-I 15A4S -260- wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R 6 may be mono- or disubstituted by fluorine, chlorine or bromine atoms, by C 1 3 -alkyl, trifluoromethyl, hydroxy, C 1 3 -alkoxy, carboxy, C1- 3 -alkoxycarbonyl, aminocarbonyl, C 1 3 -alkyl-aminocarbonyl, aminosulphonyl, C 1 3 -alkyl-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different, or two adjacent hydrogen atoms of the phenyl groups may be replaced by a methylenedioxy group, and R 5 denotes a hydrogen atom or a C 1 3 -alkyl group, whilst by a heteroaryl group as mentioned above is meant a pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, pyrrolyl, furyl, thienyl, oxazolyl, thiazolyl, pyrazolyl, imidazolyl or triazolyl group optionally substituted in the carbon skeleton by a C 1 3 -alkyl group wherein a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl or phenyl-C 1 3 -alkyl group and wherein the 5-membered heteroaryl groups containing at least one imino group are bound via a carbon or nitrogen atom, S 25 a hydrogen atom bound to a nitrogen atom in the **0 abovementioned groups may each be replaced by a hydroxy group, an acyl group, an allyloxycarbonyl group, a C 1 16 ***alkoxycarbonyl group, a phenyl-C 1 6 -alkoxycarbonyl group, a C 1 3 -alkylsulfonyl-C 2 -4-alkoxycarbonyl, C 1 3 -alkoxy-C 2 -4-alkoxy- C2-4-alkoxycarbonyl or RcCO-O-RfCR,) -O-CO-group wherein P.OPERU\Jl0233.01 clims doc-14/4M 260A Rc denotes a C 1 i--alkyl, Cs- 7 -cycloalkyl, phenyl or phenyl-Ci- 3 alkyl group, Rf denotes a hydrogen atom, a Cj- 3 -alkyl, C 5 -7-cycloalkyl or phenyl group, and Rg denotes a hydrogen atom, a C1- 3 alkyl, or Re-CO-O-(RfCRh)-O- group, wherein Re and Rf are as hereinbefore defined and Rh is a hydrogen atom or a C1- 3 alkyl group, the carboxy groups contained in the abovementioned groups may each be replaced by a tert.butoxycarbonyl precursor group, some or all of the hydrogen atoms in the abovementioned alkyl and alkoxy groups or in the alkyl moieties contained in the above-defined groups of formula I may be replaced by fluorine atoms and 261 the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof. 3. Indolinones of general formula I according to claim 1, wherein X denotes an oxygen atom, RI denotes a hydrogen atom, R 2 denotes a carboxy group, a straight-chain or branched C, 4 -alkoxycarbonyl group or a phenoxycarbonyl group, a straight-chain or branched C _3-alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, carboxy, C 1 3 -alkoxycarbonyl, aminocarbonyl, C_3-alkylaminocarbonyl or di- (C_3-alkyl)-aminocarbonyl group, a straight-chain or branched C2-3-alkoxy-carbonyl group which is terminally substituted in the alkyl moiety by a hydroxy, C 1 _3-alkoxy, amino, C 1 3 -alkylamino or di-(C 1 3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 1 3 -alkoxy group or, if R 4 does not denote an aminosulphonyl-phenyl or N-(Cis-alkyl)-C_ 3 -alkylaminocarbonyl-phenyl group, it may also denote a di-(C 1 2 -alkyl)-aminocarbonyl group, R 3 denotes a C 1 _4-alkyl group or a phenyl group which may be substituted by a fluorine, chlorine or bromine atom, by a trifluoromethyl, C,_ 3 -alkyl, hydroxy or Ci.3-alkoxy group, R 4 denotes a C 5 s 6 -cycloalkyl group, 262 wherein the methylene group in position 4 of the cyclohexyl group may be substituted by an amino, C_3-alkylanino or di- tC-alky)-amino group or replaced by an -NH or -N(C 1 _3-alkyl) group, a phenyl group, a phenyl group disubstituted by C 1 _3-alkyl, C 1 .3-alkoxy or nitro groups, wherein the substituents may be identical or different, or a phenyl group substituted by the group R 6 which may additionally be substituted by a fluorine, chlorine or bromine atom or by an amino or nitro group, wherein R 6 denotes a fluorine, chlorine or bromine atom, a C, 1 3 -alkyl, Cl-alkoxy, nitro, amino or C,_ 6 -cycloalkyl group, a pyrrolyl, pyrazolyl, imidazolyl, triazolyl or tetrazolyl group bound via a carbon atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be substituted by a C _3-alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 _3-alkyl or phenyl-C 1 _3-alkyl group, the group of formula O 0 NH CH N H a carboxy, C,- 4 alkoxycarbonyl, phenyl-C, 3 -alkylamino-carbonyl or C,,-cycloalkyl-carbonyl group, a 5 or 6-membered cycloalkyleneimino group, wherein 263 the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an -NH or -N(C 1 3 -alkyl) group, an unbranched C 1 3 -alkyl group terminally substituted by the group wherein R 7 denotes a Cs,_-cycloalkyl group, wherein in a 5 or 6-membered cycloalkyl group a -(CH 2 2 group may be replaced by a -CO-NH group, a -(CH 2 3 group may be replaced by an -NH-CO-NH- or a group may be replaced by an -NH-CO-NH-CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C 1 3 -alkyl group, a phenyl or pyridinyl group or a pyrrolyl, pyrazolyl, imidazolyl or triazolyl group bound via a carbon or nitrogen atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be substituted by a C 1 3 -alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C_ 3 -alkyl group, a hydroxy or C1.3-alkoxy group, an amino, C 1 6 -alkylamino, di-(C. 6 -alkyl)-amino, phenylamino, N-phenyl-C 1 3 -alkylamino, phenyl-Ci_,-alkylamino or N-(C_-3-alkyl)-phenyl- C 1 3 -alkylamino group, a o-hydroxy-C 2 3 -alkyl-amino, N-(C 3 -alkyl) -o-hydroxy-C2- 3 -alkylamino, di- (o-hydroxy-C 2 3 -alkyl)-amino or di- 3 -alkoxy)-C 2 3 alkyl)-amino group, 0 264 a C 3 -alkylcarbonylamino-C 2 3 -alkyl-amino or C 3 -alkylcarbonylamino-C 2 3 -alkyl-N- (C 13 -alkyl) -amino group, a C.,--alkylsulphonylamino, N- (C,-,-alkyl) C- 3 -a lkylsulphonylamino, -alkylsulphonylamino- -C 2 3 -alkylamino or C- 3 -al kylsuiphonylamino- -C 23 -alkyl-N- (C 13 -alkyl) -amino group, a hydroxycarbony1-C,-,-alkylamino or N- (Cl. 3 -alkyl) -hydroxycarbonyl-C 1 3 -alkyl-amino group, a guanidino group wherein a hydrogen atom may be replaced by a -alkyl group, a group of formula 2 )n-R 9 (II), wherein R 8 denotes a hydrogen atom or a -alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and R 9 denotes an amino, C 1 3 -alkylamino, di-(CI- 3 -alkyl) -amino or Cl-, lkoxy group, a 5- or 6- membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH, -N(Cl 1 3 -alkyl) or -N(C 1 3 -alkyl-carbonyl) group, or, if n denotes one of the numbers 1, 2 or 3, R 9 may also denote a hydrogen atom, a group of formula -N(R 0 (CH2)m-(CO) 0 -Rjj (II (III) 265 wherein R, 0 denotes a hydrogen atom or a C,..-alkyl group, m denotes one of the numbers 1, 2 or 3, o denotes the number 1 or, if m is one of the numbers 2 or 3, o may also denote the number 0 and RI, denotes an amino, C 1 3 -alkylamino, di-(C 1 3 -alkyl)-amino, C 1 4 -alkoxy or methoxy-C 1 -alkoxy group or a 5- or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an -NH, -N(C 1 _3-alkyl) or -N(C 1 3 -alkyl-carbonyl) group, an azetidino, pyrrolidino, piperidino, 2,6-dimethyl-piperidino, 3,5-dimethyl-piperidino or azepino group, wherein the methylene group in position 3 of the pyrrolidino group may be substituted by a hydroxy group, the methylene group in position 4 of the piperidino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl or C 1 3 -alkoxy group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl), -N(C 1 .3-alkyl- carbonyl), -N(benzoyl) or -N(phenyl-C 1 3 -alkyl-carbonyl) group, wherein a methylene group linked to an imino- nitrogen atom of the pyrrolidino, piperidino or 266 piperazino group may be replaced by a carbonyl group, or RG denotes a straight-chain C 1 _-alkyl group which is terminally substituted by a carboxy or C_ 3 -alkoxy-carbonyl group, a group of formula -N(RI2)-CO-(CH2)p-R13 (IV), wherein R 12 denotes a hydrogen atom, a C,- 3 -alkyl or phenyl- C 1 3 -alkyl group, p denotes one of the numbers 0, 1 or 2 and Ri 3 denotes an amino, C, 4 -alkylamino, di-(C 1 _4-alkyl)-amino, benzylamino, N- (C_.3-alkyl) -benzylamino, C_ 3 -alkoxy-C_ 3 -alkylamino, N- (C_.3-alkyl)- C~ 3-alkoxy-Cl. 3 -alkylamino, di- (2-methoxy-ethyl) -amino, di- (o-hydroxy-C2-3-alkyl) -amino or aminocarbonyl-methyl-N- (methyl)-amino group, a pyrrolyl, pyrazolyl or imidazolyl group bound via a nitrogen atom and optionally substituted by a C,_ 3 -alkyl group, a pyrrolidino, piperidino, morpholino, thiomorpholino or a piperazino group optionally substituted in the 4 position by a C_.3-alkyl, phenyl-C 1 3 -alkyl, C_.3-alkylcarbonyl or C -4-alkoxycarbonyl group or, if n denotes the number 1 or 2, it may also denote a hydrogen atom, 267 a group of formula -N(RI 4 -(CH2)q-(CO)r-R5 wherein R, 4 denotes a hydrogen atom, a C 1 _-alkyl, C. 3 -alkyl- carbonyl, phenylcarbonyl, phenyl-C 1 3 -alkylcarbonyl, furyl- carbonyl, pyridinyl-carbonyl, furyl-C, 3 -alkylcarbonyl, pyridinyl-C 1 3 -alkylcarbonyl, C 1 4 -alkylsulphonyl, phenylsulphonyl or phenyl-CI 3 -alkylsulphonyl group, q denotes one of the numbers 1, 2 or 3, r denotes the number 1 or, if q is one of the numbers 2 or 3, it may also denote the number 0 and Rs denotes an amino, C 1 -4-alkylamino, di-(C 1 4 -alkyl)-amino, phenylamino, N-(C 14 -alkyl)-phenylamino, benzylamino or N-(CI.4-alkyl)-benzylamino group, or a group of formula -N(R 16 )-S0 2 -R 1 7 (VI), wherein R 16 denotes a hydrogen atom or a C_, 3 -alkyl group optionally terminally substituted by a cyano, trifluoromethyl-carbonylamino or 3 -alkyl)-trifluoromethyl-carbonyl-amino group and R 1 denotes a C,13-alkyl group, wherein all the single-bonded or fused phenyl groups contained in the groups mentioned under R, may be substituted by a fluorine, chlorine or bromine atom, by 268 a methyl, trifluoromethyl, methoxy, nitro or cyano group and R 5 denotes a hydrogen atom, wherein a hydrogen atom bound to a nitrogen atom in the abovementioned groups may be replaced by an acetyl or tert.butoxycarbonyl group, the carboxy groups contained in the abovementioned groups may also be present in the form of the tert.butoxycarbonyl precursor group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof. 4. Indolinones of general formula I according to claim 1, wherein X denotes an oxygen atom, Ri and R 5 each denote a hydrogen atom, R 2 denotes a methoxycarbonyl, ethoxycarbonyl or aminocarbonyl group, R 3 denotes a phenyl group and R 4 denotes a phenyl group monosubstituted by the group R,, wherein R 6 denotes an N-methyl-imidazol-2-yl group, an unbranched C 1 3 -alkyl group which is terminally substituted by a C_.4-alkylamino, di-(C 1 4 -alkyl)-amino, piperidino or 2,6-dimethyl-piperidino group, 269 a group of formula -N(R!2)-CO-(CH2)p-Ri3 (IV); wherein R 12 denotes a C_ 3 -alkyl group, p denotes one of the numbers 1 or 2 and R 13 denotes a di-(C 1 3 -alkyl)-amino group, or a group of formula -N(R 1 4 (CH2)q-(CO)r-R15 wherein R, 4 denotes a C 1 3 -alkyl-carbonyl or C-3-alkylsulphonyl group, q denotes one of the numbers 1, 2 or 3, r denotes the number 1 or, if q is one of the numbers 2 or 3, r may also denote the number 0 and R 15 denotes a di-(C 1 alkyl)-amino group, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof. 270 The following substituted indolinones of general formula I according to claim 1: 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- [(1-(4-(piperidin-l-yl-methyl)-anilino)---phenyl- methylene] -6-carbamoyl-2-indolinone, 3-Z- (pipe ridin-1-yl--methyl) -anilino) -1-phenyl- methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- [l-(4-(dimethylaminomethyl)-anilino) -1-phenyl- methylene] ethoxycarbonyl indol inone, 3-Z- [1-(4-((2,6-dimethyl-piperidin-1-yl) -methyl) -anilino)- 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- [1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-ani- lino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- [1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-ani- lino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, 3-Z- (2-dimethylamino-ethyl) -N-methylsulphonyl- amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2- indolinone, 3-Z- [1-(4-(dimethylaminomethyl)-anilino)-1-phenyl- methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- (N-acetyl-N-dimethylaminocarbonylmethyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, 3-Z- [1-(4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6- methoxycarbonyl indol inone, PAOPER~gc~l0233-0l claims dcc.l VAMS -271 3-Z-[1-(4-(l-methyl-imidazol-2-yl)-anilino)--phenyl- methylenel -6-methoxycarbonyl-2-inlolinone, (in) 3-Z- (N-dimethylaminomethylcarbonyl-N-methyl- amino) -anhlino) -1-phenyl-methylene] -6-methoxycarbonyl-2- indolinone, (2-cimethylamino-ethyl)-N-methylsulphonyl- amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2- inclolinone, 3-Z-I1- (3-cimethylamino-propyl) -N- methylsulphonyl-amino) -anilino) -1-phenyl-methylene]-6- methoxycarbonyl-2-indolinone, (q*--l(-N(2dmtylmn-ty)croy) (N-(2dimethylaminoaronyyl-N-eyamn) ()3[-4methyl- amino hy-anilino) 1 -phenyl-e]-- mtee-6-m etoxycarbonyl-2-inciolinone MOPER\JgcIO233- caimd-IA44V -271A- 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)- methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl- methylene]-6-methoxycarbonyl-2-indolinone the tautomers, the mixtures and the salts thereof. 6. 3-Z-[1-(4-(N-((4-methyl-piperazin-l-yl)- methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl- methylene]-6-methoxycarbonyl-2-indolinone a tautomer or a salt thereof. 7. Physiologically acceptable salts of the compounds according to claims 1 to 6. 15 8. Pharmaceutical compositions containing a compound according to any one of claims 1 to 6 or a salt according to o claim 7 optionally together with one or more inert carriers and/or diluents. o. 20 9. Use of a compound according to any one of claims 1 to 6 or a salt according to claim 7 for preparing a pharmaceutical composition which is suitable for treating excessive or anomalous cell proliferation.
10. Process for preparing a pharmaceutical composition according to claim 8, wherein a compound according to at least one of claims 1 to 6 or a salt according to claim 7 is incorporated in one or more inert carriers and/or diluents by a non-chemical method. PAOPERJgcL102331 claims dc-.IA4ffi -272-
11. Process for preparing the compounds according to claims 1 to 7, wherein a. a compound of general formula R3 X (VII), R 2 I R18 wherein X and R 3 are defined as in claims 1 to R 2 has the meanings given for R 2 in claims 1 to 10 R 18 denotes a hydrogen atom or a protecting group for the nitrogen atom of the lactam group, wherein one of the groups R 2 and R 18 may also denote a bond to a solid phase optionally formed via a spacer and the other one of the groups R 2 and R 1 8 273 has the abovementioned meanings, and Z, denotes a halogen atom, a hydroxy, alkoxy or aryl-alkoxy group, is reacted with an amine of general formula H N (VIII), R4 wherein R 4 and R 5 are defined as in claims 1 to and subsequently, if required, any protecting group used for the nitrogen atom of the lactam group is cleaved or a compound thus obtained is cleaved from a solid phase, or b. in order to prepare a compound of general formula I wherein R 2 has the meanings given in claims 1 to 5, with the exception of the carboxy group, a compound of general formula R 3 R4 N O (IX), HOOC N RI wherein RI and R 3 to R 5 are defined as in claims 1 to or a reactive derivative thereof, is reacted with a compound of general formula 0 274 H R 19 WX) wherein R, 9 deniotes a C- 1 6 -alkanGL1O1, a C 4 7 -Ycloalkanol o~r an aromatic alcohol, a C 1-6-alkanol which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C 13 ,-alkoxy-carbonyl, aminocarbonyl, C 13 ,-alkylamino-carbonyl or di- (Cl- 3 -alkyl) -aminocarbonyl group, a C_ 6 -alkanol which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C 1 3 -alkoxy, amino, C 1 3 -alkylamino or di- (C- 3 -alkyl) -amino group, an amino or methylamino group, an ethylamino group optionally substituted in the 2 position of the ethyl group by a hydroxy or C 1 3 -al koxy group or a di- (C 12 -alkyl) -amino group, or C. in order to prepare a compound of general formula I, wherein R 4 denotes a Cl- 4 -alkyl group substituted by the group R 7 wherein R, denotes an amino, C,-,-alkylamino, di- (C 1 7 -alkyl) -amino, phenylamino, N-phenyl-C 1 3 -alkyl -amino, phenyl-C- 3 -alkyl- amino, N- (Cl- 3 -alkyl) -phenyl-C 1 3 ,-alkylamino or di- (phenyl-Cl- 3 -alkyl) -amino group, a wo-hydroxy-C 2 3 -alkyl -amino, N- (Cl- 3 -alkyl) -o-hydroxy-C 2 3 -alkyl -amino, di- ((o-hydroxy-C 2 3 -alkyl) -amino, di- (co- (Cl- 3 -alkoxy) -C 2 3 -alkyl) -amino or N- (dioxolan-2-yl) -C 1 3 -alkyl-amino group, 275 a C, -alkylcarbonylamiio-C 23 -alkyl-amino or C- 3 -al kylcarbonylamino-C 2 alkyl-N- (C,-,-alkyl) -amino group, a C 1 3 alkylsulphonyl ari non N- (Cr_ 3 -alkyl.)- C 1 3 -al kylsuiphonylamino, C- 3 -al kylsulphonylamino-C 2 3 -alkyl -aminlo or C- 3 -al kylsulphonylamino-C 23 -alkyl-N- (C 1 3 -alkyl) -amino group, a group of formula N(R 0 (CH2)m-(CO) 0 -Rjj (II wherein Rio denotes a hydrogen atom, a CI-3-al kyl group, a C 1 3 -alkylcarbonyl, arylcarbonyl, phenyl-Cl- 3 -alkyl- carbonyl, C,- 3 -alkylsulphonyl, arylsuiphonyl or phenyl- Cl- 3 -alkylsulphonyl group, m denote's one of the numbers 1, 2, 3 or 4, o denotes the number 1 and denotes an amino, Cl- 4 -alkylamino, di- (Cl- 4 -alkyl) -amino, phenylarnino, N- (C, 4 -alkyl) -phenylamino, benzylamino, N- (C 1 4 -alkyl) -benzylamino, C 1 4 ,-alkoxy or C- 3 -alkoxy-Cl- 3 -alkoxy group, a di- (Cl 1 4 -alkyl) -amino-Cl- 3 alkylamino group optionally substituted in the 1 position by a C 1 3 -alkyl group, or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl ring or in each case the methylene group in the 4 position of a 6- or 7- membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a suiphinyl, sulphonyl, -NH, 276 -N(C 1 3 -alkyl), -N(phenyl), -N(C 1 3 -alkyl-carbonyl) or -N(benzoyl) group, aC n-cycloalkylamino, C 4 -iycalkyl-C. 3 -alkylamino or 17 4 _jI C 4 ,-cycloalkenylamino group wherein position 1 of the ring is not involved in the double bond and wherein the abovementioned groups may each additionally be substituted at the amino-nitrogen atom by a C,,-cycloalkyl, C, 2 4 -alkenyl or C' 1 4 -alkyl group, or a 4- to 7-membered cycloalkyleneimino group, wherein the cycloalkylene moiety may be fused to a phenyl group or to an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted by a fluorine, chlorine, bromine or iodine atom, by a nitro, Cl- 3 -alkyl, C 1 3 -alkoxy or amino group, and/or one or two hydrogen atoms may each be replaced by a C 1 3 -alkyl, C, 7 -cycloalkyl or phenyl group and/or the methylene group in the 3 position of a cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 1 3 -alkyl, Cl-3-alkoxy or C1- 3 -alkoxy-C, 3 -alkyl group, in each case the methylene group in the 3 or 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a hydroxy, hydroxy-C 3 -alkyl, Cl- 3 -alkoxy, C 1 3 -alkoxy-Cl -alkyl, C 1 4 -alkoxycarbonyl, aminocarbonyl, Cl_3-alkylaminocarbonyl, di-(C, 3 -alkyl)- aminocarbonyl, phenyl-Cl_ 3 -alkylamino or N-(C, 3 -alkyl)- phenyl-Cl- 3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, -NH, -N(C 1 3 -alkyl-), -N(phenyl), 277 -N(phenyl-C 1 3 -alkyl-) -N(C 1 3 -alkyl-carbonyl-), -N(Ci, 4 -alkoxy-carbonyl-), -N(benzoyl-) or -N(phenyl-C, 3 -alkyl-carbonyl-) group, wherein a methylene group linked to an imino- nitrogen atom of the cycloalkyleneimino group may be replaced by a carbonyl or sulphonyl group or in a to 7-membered monocyclic cycloalkyleneimino group or a cycloalkyleneimino group fused to a phenyl group the two methylene groups linked to the imino- nitrogen atom may each be replaced by a carbonyl group, a compound of general formula R 3 R I A-Z2 N x (XI), N R2' I R 1 8 wherein R 3 R s and X are defined as in claims 1 to R 2 has the meanings given for R 2 in claims 1 to Ri 8 denotes a hydrogen atom or a protecting group for the nitrogen atom of the lactam group, wherein one of the groups R 2 and Ri 8 may also denote a bond to a solid phase optionally formed via a spacer and the other one of the groups R 2 and R, 1 has the abovementioned meanings, A denotes a C 1 -alkyl group and Z 2 denotes a leaving group, 278 is reacted with an amine of general formula (XII), wherein R 7 has the meanings given for R 7 hereinbefore, and subsequently, if necessary, any protecting group used for the nitrogen atom of the lactam group is cleaved, or a compound thus obtained is cleaved from a solid phase, and subsequently, if desired, a compound of general formula I thus obtained which contains an alkoxycarbonyl group is converted by hydrolysis into a corresponding carboxy compound, or a compound of general formula I thus obtained which contains an amino or alkylamino group is converted by reductive alkylation into a corresponding alkylamino or dialkylamino compound, or a compound of general formula I thus obtained which contains an amino or alkylamino group is converted by acylation or sulphonation into a corresponding acyl or sulphonyl compound or a compound of general formula I thus obtained which contains a carboxy group is converted by esterification or amidation into a corresponding ester or aminocarbonyl compound or a compound of general formula I thus obtained which contains a cycloalkyleneimino group wherein a methylene group is replaced by a sulphur atom is converted by oxidation into a corresponding sulphinyl or sulphonyl compound, or 279 a compound of general formula I thus obtained which contains a nitro group is converted by reduction into a corresponding amino compound, or a compound of general formula I thus obtained wherein R 4 denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group is converted, by reaction with a corresponding cyanate, isocyanate or carbamoyl halide, into a corresponding urea compound of general formula I or a compound of general formula I thus obtained wherein R, denotes a phenyl group substituted by an amino, alkylamino, aminoalkyl or N-alkyl-amino group is converted, by reaction with a corresponding compound which transfers the amidino group or by reaction with a corresponding nitrile, into a corresponding guanidino compound of general formula I, or if necessary any protecting group used during the reactions to protect reactive groups is cleaved or subsequently, if desired, a compound of general formula I thus obtained is resolved into the stereoisomers thereof or a compound of general formula I thus obtained is converted into the salts thereof, particularly, for pharmaceutical use, into the physiologically acceptable salts thereof with an inorganic or organic acid or base. PAOPER~geOZ233-I d.amsdocm-4i)4MV5 -280-
12. Use of a compound according to any one of claims 1 to 6 or a salt according to claim 7 for treating excessive or an anomalous cell proliferation.
13. Method of treating excessive or an anomalous cell proliferation in a patient by administering a compound according to any one of claims 1 to 6 or a salt according to claim 7 to a patient in need of treatment.
14. Indolinones of general formula I according to claim 1 substantially as hereinbefore described with reference to the Examples. 15 DATED this 15 th day of April, 2005 Boehringer Ingelheim Pharma GmbH Co. KG by DAVIES COLLISON CAVE S: 2 *o
AU10233/01A 1999-10-13 2000-10-09 6-position substituted indoline, production and use thereof as a medicament Active 2025-10-09 AU781939B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19949208A DE19949208A1 (en) 1999-10-13 1999-10-13 New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
DE19949208 1999-10-13
DE2000142696 DE10042696A1 (en) 2000-08-31 2000-08-31 New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
DE10042696 2000-08-31
PCT/EP2000/009867 WO2001027081A1 (en) 1999-10-13 2000-10-09 6-position substituted indoline, production and use thereof as a medicament

Publications (2)

Publication Number Publication Date
AU1023301A AU1023301A (en) 2001-04-23
AU781939B2 true AU781939B2 (en) 2005-06-23

Family

ID=26006858

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10233/01A Active 2025-10-09 AU781939B2 (en) 1999-10-13 2000-10-09 6-position substituted indoline, production and use thereof as a medicament

Country Status (42)

Country Link
EP (2) EP1224170B9 (en)
JP (2) JP4021664B2 (en)
KR (2) KR100857734B1 (en)
CN (1) CN100455568C (en)
AR (1) AR026036A1 (en)
AT (1) ATE439342T1 (en)
AU (1) AU781939B2 (en)
BE (1) BE2015C018I2 (en)
BG (1) BG65983B1 (en)
BR (1) BRPI0014735B8 (en)
CA (1) CA2387013C (en)
CO (1) CO5261488A1 (en)
CY (2) CY1110067T1 (en)
CZ (1) CZ301073B6 (en)
DE (1) DE50015711D1 (en)
DK (1) DK1224170T5 (en)
EA (1) EA006080B1 (en)
EE (1) EE05427B1 (en)
EG (1) EG25931A (en)
ES (1) ES2331459T3 (en)
FR (1) FR15C0024I2 (en)
HK (1) HK1052505B (en)
HR (1) HRP20020306B1 (en)
HU (2) HU230416B1 (en)
IL (2) IL148756A0 (en)
LU (1) LU92681I2 (en)
ME (1) MEP45408A (en)
MX (1) MXPA02002799A (en)
MY (1) MY127956A (en)
NL (1) NL300725I2 (en)
NO (3) NO322746B1 (en)
NZ (1) NZ518489A (en)
PE (1) PE20010671A1 (en)
PL (1) PL207445B1 (en)
PT (1) PT1224170E (en)
RS (1) RS51013B (en)
SA (1) SA01210704B1 (en)
SI (1) SI1224170T1 (en)
SK (1) SK287312B6 (en)
TW (1) TWI268922B (en)
UA (1) UA75054C2 (en)
WO (1) WO2001027081A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642851B2 (en) 2012-12-06 2017-05-09 Kbp Biosciences Co., Ltd. Indolinone derivative as tyrosine kinase inhibitor

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19816624A1 (en) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Novel substituted indolinones, their preparation and their use as pharmaceuticals
KR100589032B1 (en) 2000-10-20 2006-06-14 에자이 가부시키가이샤 Nitrogenous aromatic ring compounds
US6638965B2 (en) 2000-11-01 2003-10-28 Boehringer Ingelheim Pharma Kg Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
DE10117204A1 (en) 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma Indolinones substituted in the 6-position, their preparation and their use as medicaments
US20030091974A1 (en) * 2001-06-29 2003-05-15 Alain Moussy Method for screening compounds capable of depleting mast cells
JP2004537537A (en) 2001-06-29 2004-12-16 アブ サイエンス Uses of tyrosine kinase inhibitors to treat inflammatory diseases
WO2003002106A2 (en) 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitions for treating allergic diseases
ATE343415T1 (en) 2001-06-29 2006-11-15 Ab Science THE USE OF C-KIT INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
DE60227709D1 (en) * 2001-06-29 2008-08-28 Ab Science THE USE OF C-CRITERIA FOR THE TREATMENT OF AUTOIMMUNE DISEASES
US7727731B2 (en) 2001-06-29 2010-06-01 Ab Science Potent, selective and non toxic c-kit inhibitors
CA2461812C (en) * 2001-09-27 2011-09-20 Allergan, Inc. 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
EP1458713B1 (en) 2001-12-27 2005-08-24 Theravance, Inc. Indolinone derivatives useful as protein kinase inhibitors
SE0302546D0 (en) 2003-09-24 2003-09-24 Astrazeneca Ab New compounds
ITBO20020198A1 (en) * 2002-04-12 2003-10-13 Univ Bologna DERIVATIVES 2, 5 BIS DIAMMINO 1, 4 BENZOCHENIONIC USEFUL FOR THE TREATMENT OF ALZHEIMER DISEASE, METHOD FOR THEIR PREPARATION AND
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
US7514468B2 (en) 2002-07-23 2009-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
DE10233500A1 (en) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z- [1- (4- (N - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone monoethanesulfonate and its use as a medicament
US20040204458A1 (en) 2002-08-16 2004-10-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of Lck inhibitors for treatment of immunologic diseases
DE10237423A1 (en) 2002-08-16 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treating immunological (or related) diseases, e.g. inflammatory bowel disease, rheumatoid arthritis or psoriasis, comprises administration of 3-methylene-2-indolinone derivative or quinazoline compound
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (en) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド Kinase inhibitors for the treatment of diseases
US20050043233A1 (en) * 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
WO2005044788A1 (en) 2003-11-11 2005-05-19 Eisai Co., Ltd. Urea derivative and process for producing the same
SE0401790D0 (en) * 2004-07-07 2004-07-07 Forskarpatent I Syd Ab Tamoxifen response in pre- and postmenopausal breast cancer patients
US20060058311A1 (en) * 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
EP2364699A1 (en) 2004-09-13 2011-09-14 Eisai R&D Management Co., Ltd. Joint use of sulfonamide based compound with angiogenesis inhibitor
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
AU2005283422C1 (en) 2004-09-17 2017-02-02 Eisai R & D Management Co., Ltd. Medicinal composition
PE20060777A1 (en) * 2004-12-24 2006-10-06 Boehringer Ingelheim Int INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
EP2281901B1 (en) 2005-08-02 2013-11-27 Eisai R&D Management Co., Ltd. Anti-tumour pharmaceutical composition with angiogenesis inhibitors
WO2007057397A1 (en) * 2005-11-15 2007-05-24 Boehringer Ingelheim International Gmbh Treatment of cancer
CN104706637A (en) 2006-05-18 2015-06-17 卫材R&D管理有限公司 Antitumor agent for thyroid cancer
EP1870400A1 (en) * 2006-06-08 2007-12-26 Boehringer Ingelheim Pharma GmbH & Co. KG Salts and crystalline salt forms of an 2-indolinone derivative
KR101472600B1 (en) 2006-08-28 2014-12-15 에자이 알앤드디 매니지먼트 가부시키가이샤 Antitumor agent for undifferentiated gastric cancer
JP5319306B2 (en) 2007-01-29 2013-10-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 Composition for treatment of undifferentiated gastric cancer
WO2008152013A1 (en) * 2007-06-12 2008-12-18 Boehringer Ingelheim International Gmbh Indolinone derivatives and their use in treating disease-states such as cancer
ES2435454T3 (en) 2007-06-21 2013-12-19 Janssen Pharmaceutica, N.V. Indolin-2-one and aza-indolin-2-one
KR101513326B1 (en) 2007-11-09 2015-04-17 에자이 알앤드디 매니지먼트 가부시키가이샤 Combination of anti-angiogenic substance and anti-tumor platinum complex
PE20091445A1 (en) * 2007-12-03 2009-10-19 Boehringer Ingelheim Int INDOLINONE DERIVATIVES AND PROCEDURE FOR ITS MANUFACTURE
CN101883756A (en) 2007-12-03 2010-11-10 贝林格尔.英格海姆国际有限公司 Process for preparing indolinone derivatives
ES2662824T3 (en) 2008-06-06 2018-04-09 Boehringer Ingelheim International Gmbh Pharmaceutical combination
EP2471787A1 (en) 2008-07-29 2012-07-04 Boehringer Ingelheim International GmbH New compounds
JP2012515184A (en) 2009-01-14 2012-07-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング How to treat colorectal cancer
US8802384B2 (en) 2009-03-12 2014-08-12 Boehringer Ingelheim International Gmbh Method or system using biomarkers for the monitoring of a treatment
WO2010108503A1 (en) 2009-03-24 2010-09-30 Life & Brain Gmbh Promotion of neuronal integration in neural stem cell grafts
EP2429520A1 (en) 2009-05-14 2012-03-21 Boehringer Ingelheim International GmbH New combination therapy in treatment of oncological and fibrotic diseases
US20120107304A1 (en) 2010-04-27 2012-05-03 Boehringer Ingelheim International Gmbh Combination therapy in treatment of oncological and fibrotic diseases
JP5898074B2 (en) 2010-06-25 2016-04-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 Antitumor agent by combined use of compounds having kinase inhibitory action
WO2012068441A2 (en) 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
KR101762999B1 (en) 2011-04-18 2017-07-28 에자이 알앤드디 매니지먼트 가부시키가이샤 Therapeutic agent for tumor
EP3444363B1 (en) 2011-06-03 2020-11-25 Eisai R&D Management Co., Ltd. Biomarkers for prediciting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
WO2013059740A1 (en) 2011-10-21 2013-04-25 Foundation Medicine, Inc. Novel alk and ntrk1 fusion molecules and uses thereof
EP3604307A1 (en) 2012-01-26 2020-02-05 Angion Biomedica Corp. Anti-fibrotic compounds and uses thereof
CA2890346A1 (en) 2012-11-05 2014-05-08 Foundation Medicine, Inc. Novel fusion molecules and uses thereof
EP2914621B1 (en) 2012-11-05 2023-06-07 Foundation Medicine, Inc. Novel ntrk1 fusion molecules and uses thereof
MX2015004979A (en) 2012-12-21 2015-07-17 Eisai R&D Man Co Ltd Amorphous form of quinoline derivative, and method for producing same.
WO2014113729A2 (en) 2013-01-18 2014-07-24 Foundation Mecicine, Inc. Methods of treating cholangiocarcinoma
US20140350022A1 (en) 2013-05-10 2014-11-27 Boehringer Ingelheim International Gmbh Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
SG11201509278XA (en) 2013-05-14 2015-12-30 Eisai R&D Man Co Ltd Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
CN104003925B (en) * 2013-06-05 2016-03-30 四川大学 Indolinone compound or its derivative and use thereof
WO2015009889A1 (en) * 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
WO2015017728A1 (en) 2013-07-31 2015-02-05 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
RS63559B1 (en) 2014-08-28 2022-10-31 Eisai R&D Man Co Ltd High-purity quinoline derivative and method for manufacturing same
CN104262232B (en) * 2014-09-09 2016-05-04 苏州明锐医药科技有限公司 The preparation method of Ni Taidani
SG11201706630UA (en) 2015-02-25 2017-09-28 Eisai R&D Man Co Ltd Method for suppressing bitterness of quinoline derivative
AU2015384801B2 (en) 2015-03-04 2022-01-06 Eisai R&D Management Co., Ltd. Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
WO2016178064A1 (en) 2015-05-06 2016-11-10 Suven Life Sciences Limited Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof
CN104844499B (en) * 2015-06-05 2017-03-08 北京康立生医药技术开发有限公司 One kettle way prepares the synthetic method of Nintedanib
EP4335418A3 (en) 2015-06-06 2024-05-22 Cloudbreak Therapeutics, LLC Compositions and methods for treating pterygium
CA2988707C (en) 2015-06-16 2023-10-10 Eisai R&D Management Co., Ltd. Combination of cbp/catenin inhibitor and immune checkpoint inhibitor for treating cancer
CN105126909B (en) * 2015-07-13 2018-01-23 淮海工学院 Application of the immobilized palladium catalyst in the synthesis of the nitrobenzene methyl of 4 phenylacetylene base 3
CZ308695B6 (en) 2015-07-29 2021-03-03 Zentiva, K.S. Process for preparing methyl (Z) -3 - [[4- [methyl [2- (4-methyl-1-piperazinyl) acetyl] amino] phenyl] amino] phenylmethylene) -oxindole-6-carboxylate (intedanib, nintedanib)
CN106467500A (en) * 2015-08-14 2017-03-01 廊坊百瑞化工有限公司 A kind of one pot synthesis synthesize the new method of Nintedanib key intermediate
RU2718048C2 (en) 2015-08-20 2020-03-30 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Antitumour therapeutic agent
CN109302846B (en) 2015-12-24 2021-05-11 莱斯彼维特有限公司 Indolinone compounds and their use in the treatment of fibrotic diseases
CZ2016104A3 (en) 2016-02-24 2017-09-06 Zentiva, K.S. Crystalline modifications of methyl (3Z)-3- {[(4-{methyl[(4-methylpiperazin-1yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2oxo-2,3-dihydro-1H-indole-6-carboxylate and the methods of their preparation
AU2017231860C1 (en) 2016-03-08 2022-01-20 Respivert Limited Indole derivatives and their use as protein kinase inhibitors
WO2017178428A1 (en) 2016-04-13 2017-10-19 Boehringer Ingelheim International Gmbh Pharmaceutical combination of nintedanib, trifluridine and tipiracil for treating colorectal cancer
EP3246029A1 (en) 2016-05-19 2017-11-22 Boehringer Ingelheim International Gmbh Pharmaceutical combination of nintedanib and capecitabine for the treatment of colorectal cancer
US20190275032A1 (en) 2016-05-27 2019-09-12 Boehringer Ingelheim International Gmbh Use of ecm biomarkers for determining the treatment onset with nintedanib and pirfenidone
WO2017207643A1 (en) 2016-06-01 2017-12-07 Boehringer Ingelheim International Gmbh Use of ecm biomarkers for the determining the treatment onset with nintedanib and pirfenidone
AU2017274195B2 (en) 2016-06-02 2022-04-07 Ads Therapeutics Llc Compositions and methods of using nintedanib for improving glaucoma surgery success
CN109789127B (en) 2016-07-29 2022-03-25 英克特诺治疗公司 Use of indolinone compounds
CN106748961A (en) * 2016-11-30 2017-05-31 瑞阳制药有限公司 The impurity compound of Nintedanib, preparation method, using and its detection method
CN106748960A (en) * 2016-11-30 2017-05-31 瑞阳制药有限公司 The potential impurity compound of Nintedanib, preparation method, using and its detection method
WO2018108669A1 (en) 2016-12-12 2018-06-21 Boehringer Ingelheim International Gmbh Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol
EP3600322A1 (en) 2017-03-28 2020-02-05 Boehringer Ingelheim International GmbH Nintedanib for use in methods for the treatment of muscular dystrophy
MA50441A (en) 2017-10-23 2020-09-02 Boehringer Ingelheim Int NEW ASSOCIATION OF ACTIVE AGENTS FOR THE TREATMENT OF PROGRESSIVE INTERSTITIAL FIBROSAN PNEUMOPATHIES (PF-ILD)
US11261158B2 (en) 2017-11-17 2022-03-01 Fermion Oy Synthesis of 2-indolinone derivatives
JP7061310B2 (en) * 2018-04-05 2022-04-28 国立大学法人 大分大学 Pharmaceuticals for the prevention and treatment of chronic fatty diseases
CN108358827A (en) * 2018-05-07 2018-08-03 日照市普达医药科技有限公司 It is a kind of to treat psoriasic 2- oxo-indoles analog derivative and preparation method thereof
US12156873B2 (en) 2018-05-25 2024-12-03 Ads Therapeutics Llc Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the same
MX2021003945A (en) * 2018-10-05 2021-05-27 Ichnos Sciences S A Indolinone compounds for use as map4k1 inhibitors.
CN115361950A (en) 2020-04-01 2022-11-18 勃林格殷格翰国际有限公司 Use of biomarkers in the treatment of fibrotic disorders
CN111848490B (en) * 2020-08-24 2021-09-24 江西国药有限责任公司 Preparation method of high-purity ethanesulfonic acid nintedanib
CN112574094B (en) * 2020-12-14 2022-07-01 成都大学 Indolinone derivatives and their pharmaceutical uses
WO2022158956A1 (en) 2021-01-25 2022-07-28 주식회사 나이벡 Peptide for preventing and treating fibrosis
EP4098246A1 (en) 2021-05-31 2022-12-07 Lotus Pharmaceutical Co., Ltd. Formulation of nintedanib
CN115703758B (en) * 2021-08-12 2024-03-26 中国医学科学院药物研究所 A class of compounds used as kinase inhibitors and preparation methods and uses thereof
WO2024037982A1 (en) 2022-08-16 2024-02-22 Boehringer Ingelheim International Gmbh Pharmaceutical formulations of nintedanib for intraocular use
TWI857798B (en) * 2023-09-28 2024-10-01 國立臺灣大學 Indoline derivatives for treatment and/or prevention of tumor or cell proliferative and fibrosis diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015500A1 (en) * 1997-09-05 1999-04-01 Glaxo Group Limited Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL96047C (en) * 1956-06-08
WO1995030420A1 (en) * 1994-05-06 1995-11-16 Alcon Laboratories, Inc. Use of vitamin e tocopheryl derivatives in ophthalmic compositions
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
ATE243034T1 (en) * 1996-01-17 2003-07-15 Taiho Pharmaceutical Co Ltd INTIMAL THICKENING INHIBITORS
DE19815020A1 (en) * 1998-04-03 1999-10-07 Boehringer Ingelheim Pharma New substituted indolinones, their production and their use as medicines
DE19816624A1 (en) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Novel substituted indolinones, their preparation and their use as pharmaceuticals
DE19824922A1 (en) * 1998-06-04 1999-12-09 Boehringer Ingelheim Pharma Novel substituted indolinones, their preparation and their use as pharmaceuticals
GB9904933D0 (en) * 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015500A1 (en) * 1997-09-05 1999-04-01 Glaxo Group Limited Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642851B2 (en) 2012-12-06 2017-05-09 Kbp Biosciences Co., Ltd. Indolinone derivative as tyrosine kinase inhibitor

Also Published As

Publication number Publication date
BRPI0014735B1 (en) 2012-07-10
UA75054C2 (en) 2006-03-15
NO2015009I2 (en) 2015-03-18
NO20021719D0 (en) 2002-04-11
HUS1600022I1 (en) 2017-02-28
HK1052505B (en) 2009-06-26
ES2331459T3 (en) 2010-01-05
NO20021719L (en) 2002-04-11
HRP20020306A2 (en) 2003-10-31
KR20020038949A (en) 2002-05-24
AU1023301A (en) 2001-04-23
EP2157081A1 (en) 2010-02-24
CZ301073B6 (en) 2009-10-29
EE05427B1 (en) 2011-06-15
FR15C0024I2 (en) 2016-08-26
PT1224170E (en) 2009-10-01
MEP45408A (en) 2011-02-10
EP1224170A1 (en) 2002-07-24
HK1052505A1 (en) 2003-09-19
DK1224170T3 (en) 2009-12-07
NL300725I2 (en) 2017-07-13
WO2001027081A1 (en) 2001-04-19
BG106587A (en) 2003-01-31
KR100857734B1 (en) 2008-09-10
JP2007302697A (en) 2007-11-22
DK1224170T5 (en) 2018-01-22
HUP0204587A2 (en) 2003-05-28
CN100455568C (en) 2009-01-28
KR20070095996A (en) 2007-10-01
EA200200380A1 (en) 2002-10-31
CY1110067T1 (en) 2015-01-14
NZ518489A (en) 2005-05-27
HU230416B1 (en) 2016-05-30
CY2015009PI1 (en) 2016-12-14
JP2003511441A (en) 2003-03-25
PE20010671A1 (en) 2001-06-28
SK6462002A3 (en) 2002-08-06
LU92681I9 (en) 2019-01-03
AR026036A1 (en) 2002-12-26
HUP0204587A3 (en) 2004-07-28
KR100835546B1 (en) 2008-06-09
IL148756A0 (en) 2002-09-12
EP1224170B1 (en) 2009-08-12
EE200200197A (en) 2003-06-16
JP4021664B2 (en) 2007-12-12
SK287312B6 (en) 2010-06-07
CN1391557A (en) 2003-01-15
EP1224170B9 (en) 2017-11-22
PL355433A1 (en) 2004-04-19
CZ20021410A3 (en) 2002-07-17
HRP20020306B1 (en) 2010-09-30
EG25931A (en) 2012-10-24
LU92681I2 (en) 2015-05-18
PL207445B1 (en) 2010-12-31
BG65983B1 (en) 2010-08-31
MXPA02002799A (en) 2003-02-27
EA006080B1 (en) 2005-08-25
YU26602A (en) 2004-11-25
BE2015C018I2 (en) 2019-10-23
ATE439342T1 (en) 2009-08-15
CO5261488A1 (en) 2003-03-31
RS51013B (en) 2010-10-31
NO322746B1 (en) 2006-12-04
CA2387013A1 (en) 2001-04-19
NO2023033I1 (en) 2023-09-05
SA01210704B1 (en) 2006-12-05
IL148756A (en) 2007-10-31
CA2387013C (en) 2009-12-29
MY127956A (en) 2007-01-31
DE50015711D1 (en) 2009-09-24
BRPI0014735B8 (en) 2021-07-06
FR15C0024I1 (en) 2015-04-17
CY2015009PI2 (en) 2016-12-14
TWI268922B (en) 2006-12-21
NO2015009I1 (en) 2015-03-30
SI1224170T1 (en) 2009-12-31
BRPI0014735A (en) 2002-07-16

Similar Documents

Publication Publication Date Title
AU781939B2 (en) 6-position substituted indoline, production and use thereof as a medicament
US6762180B1 (en) Substituted indolines which inhibit receptor tyrosine kinases
US6794395B1 (en) Substituted indolinones, their manufacture and their use as medicaments
US7148249B2 (en) Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
AU6086399A (en) Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
US20030092756A1 (en) Substituted indolinones
MXPA04012937A (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments.
JP2005537276A (en) 6-substituted indolinone derivatives, their preparation and use as pharmaceutical compositions
US7514468B2 (en) Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
DE10042696A1 (en) New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
DE19949208A1 (en) New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: BOEHRINGER INGELHEIM PHARMA GMBH AND CO. KG

Free format text: FORMER NAME: BOEHRINGER INGELHEIM PHARMA KG